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Abbreviations 
 
i) Abbreviations 
4NPP   4-nitrophenyl phosphate 
ANTS   8-aminonaphthalene-1,3,6-trisulfonic acid 
APPK   Alkaline phosphatase (from porcine kidney) 
ATP   Adenosine triphosphate 
CAM   Cell adhesion molecule 
CHO   Chinese hamster ovaries 
CPP   Cell-penetrating peptide 
ddH2O   Double distilled water 
DIC   Differential interference contrast 
DLS   Dynamic light scattering 
DMEM   Dulbecco’s modified Eagle’s medium 
DMSO   Dimethyl sulfoxide 
DOPE-PEG  1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N- 
    (methoxy(polyethylene glycol)-2000) 
DPX   p-xylene-bis-pyridinium bromide (DPX) 
EPR   Electron paramagnetic resonance 
FCS   Fetal calf serum 
GUV   Giant unilamellar vesicle 
HIV   Human immunodeficiency virus 
HPLC   High-performance liquid chromatography 
ITC   Isothermal titration calorimetry 
LUV   Large unilamellar vesicle 
NMR   Nuclear magnetic resonance 
OD   Optical density 
PBS   Phosphate buffered saline 
PDI   Polydispersity index 
PEG   Poly(ethylene glycol) 
PEI   Polyethyleneimine 
pen-2AL   Penetratin mutant A9A10L13 
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 pen-Antp   Penetratin peptide (RQIKIWFQNRRMKWKK) 
pen-AYL   Penetratin mutant A9Y10L13 
pen-A(pY)L  Penetratin mutant A9(pY)10L13 
PMT   Photomultiplier tube 
POPC   1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
POPG   1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-glycerol 
PTD   Protein transduction domain 
RNA   Ribonucleic acid 
SLS   Static light scattering 
SUV   Small unilamellar vesicle 
TAMRA   Tetramethylrhodamine 
TAT   Trans-activator of transcription 
TBS   Tris buffered saline 
TEMPO   (2,2,6,6-tetramethylpiperidin-1-yl)oxyl 
TFA   Trifluoroacetic acid 
Tris   Tris(hydroxymethyl)aminoethane 
Trp   L-Tryptophan 
TX100   Triton X-100 
Tyr   L-Tyrosine 
UV-vis   Ultraviolet-visible (light) 
WR9   Nona-arginine (WRRRRRRRRR) 
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Summary 
 
ii) Summary 
The fruitful research in molecular biology over the course of the last 50 years has 
revolutionized our comprehension of the processes that happen inside a cell. 
Understanding of intracellular regulatory pathways and the protein synthesis by 
translation of gene transcripts allow the development of powerful methods to fight a 
broad spectrum of human health issues that are traditionally very hard to treat. An 
important requisite, however, is access of the agent to the cell interior. In this respect, 
the plasma membrane of eukaryotic cells poses an efficient barrier for many potential 
agents and methods that allow an agent’s transit across it are therefore in high demand. 
Promising vectors in this regard are cell-penetrating peptides (CPPs): short 
polycationic peptides that were shown to be capable of transporting compounds of 
interest inside eukaryotic cells. To date, the mechanism of their translocation is still 
under much debate. Also, their application as drug vector is potentially delicate because 
some CPPs showed a concentration dependent toxicity for cells. 
Penetratin (pen-Antp) is among the best studied CPPs. Interestingly, it does not 
show translocation across model membranes such as unilamellar vesicles (LUVs). A 
more hydrophobic pen-Antp mutant called pen-2AL, however, does show permeation of 
model membranes. We were interested in the potential modification of pen-2AL with a 
phosphorylated tyrosine (named pen-A(pY)L) in order to create a CPP which is only 
active after dephosphorylation e.g. by a protein phosphatase. In doing so, we aimed for 
an inducible CPP that would only be activated by cellular phosphatases. 
 
In the following chapters we discuss various aspects of the design of the pen-
A(pY)L peptide and the investigation of its effect on both model and biological 
membranes. In Chapter 1 we present the methodical basis for the investigation of the 
interaction of CPPs with model membrane systems. Both the creation of lipid model 
membranes and their thermodynamical characterization in presence of CPPs are 
described and supplemented with minute protocols for every method. Exemplary data 
show that pen-2AL destabilizes model membranes in a detergent-like manner whereas 
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pen-Antp does not. Furthermore, we show that the use of multivalent fluorescent dyes 
can introduce a critical measurement bias upon interaction with CPPs. 
In chapter 2 we discuss the design of the pen-A(pY)L peptide and show its effect 
on LUVs and CHO cells by means of a permeation (leakage) assay and confocal 
microscopy, respectively. Our leakage data suggest that the phosphorylated pen-A(pY)L 
does not permeate LUVs at low micromolar concentrations whereas the 
unphosphorylated pen-AYL shows strong permeation at these conditions. We could also 
successfully activate pen-A(pY)L by dephosphorylation as demonstrated by inducible 
dye leakage from LUVs after addition of a phosphatase. Lastly, CHO cells show uptake 
of TAMRA-labeled pen-A(pY)L after incubation with 20 µM of the CPP. The peptide 
seems also to successfully reach the cytosol without damaging the cells. 
We then investigated the effect of the used medium during incubation of CHO cells 
with either peptide as discussed in chapter 3. Using plain phosphate buffered saline 
(PBS) as incubation medium led to strong detachment of the cells during incubation 
with low peptide concentration. In contrast, this could not be observed after incubation 
with either peptide dissolved in DMEM/F12. Furthermore, the images made with 
differential interference contrast suggest that incubation of CHO cells with 20 µM 
TAMRA-pen-AYL is toxic for the cells. 
In chapter 4 we describe the observed propensity of pen-A(pY)L for gel formation 
at low millimolar concentration. The peptide gets compared with its unphosphorylated 
counterpart in order to assess their tendency to aggregate under various conditions in 
order to identify the potential molecular interactions that promote gel formation. We 
thereby find that it is probably hydrophobic attraction between the peptide that leads to 
the clustering of pen-A(pY)L which may have been introduced by the tyrosine’s phenol 
group. However, the bulk of peptide seems to remain dissolved at low micromolar 
concentrations i.e. at the relevant concentration for a potential application of the CPP. 
Lastly, as a consequence of the earlier observed bias due to the interaction of 
multivalent fluorescent dyes with certain CPPs we propose in chapter 5 an alternative 
molecular probe for the detection of membrane permeation by CPPs. Instead of the 
dequenching of fluorescent dye we exploit the concentration dependence of the electron 
paramagnetic resonance (EPR) signal of spin labels to detect their leakage out of LUVs. 
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Summary 
 
We can show that the EPR signal is, in contrary to fluorescent dyes, independent of the 
presence of CPPs. However, we also experienced difficulties in enclosing sufficient spin 
label concentrations into LUVs. Nevertheless, we value electron-spin labels as 
promising option for such an assay. 
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1.1. General introduction to cell-penetrating peptides 
 
Chapter 1: 
 
Thermodynamics of Lipid Interactions 
with Cell-Penetrating Peptides1 
 
 
1.1. General introduction to cell-penetrating peptides 
The transition from classical screening in drug design to rational drug design including 
drug delivery 
Drug design underwent a rational evolution during the last decades because of 
combined advances in the disciplines molecular genetics, combinatorial chemistry and 
high throughput screening. Originally, many drugs were designed to target enzymes and 
cell-surface receptors. Most of these drugs were water soluble compounds with a 
molecular mass low enough to still enable passage over biological membranes 
(Lipinski’s “rule of 5”) (2). However, proteomics has identified many more interesting 
signaling proteins involved in intracellular regulatory pathways. Further intracellular 
drug targets were identified because the structures responsible for protein biosynthesis 
i.e. the very target of gene therapy or RNA silencing are located in the cell interior as 
well. The challenge in exploiting these targets for modern medicine thus lies in the 
                                                 
1 Sections 1.2. to 1.7. of this chapter consist of the publication “Thermodynamics of lipid interactions 
with cell-penetrating peptides” (1. Sauder R, Seelig J, Ziegler A. 2011. Methods in molecular biology 
683: 129-55). 
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combined efforts to design the ligands and develop reagents that provide their effective 
delivery inside cells of specific tissues or organs. 
 
Cell membranes as obstacle for intracellular drug delivery 
The main barrier in this regard is the ~60 to 70 Å thick cell membrane (only 
accounting for the lipid part including hydrated headgroups; the thickness increases 
when glycosylated membrane proteins are included) which delineates not only distinct 
intracellular compartments (“organelles”), but also the whole biological cell from the 
outside. The cell membrane (described in more detail in (3, 4)) consists of two parts: a 
double layer of phospholipid2 molecules (the so-called lipid bilayer) and the therein 
embedded proteins which maintain both signaling and transport of cellular nutrients, 
electrolytes, water or metabolic waste products across the membrane. The 
phospholipids of the membrane predominantly provide its barrier function by means of 
the hydrophobic nature of the fatty acid part of the various lipids. This hydrophobic core 
of the lipid bilayer drastically reduces its permeability of most common solutes of the 
cytosol, the extracellular fluid or the blood plasma (e.g. electrolytes, ATP, glucose or 
proteins) due to the high energy needed for such molecules to passively diffuse across 
(5). As a consequence, the drug design must not only respect specific binding to the 
target, but also shape, size, solubility and permeability to actually reach the target that 
might be located intracellularly (2). This is especially true for gene therapy methods 
using nucleic acids that are highly negatively charged because of their phosphate 
backbone. The delivery of such compounds into biological cells therefore poses a 
challenge. At best, the drug delivery is specific to a proper tissue (drug targeting) thus 
causing least side-effects to other tissue of the organism. 
 
Vectors to transport compounds across cell membranes 
There are established methods for intracellular drug delivery in simple biological 
systems: for example, cell culture of eukaryotic cells is an excellent model system to 
study the delivery of desired compounds across a biological membrane. Techniques 
                                                 
2 Technically, the lipid bilayer does not exclusively consist of phospholipids (e.g. ceramides) but they 
form the bulk of it. 
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such as electroporation (6), viral vectors (7, 8), nanoparticles (9), or liposomes (10) 
have all been shown to successfully deliver a broad range of compounds into cells in 
culture and could, in some cases, even be applied to treat human diseases (e.g. viral 
vectors for severe combined immunodeficiency (11)). However, most of those methods 
have a limited efficacy or transport capacity for drugs; also toxic side effects might 
restrict their use in humans. The interest in alternative approaches for intracellular drug 
delivery is thus ongoing. 
 
CPPs - Alternative vectors 
Promising candidates for intracellular drug delivery are so-called cell-penetrating 
peptides (CPPs, also termed Trojan peptides or protein transduction domains (PTD); 
reviewed in (12, 13)). CPPs are a group of short cationic peptides that have the capacity 
to permeate biological membranes at low micromolar concentration; they can be 
conjugated to biologically relevant (macro)molecules such as peptides (14, 15), proteins 
(16, 17) or nucleic acids (18). Their discovery in the late 80’s by the cellular uptake of 
both the HIV-1 TAT (19-21) and the penetratin peptide (derived from the Antennapedia 
transcription factor from Drosophila melanogaster (22)) was, to some degree, 
anticipated from earlier work on the cellular uptake of large polycationic homopolymers 
or proteins (23). Compounds such as polylysine (23) or polyethylenimine (24) were 
shown to help delivering conjugated drug molecules or nucleic acids into living cells. 
As these polycationic molecules bind to anionic, cell-surface bound polysaccharides 
(25), the proposed uptake mechanism was of endocytotic nature (26). Upon closer 
inspection, endocytotic uptake routes comprise several independent and highly 
regulated pathways (27, 28) involving signaling receptors and protein machinery driven 
by ATP hydrolysis. However, as cellular uptake of CPPs could be observed at low 
temperature (≤4 °C) (21, 22, 29-32) (where endocytosis does not take place), in the 
presence of endocytosis inhibitors (30, 31, 33), with CPPs as D-isomers (34, 35) or 
(retro-)inverso sequence (36, 37) it became clear that membrane permeation by CPPs 
was not exclusively based on a common endocytotic pathway. The need for a broader 
perspective on the topic became apparent when further investigations (38-40) corrected 
some of those observations as possible artifacts of the cell fixation.  
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Interaction of CPPs with model lipid bilayers 
Alternative mechanisms of membrane permeation were suggested considering the 
hypothesis that CPPs not only interact with cell-surface proteins or carbohydrates, but 
also with the lipid portion of a biological membrane. In the latter case, the permeation 
should be observable when using a corresponding lipid bilayer model. One frequent 
lipid bilayer model are, for example, liposomes, that are spherules composed of desired 
mixtures of lipid molecules of synthetic or natural origin (41). Phospholipids serve as a 
well-established and easy-to-handle model for the lipid portion of biological membranes 
(reviewed in (42) and (43); already in the 1960s, Bangham et al. used this model to 
study the permeability of model membranes to ions and nonelectrolytes (44, 45)). 
Depending on their mode of preparation, both small (SUVs (46)) and large unilamellar 
vesicles (LUVs (47, 48)) with a homogeneous size distribution at an approximate 
diameter of 30 and 100 nm, respectively, were widely used in the past decades to study 
permeation of lipid bilayers by CPPs. The diameter of LUVs is in the same dimension 
as endosomes found in biological cells and is thus especially suited to study a potential 
intracellular escape from such structures. 
The combination of spectroscopic methods with thermodynamic analysis yields 
important parameters of the interaction between CPPs and model lipid bilayers, such as 
the binding constant, conformational change or bilayer stability in presence of the CPP. 
For example, it was shown that the affinity of an individual CPP to the lipid bilayer 
might dependent on both the amphipathicity and the anionic lipid content of the bilayer 
(13), depending on the structure of the CPP. In the in vivo situation, binding to other 
potential cell-surface molecules, such as extracellular polysaccharides, might exceed 
binding to membranes of low anionic lipid content (49, 50) such as found in eukaryotic 
animal cell membranes (51). 
Many studies consent that the highly charged CPPs do not permeate lipid bilayers 
by passive diffusion (13, 52, 53) unless they are of amphipathic nature (54-56) or in 
presence of a transmembrane potential (57, 58) (corresponding mechanisms were 
discussed in earlier reviews (59)). The observation that membrane permeation of model 
membranes is closely linked to the peptides’ amphipathicity lead to classification of 
CPPs by their amphipathic nature (for details (13, 60)). This helped to resolve 
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controversial findings of a very heterogenous class of peptides with diverse structural 
properties that likely do not share a common uptake pathway. Depending on their 
structure, the various CPPs can be assigned with distinct uptake pathways. 
The thermodynamic analysis of their interaction properties is therefore of great 
value when it comes to identify (un)favorable interactions between CPPs and potential 
binding partners as well as their ability to permeate model lipid membranes. Many 
experimental pitfalls may result when working with such highly charged molecules, so 
that the following publication covers the most important methods to investigate these 
peptides and their properties with detailed protocols. Specifically, the article addresses 
the i) preparation of lipid vesicles of desired lipid composition and size with particular 
focus to prevent aggregation with CPPs, ii) analytical determination of both lipid and 
peptide concentrations, iii) CPP-phospholipid interaction by isothermal titration 
calorimetry (ITC), iv) detection of membrane permeation by fluorescence spectroscopy 
and v) membrane stability in presence of CPPs by nuclear magnetic resonance (NMR) 
 
 
1.2. Introduction to thermodynamics of lipid interactions with cell-
penetrating peptides 
Past (61, 62) and current research studies (63-65) have shown that eukaryotic cells 
take up polycationic compounds, such as cell-penetrating peptides (CPPs) or other 
cationic homopolymers (e.g. polyethylenimine (66) or DEAE-dextran (67)), at 
(sub)micromolar concentration by binding them to anionic cell-surface glycans and 
subsequent endocytosis. Entrapment of CPPs in endocytotic vesicles is of moderate 
biomedical interest, because a CPP-attached cargo (e.g. plasmid DNA, siRNA) would 
be rapidly degraded when passing from endocytotic vesicles to late endosomes or 
lysosomes. This way, no or only few cargo molecules would reach their intracellular 
target, e.g. the nucleus for gene expression. 
In this respect, the work of Frankel (19) and Green (20) on the CPP HIV-1 Tat 
received much attention because the effect of extracellularly added Tat on cellular gene 
expression suggested that many more Tat molecules reached the nucleus than could be 
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provided by endocytosis. The delivery of CPPs into cytosol and nucleus thus became of 
high biomedical interest, and the work of Frankel and Green initiated a revival of 
research on cationic peptides, 20 years after the first studies on polylysine had been 
published (62). 
Subsequent studies with fluorescently labeled CPPs confirmed that various CPPs 
could indeed enter the cytosol and reach the nucleus of biological cells (21, 32, 68-77). 
The translocation of CPPs into the cytosol was also observed in cells that were 
incompetent for endocytosis (e.g. bacteria) (78-80). Both observations were surprising, 
because this meant that some CPPs may overcome the cytoplasmic and/or endosome 
membrane in spite of their polycationic character that argues against a rapid passive 
diffusion across lipid bilayers (81). These experimental observations led to rather 
controversial views on the apparently "magic" (82) uptake into cytosol and cell nucleus. 
Some of the observations could have been biased by experimental artifacts: 
Surface-bound CPP molecules, for example, may enter cells post-mortem, because the 
cell treatment with methanol, ethanol or paraformaldehyde typically used for cell 
fixation in microscopy can disrupt the membrane (40). This criticism does not apply to 
studies on living or unfixated cells (21, 32, 68-77). A detailed comparison of the 
conditions required for this cytosolic CPP entry suggests, however, that the cytosolic 
delivery of CPPs likely proceeds by more than one mechanism (13). 
Some amphipathic CPPs have detergent-like properties. They have a high affinity 
for charged and uncharged lipids, they partition into the hydrophobic membrane core 
and disturb model membranes already at low micromolar concentrations - in analogy to 
many amphipathic antibiotic peptides (83, 84). These amphipathic CPPs translocate 
almost equally across pure lipid membranes (exempt of membrane proteins or glycans) 
or the plasma membrane of living cells (85). Molecular pathways of cell entry include, 
for example, pore and carpet formation – as can be demonstrated in model membranes 
(86, 87). In some cases, CPPs may also leak out of endosomes ("endosomolytic" or 
fusogenic peptides) as a result of their pH–dependant structural change and lipid 
interaction (75, 88, 89). As a drawback for their intrinsic membrane disturbing property, 
amphipathic CPPs typically have a higher cell toxicity than non-amphipathic CPPs (90, 
 
 
16 
1.2. Introduction to thermodynamics of lipid interactions with cell-penetrating peptides 
 
91) which might render biomedical applications problematic which is also known from 
lipid-based transfection reagents. 
In contrast, non-amphipathic CPPs, such as homopolymers of arginine, are less 
toxic (90), but they bind lipid membranes only with poor affinity, because the fraction 
of anionic lipids encountered in mammalian cells is usually quite low. Also, partitioning 
into the hydrophobic bilayer core is lacking (92-94). They do not induce membrane 
leakage at low micromolar concentrations even though they enter the cytosol of living 
cells at this concentration. This suggests that not the lipids, but other cellular 
compounds are required for their translocation into the cytosol (13). Their membrane 
permeation on model membranes (devoid of proteins or glycans) has been observed 
only for special conditions, e.g. high micromolar concentrations (electroporation-like), 
unphysiological counterions (95, 96), electro-chemical gradients (97), repeated lipid 
phase-cycling (98) or delicate vesicles (99, 100). 
The present chapter describes protocols that allow for quantification and 
comparison of membrane interactions and perturbations of CPPs. Using selected CPPs 
it is shown that amphipathic CPPs destabilize model membranes already at low 
micromolar CPP concentration - in contrast to non-amphipathic CPPs. The distinction 
of both CPP classes resides on the strategy of making CPPs more amphipathic by either 
linking a membrane anchor to them ("acylation") (101) or by a previous report on an 
amphipahtic penetratin mutant ("p2AL") designed from helical wheel projections (55). 
Each protocol consists of an initial descriptive on required parameters and related 
literature, followed by the protocol itself. Conclusions from example data (see Figures) 
are described in Subheading 1.5. 
 
 
1.3. Materials 
1.3.1. Chemicals 
 1.  Ammonium molybdate, (NH4)6Mo7O24·4 H2O (Merck) 
 2.  ANTS, 8-aminonaphthalene-1,3,6-trisulfonic acid, disodium salt  
  (Molecular Probes) 
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 3.  Buffer for leakage experiments: 20 mM Tris, 134 mM NaCl, pH 8.5 
 4.  Buffer for ITC experiments: 20 mM Tris, 100 mM NaCl, pH7.4 
 5.  Calcein (Sigma-Aldrich) 
 6.  Contrad 90 (Socochim) 
 7.  DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (Avanti Polar 
  Lipids) 
 8.  DOPE-PEG2000, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-
  [methoxy(polyethylene glycol)-2000], ammonium salt (Avanti Polar 
  Lipids) 
 9.  Malachite green oxalate (Merck) 
 10.  DPX, p-xylene-bis-pyridinium bromide (Molecular Probes) 
 11.  Perchloric acid 70% (Merck) 
 12.  Phosphoric acid 85% (Sigma-Aldrich) 
 13.  POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (Avanti Polar 
  Lipids) 
 14. POPE, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (Avanti 
  Polar Lipids) 
 15.  POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-sn-glycerol), 
  sodium salt (Avanti Polar Lipids) 
 16.  Potassium phosphate monobasic, KH2PO4 (Sigma-Aldrich) 
 17.  Sepharose CL-6B (Sigma-Aldrich) 
 18.  Tris, Tris(hydroxymethyl)aminomethane (Merck) 
 19.  Triton X-100 (BioChemika) 
 
1.3.2. Instruments 
 1.  Fluorescence spectrophotometer F-4500 (Hitachi; Tokyo, Japan). 
 2.  Isothermal titration calorimetry (ITC): itc200 (Microcal/GE Healthcare; 
  Northampton,  USA) having a reaction cell volume of 203.7 µL and a 
  syringe volume of 38.45 µL. 
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 3.  NMR measurements: DRX-400 (Bruker; Karlsruhe, Germany) operating 
  at a resonance frequency of 400 MHz for 1H and 162 MHz for 31P. 
 4.  UV-visible spectrophotometer 8453 (HP; Waldbronn, Germany) 
 
1.3.3. Vesicle preparation (MLVs) 
A well-defined physical structure of model membranes facilitates many aspects in 
the thermodynamic analysis of peptide-lipid interactions, especially when the membrane 
passage of a peptide (i.e. access to inner leaflets or lamellae) is unknown. We therefore 
start reviewing important steps in the membrane preparation. 
When dispersed in water, phospholipids, such as charge-neutral POPC, tend to self-
associate: At the air-water interface, they slowly assemble to a monolayer and in the 
bulk phase rapidly to bilayer forming lipid vesicles (“liposomes”) (102, 103). The 
dissociation constant of this self-assembly is in the order of 10-10 M-1 (104), the cross-
sectional lipid area of POPC is 68Å2 (105) and the thickness of the hydrophobic core 
and P-P distance in the fluid state is 27 and 38 Å, respectively (106). Length, number 
and position of double bonds of the acyl chains greatly influence the gel-to-fluid phase 
transition temperature (Tm) which characterizes the transition from the frozen (Lβ; 
lamellar gel) to the fluid (Lα; liquid crystalline) phase. For POPC, this transition 
temperature is -2 °C (107). 
Most biological membranes are in the liquid-crystalline phase (108), and cycling 
across the transition temperature renders bilayers leaky - even to larger compounds 
(109-111) which is important for observations on CPP leakage across model membranes 
(98). Lipid polymorphism is regulated, in part, by the ratio between cross-sectional area 
of lipid head groups compared to the cross section of the acyl chains. Lipids with a 
small headgroup, such as DOPE, do not form contiguous bilayers, but inverted 
hexagonal (Hii) phases (112). As a result, DOPE is frequently used in transfection 
reagent mixtures for destabilizing membranes and improving their membrane 
translocation (113). In this regard, CPPs have been also proposed to form inverted lipid 
micellar structures as part of their membrane translocation (114).  
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Model membranes can be prepared by different methods, such as filter extrusion, 
sonication, reverse phase evaporation or detergent dilution (for a review see ref. (41)). 
Resulting vesicles differ not only in size, but also in stability, lipid packing density, 
outer/inner layer lipid stoichiometry, and binding enthalpies. Giant unilamellar vesicles 
(GUVs), for example, are particularly delicate (115). In contrast, large unilamellar 
vesicles (LUVs) with a defined diameter of ~100 nm produced by filter extrusion have a 
small polydispersity (116), excellent storage stability, a lateral packing density close to 
eukaryotes (28-35 mN/m) (117, 118) and a balanced inside/outside leaflet lipid 
stoichiometry. Finally, small unilamellar vesicles (SUVs) with a diameter of 30-50 nm, 
produced by sonication, have more lipid molecules on the outside than on the inside 
leaflet for sterical reasons (119). This is important when considering the lipid binding 
stoichiometry for peptides that have no access to the inner membrane leaflet. Peptide 
interactions with SUVs also might have different binding enthalpies in ITC experiments 
(as compared to LUVs) which can be favorable when working at low concentration 
(120). The number of water molecules (nw) required for full hydration of a phospholipid 
molecule has been estimated to be 17-38 (121, 122), so that the lipid hydration must 
exceed ~0.4-0.9 g water/g lipid especially when working with concentrated NMR 
samples, and additional intravesicular water might be considered (123). 
Lipid stock solutions in chloroform (Avanti Polar Lipids, Alabaster, USA) or in 
dichloromethane are more convenient to aliquot than greasy phospholipid "powders". 
On the other hand, the organic solvent requires non-plastic vials/pipets, pipetting at low 
room temperatures (the boiling point of dichloromethane and chloroform is 40 and 62 
°C, respectively, at 760 mm Hg) and removal by rotary evaporation. 
 
1. A lipid suspension (16 mM, 2 mL, molar ratio POPG/POPC = 1/1) is prepared as 
follows. 
2. The weight of an empty 5-mL pear-shaped flask is noted. An aliquot of 12.16 mg of 
POPC (e.g. 0.608 mL of a 20 mg/mL stock) is pipetted into the flask. The solvent is 
removed by rotary evaporation and subsequent high-vacuum (0.1 mbar) for >4 hours. 
The weight of the flask is again noted. 
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3. The second lipid is added, e.g. 12.34 mg POPG (0.617 mL of a 20 mg/mL stock 
solution), and the solvent is also used to mix the second lipid with the first one. The 
solvent is removed by rotary evaporation and subsequent high-vacuum (0.1 mbar) for 
>4 hours. The weight of the flask is noted in order to determine the lipid weight ratio. 
The total lipid concentration is determined according to Subheading 1.3.8. 
4. Additional lipids, such as pegylated lipids (DOPE-PEG2000), might be added in 
analogy to step 3 (see also Subheading 1.3.7 Lipid choice). 
5. The dry lipid film is hydrated with ~2.0 mL of buffer (the concrete volume is chosen 
according to measured lipid weight), topped with an Argon layer, vortexed and hydrated 
at room temperature during 1 h (44). Thereafter, the flask is again vigorously shaken 
using a table top shaker ("vortex") resulting in multilamellar vesicles (MLVs) of 16 mM 
total lipids and a wide size distribution range between 0.5-10 µm. Due to the large 
vesicle size, the light scattering is high and the appearance is milky. Occasional 
sediments may exist originating from slow hydration of inner lamellae, especially if 
hydration time was too short or lipid films after solvent evaporation to thick. 
6. LUVs or SUVs are prepared by disrupting the MLVs using sonication (46) or freeze-
thaw cycling followed by extrusion through a filter of defined pore size (47), as 
described under Subheadings 1.3.4 and 1.3.5, respectively. 
 
1.3.4. LUVs 
1. The MLV dispersion (prepared under Subheading 1.3.3) is subjected to 5 freeze-
thaw cycles which reduces the lamellarity (124), vesicle size (<1 µm) and size 
distribution (125). This is done by placing the flask for 20 min into a -80 °C freezer 
followed by an ambient temperature water bath. Typically, no sediments are observed 
any longer after this step. 
2. The suspension is aspired by a first 2.5-mL Hamilton syringe and extruded into a 
second Hamilton through a 19-mm syringe filter holder from Avanti Polar Lipids 
(Alabaster, USA), Avestin (Ottawa, Canada), or Eastern Scientific (Rockville, USA). 
The filter holder contains a stack of 2 polyethylene drain disks (art. 230300, Whatman; 
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Maidstone, UK), 2 polycarbonate nucleopore track-etch membranes with a 0.1 µm pore 
size (art. 800309, Whatman; Maidstone, UK), and again 2 drain disc. Importantly, 
extrusion is performed above the Tm of the lipids, because of the rapid vesicle fusion 
below Tm (126, 127). Depending on the lipid mixture, a heater block (Avanti Polar 
Lipids or Eastern Scientific) for the assembly is required. Without disconnecting the 
assembly, extrusion is repeated between the 2 syringes for at least 11 cycles (47, 128). 
The sample is recovered from the second syringe in order to ensure removal of any 
larger particles of the original suspension. Pore sizes available are 50, 100, or 200 nm; 
larger pores no longer produce narrow vesicle size distributions (128). For larger sample 
volumes, larger Hamilton syringes can be used or barrel extruders (Avestin; Ottawa, 
Canada; or Northern Lipids; Burnaby, Canada). 
3. Because of the vesicle size reduction, the lipid dispersion becomes less opaque. 
Experimental verification of the vesicle size and distribution is recommended which is 
performed within a few minutes using dynamic light scattering (DLS). 
4. The prepared vesicles are topped with Argon (to prevent oxidation) and stored at 4 °C 
(to prevent hydrolysis (129), so that the vesicles can be used during several days before 
fusion is observed (130). Freezing or cycling across the lipid phase transition 
temperature should be avoided (131, 132). The vesicle size is checked prior to 
experiments using DLS. Changes in vesicle size (fusion) and lamellarity occur after 
days or months, where the kinetics depends on lipid type and co-solutes. Generally, 
fusion is prevented by higher amounts of charged lipids, and promoted by high amounts 
of divalent ions or PEG. Studies on vesicle stability are summarized elsewhere (130, 
131, 133). 
 
1.3.5. SUVs 
1. The MLV dispersion prepared under Subheading 1.3.3 is sonicated during 40 min 
with a tip sonicator (e.g. model 250, Branson; Danbury, USA) and 35 Watt power 
setting. During sonication, the sample is protected under a nitrogen blanket and cooled 
with a 20-mL water bath (at a T just higher than Tm of the lipids). Duration, power-to-
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volume ratio and ultrasound wavelength are critical to produce SUVs with low 
polydispersity (134). For instance, a sonication time of >35 min and 50W is required 
when using 10 mL volumes (135). Higher power-to-volume ratios might de-esterify 
phospholipids (136). In contrast, bath-type sonicators (e.g. model G112SP1T; 
Laboratory supplies; Hicksville, USA) are operated at higher power settings (80 W) and 
may produce vesicles of higher polydispersity (137) and lamellarity (138); using the 
latter method, fractions of larger vesicles can be separated by centrifugation or by 
chromatography with a Sephadex G-50 column (139). Considerations on optimum 
ultrasound frequency and vesicle formation by acoustic cavitations are published 
elsewhere (140). Finally, the tip sonicator can heat the liquid rapidly to temperatures > 
60 °C which would lead to heat-induced lipid degradation so that cooling is required. 
2. After sonication, the SUVs are transferred into 2 microcentrifugation test tubes 
(Eppendorf; Hamburg, Germany), and the titanium debris from the sonicator tip (which 
would disturb optical methods such as DLS) is removed by centrifugation at 16,000 g 
for 10 min. The prepared vesicles are filled into 4-mL storage vials (art. G075S-14, 
Infochroma; Zug, Switzerland), topped with Argon and stored at 4 °C. In contrast to 
LUVs, the outer surface of the vesicle bilayer contains twice as many lipid molecules 
than the inner leaflet (119) and their high energy curvature causes fusion to larger 
vesicles already after days (141). 
 
1.3.6. NMR samples 
MLVs for NMR are prepared in analogy to steps 1-5 of Subheading 1.3.3 with the 
following exceptions: 
1. The membrane passage of CPPs to inner lamella of MLVs can't be assumed a priori. 
Therefore, the buffer (see step 5 of Subheading 1.3.3) contains already the peptide, so 
that the CPP has access to all lamellae. 
2. Prior to NMR measurements, the MLVs are subjected to 5 freeze-thaw cycles in 
order to reduce the polydispersity of the vesicles to a diameter of ~1 µm, to accelerate 
the hydration of inner lamellae and thus to improve spectral quality.  
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3. In case of rare and expensive lipids, smaller amounts of lipids (typically <5 mg) are 
dried directly inside the NMR vial (instead of a flask) to prevent losses. The organic 
solvent is removed by a gentle stream of nitrogen (because of the difficulty to connect it 
to a rotavapor). In this respect, chloroforom has not been classed as a greenhouse gas 
(142), but its inhalation might cause liver cancer (143) suggesting the work in a fume 
hood. 
 
1.3.7. Lipid choice 
1. A high POPC content is recommended for model membranes, because its transition 
temperature (Tm) is well below ambient temperature and since it is the major lipid in 
mammalian cell membranes (144). A detailed review on chain length and head-group 
composition of mammalian cells has been published (145). 
2. In view of electrostatic interactions of CPPs, the addition of anionic lipids such as 
POPG (typical for plants and bacteria) or POPS (typical for eukaryotes) is 
recommended. The membrane content of anionic lipids can be up to 50-80% in Gram-
positive bacteria (146, 147), but is only 2-12% in mammalian cells where they are 
primarily located in the inner leaflet of the plasma membrane of healthy cells (148). 
Only after cell death or apoptosis, they appear at the outer membrane leaflet which can 
be exploited for annexin V binding assays (apoptosis marker) (149). An anionic lipid 
content of 0-10% is thus reasonable for modeling eukaryotic membrane phospholipids. 
3. Because of their polycationic character, CPPs may lead to intravesicular aggregation 
and sedimentation of anionic lipid vesicles (150). This leads to precipitates and light 
scattering which disturbs optical measurements (e.g. DLS, CD, fluorescence). The 
vesicle aggregation can be prevented by including 2-4 mol% PEGylated lipids in the 
lipid mixture (151). At higher ratios (>5-8 mol% depending on PEG chain length), a  
"mushroom-to-brush" transition of the PEG chains occurs (152-154) which may either 
increase (155) or diminish peptide binding (156). 
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1.3.8. Lipid quantification 
Precise knowledge of the lipid concentration is essential in thermodynamic analysis 
of peptide-lipid interactions. Especially when preparing SUVs with a tip sonicator, 
solvent evaporation can occur. Phospholipid content is thus measured as phosphate 
content after oxidation of the phospholipids with perchloric acid. The liberated 
inorganic phosphate ion reacts with ammonium molybdate to phospho-molybdic acid 
which is measured spectrophotometrically. The sensitivity of the detection is increased 
in the presence of cationic malachite green (157). Dried KH2PO4 at 5-20 nmol is used 
for calibration. The assay is thus incompatible with phosphate based buffers. When 
using higher phosphate concentrations and readings later than 20 min after reagent 
addition, stabilization of the colored complex with surfactants such as Tween20 is 
required (158). 
 
1. Wear protection glasses, gloves and lab coat. 
2. Coloring reagent: 1.05 g of ammonium molybdate ((NH4)6MoO24·4H2O) is dissolved 
in 15 mL of 6 N HCl; this is added to 0.12 g of Malachite Green previously dissolved in 
85 mL of H2O. After 30 min of stirring, the reagent is filtered (filter paper #1,Whatman; 
Maidstone, UK). The reagent is stored at room temperature and is freshly filtered prior 
to use (0.2·µm PTFE syringe filter, Whatman; Maidstone, UK). The reagent is stable for 
6 weeks. Thereafter, the assay leads to increased OD values and non-linearity in the 
standard curve. 
3. An aliquot of ~150 nmol of phospholipids (e.g. 30 µL of a 5 mM POPC suspension) 
is placed into a 8x60 mm borosilicate glass tube (art. 26.013.201, Glas Keller; Basel; 
Switzerland)  
4. 100 µL of perchloric acid (70%) are added. 
5. Behind a protection shield and in a fumehood, the vial is hold with a forceps (tube 
opening opposed to the body) and is gently boiled with a bunsen burner for 
approximately 3-4 min, so that the solution first turns yellow and, after a short burst of 
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white smoke, gets clear again leaving ~1/2 of the original volume. After cooling, the 
solution is completed with water to 1.0 mL. 
6.1. A tenth of it (100 µL; triplicate) is placed into a disposable plastic cuvette (1 cm 
path length), and 900 µL of the freshly filtered coloring reagent is added and 
immediately mixed. 
6.2. For the blank, 100 µL of water are placed in a cuvette and 900 µL of the coloring 
reagent are added and mixed. 
6.3. For the standard curve, 5, 10, 15 ad 20 µL of a 1 mM KH2PO4 solution are placed 
into a cuvette, followed by completion with water to 100 µL and addition of 900 µL of 
the coloring reagent. 
7. A time-scan (light absorbance at 660 nm) of the most concentrated standard is 
recorded (i.e. 20 nmol of KH2PO4) , where the OD signal will increase after ~10 min to 
a ΔOD of ~ 0.9 (with regard to the blank) and will stay stable for ~30 min. 
8. The interval between addition of the coloring reagent and achievement of stable 
signal (i.e. ~10 min) is kept equal for all samples. 
 
1.3.9. Peptide quantification 
Precise knowledge of the peptide content is essential - especially for CPPs. Current 
synthesis and purification procedures typically lead to a peptide purity of >98%, not 
meaning that the peptide content of the lyophilized powder is >98%: the presence of 
anionic counterions, such as trifluoro acetate or acetate, is considerably high after 
purification because of the high content of cationic arginines and lysines in CPPs. The 
CPP R9, for example, may contain 9 TFA counter-ions after purification with HPLC 
using TFA as an ion pairing reagent. As a result, the mass content of TFA in the 
lyophilized peptide could be 40% or higher. Therefore, elemental analysis (comparing 
experimental versus theoretical nitrogen content) or amino acid analysis (quantifying 
amino acids by fluorescent tags after acid peptide lysis) (159) are required whenever 
working with CPPs.  
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Because spectrophotometers are in most laboratories, insertion of a light absorbing 
amino acid, such as tryptophane, at the N-terminus of the CPP sequence is also a good 
alternative for peptide quantification (e.g. WR9). This allows for fast quantification 
during each peptide handling step using the molar extinction coefficient of 5'500 for 
tryptophane at 280 nm during denaturation in 6 M guanidine hydrochloride (160). 
Peptides used in present protocols were made by solid-phase peptide synthesis 
using a Fmoc strategy (161) and a Rink amide resin. The carboxy terminus was 
amidated and thus uncharged. Acylation at the N-terminus with fatty acids of varying 
lengths (C14, C16, or C18) was performed on-resin by activation with PyBOP/NMM. The 
single-letter code for the peptides used are WRRRRRRRRR (WR9), myristoyl- (C14-
WR9), palmitoyl- (C16-WR9), and stearoyl-WR9 (C18-WR9), RQIKIWFQNRRMKWKK 
(penetratin; Antp) and RQIKIWFQAARMLWKK (penetratin p2AL, see ref. (55)). 
When observed in a helical wheel projection (162), WR9 and Antp are considered to be 
non-amphipathic – in contrast to the acylated WR9 derivatives ("primary amphipathic" 
according to ref. (13, 86)) and p2AL ("secondary amphipathic" according to ref. (13, 
86)). 
 
1.3.10. Fluorescent membrane leakage dyes 
Calcein is a zwitterion having a maximum of 6 negative and 2 positive charges. 
Because of the uncertainty about its pKa4 (163, 164), the net charge at pH7 is 
considered to be -3 (165, 166) or -4 (164). On the basis of published pKa values, the net 
charge of further fluorescent leakage dyes, such as ANTS, carboxyfluorescein, and 
fluorescein, is -3, ~-2.7 (167), and ~-1.6 (163) at pH 7, respectively. Because of its 
multivalency, the encapsulation of calcein (typically 70 mM) into vesicles produces a 
high ionic strength. The ionic strength (I) of a solution containing n ionic species is 
defined by 
                (1) 
where ci is the concentration of ion i, and zi is its charge number.  
∑=
n
i
ii zcI
2
2
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Assuming z = -3 or -4 for calcein at neutral pH (disodium salt), a 70 mM calcein 
solution results in an ionic strength of 0.42 or 0.7 M, respectively, which is much higher 
than that of physiologic saline (0.154 M). This is important when considering ionic 
gradients as a potential mechanism for CPP membrane disturbance (168). 
 
 
1.4. Methods 
1.4.1. Membrane leakage (calcein dequenching) 
The fluorescent dyes used in this assay are generally anionic in nature. As a result, 
they cannot cross the membrane because of the high Born charge energy barrier (81). 
Spontaneous dye leakage across the membrane proceeds only over days, but dyes of 
little charge (fluorescein, carboxfluorescein) leak faster than trivalent dyes (e.g. calcein, 
ANTS) (166). On the other hand, the multivalency of the latter dyes has the 
disadvantage of interacting with the cationic peptides (see Fig. 1.1F and G) and creating 
a strong ionic gradient across the membrane (see Subheading 1.3.10). 
The membrane leakage assay (166) resides on the principle that the dye is 
entrapped in vesicles at self-quenching concentrations. Fluorescent dyes such as 
carboxyfluorescein are self- quenching at concentrations > 0.2 M because of non-
fluorescent dimer formation and energy transfer to the dimer (169). In addition, the high 
light absorbance of the dyes causes an inner filter effect, so that the concentration for 
maximum fluorescence is observed already at low micromolar concentration depending 
on the cuvette dimension (see Fig. 1.1A). Adding a membrane-perturbing peptide then 
leads to the release of the dye out of the vesicles. Its dilution into the much larger 
extravesicular volume results in increased fluorescent signal intensity. In addition to 
self-quenching, collisional quenchers might be encapsulated (e.g. cationic DPX for 
anionic dye ANTS) so that their dilution upon membrane leakage causes also an 
increase of the fluorescence signal. 
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Fig. 1.1. Membrane leakage assay. (A) Because of the high optical absorbance of calcein, the 
observed maximum fluorescence at given concentration depends not only on quenching, but 
also on cuvette dimensions (i.e. inner-filter effect) as shown for a (●) 10 mm, (x) 5 mm and (○) 
2 mm cuvette using same photomultiplier and bandwidth settings for the cuvettes. Small path 
lengths are thus preferred, especially when working with vesicles that stray light. (B) 
Separation of calcein-loaded LUVs from free calcein on a Sepharose CL-6B column (absorbance 
detection at 495 nm; 1.6 x 23 cm column, flow rate 0.3 mL/min). (C) Leakage assay for non-
amphipathic WR9: under permanent stirring, 100 µL of 10 µM (black), 100 µM (gray) and 1000 
µM (light gray) WR9 are added (at 60s) to 1.4 mL of LUVs (total lipid = 0.45 mM, molar ratio 
POPC/POPE/POPG/DOPE-PEG = 32/32/31/5; 13 mM calcein). Final peptide concentration is 
0.7, 6.7 and 67 µM, respectively. At 600 s, 100uL of 5% Triton X-100 is added to release the 
entire vesicle content. (D) Same leakage assay, but using non-amphipathic penetratin. (E) 
Same leakage assay, but using amphipathic penetratin mutant p2AL. Indicated are final 
peptide concentrations (µM). The low fluorescence at highest p2AL concentration (70 µM) 
suggests interaction of anionic calcein with cationic CPPs. (F) Titration of 1.4 mL of 10 µM 
calcein with a 1 mM solution of 3 different CPPs. 10, 40 and 50 µL of the CPP are added at 40 s, 
80 s, and 150 s, respectively, indicating the interaction of anionic dye with cationic CPPs. (G) 
Same titration, but using 100 µM ANTS. In contrast to (F), the dye-peptide interaction 
produces a signal increase which is favorable for improved sensitivity of the leakage assay. (H) 
Leakage assay using 12.5 mM of the dye ANTS (and 45 mM of its quencher DPX) inside the 
vesicles. Despite the improved sensitivity of this assay, no membrane leakage with non-
amphipathic WR9 is observed. Buffer allover: 20 mM Tris, 134 mM NaCl, pH 8.5.  
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1. LUVs are prepared as described in Subheading 1.3.4 (total lipid concentration 
typically 15 mM) with the exception that the buffer (20 mM Tris) contains calcein (13 
mM; ionic strength of 104 mM at pH 8.5), no NaCl, and the pH is 8.5, i.e. 3 pH units 
higher than pKa3 of calcein. For this purpose, acidic calcein is first dispersed into the 
buffer, and the pH is adjusted to pH 8.5 using NaOH bringing calcein into solution. 
2. Free calcein is removed by SEC using a glass column (i.d. 1.6 cm) filled to a height 
of 23 cm with Sepharose CL-6B (Sigma-Aldrich; fractionation range of 0.01-4 MDa for 
globular proteins) as stationary phase and a running buffer of 20 mM Tris, 134 mM 
NaCl pH 8.5. In order to protect the fluorescent dye against bleaching, the column is 
wrapped with an aluminum foil. When using carboxyfluorescein as dye, spontaneous 
dye leakage occurs faster than for calcein (166) so that chromatography at 4 °C is 
recommended. 
3. Flow rate of the pump is 0.3 mL/min. 
4. Absorbance of calcein is monitored at 495 nm. 
5. Fractions of 1 mL are collected into Eppendorf tubes. 
6. Fractions between 51 and 57 min (containing calcein-loaded vesicles) are collected 
(see Fig. 1.1B). 
7. Fractions between 120 and 145 min (containing free calcein) are discarded. 
8. The size of the vesicles is checked with DLS. 
9. The lipid concentration is measured (see Subheading 1.3.8). The dilution factor as 
caused by present SEC column is typically ~6. 
10. Lipids are diluted to a final concentration of 0.1-0.45 mM, i.e. a concentration close 
to total phospholipid content of cells in culture (e.g. 68 µM respecting 25 mL culture 
medium (170)). 
11. Using a 1 cm fluorescence cuvette, 1.4 mL of the calcein loaded vesicles are placed 
into the cuvette containing a magnetic stir bar. 
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12. Under continuous stirring, a time scan of calcein fluorescence is recorded. After 60 s 
of baseline recording, a small volume (see Fig. 1.1E) of the CPP is added to produce a 
final peptide concentration in the micromolar range. 
13. When at equilibrium (e.g. 10 min), 100 uL of 5% Triton X-100 are added in order to 
release the entire vesicle content. 
14. The relative membrane leakage (Frel) induced by the CPP can be calculated 
according to 
0
0
FF
FFF
triton
CPP
rel −
−
=          (2) 
where F0, FCPP and Ftriton denote the initial (quenched) fluorescence, increased 
fluorescence after CPP addition, and maximum fluorescence after triton addition, 
respectively. Although calcein at self-quenching concentrations in 1-cm cuvettes (>0.2 
mM) has almost no fluorescence (see Fig. 1.1A), F0 in this assay is typically higher than 
zero, because of lower inner filter effects when calcein is encapsulated in diluted 
vesicles. 
15. Reporting percentual dye release according to Eq. 2 relies on a linear relation 
between dye concentration and fluorescence intensity. This is valid only when the 
fluorescence is not quenched, i.e. at a concentration below the concentration for 
maximum fluorescence (consider the logarithmic scale in Fig. 1.1A). The maximum 
fluorescence for calcein in a 1-cm cuvette, for example, is observed at a concentration 
of ~20 µM (see Fig. 1.1A). Based on a cross-sectional area of 68 Å2 per POPC and a 
sample volume of 1.4 mL, a 0.45 mM POPC LUV preparation (vesicle radius of 50 nm) 
has a total intravesicular volume of 2.15 µL. Full membrane leakage thus produces a 
dye dilution factor of 1.4 mL/2.15 µL = 651. A linear correlation between fluorescence 
intensity and concentration is thus achieved for a vesicular calcein concentration of 651 
x 20 µM = 13 mM and lower. When using a higher calcein concentration, the vesicle 
concentration must be decreased accordingly. 
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1.4.2. Membrane integrity (31P NMR spectroscopy) 
Phosphorous-31 NMR is a simple method to distinguish between lipid bilayers, 
hexagonal structures and isotropically moving phospholipids (171). Because of the slow 
rotation on a NMR time scale, MLVs produce a chemical shift anisotropy (see Fig. 
1.2A). In contrast, rapidly tumbling structures (LUVs, SUVs, detergent-solubilized 
lipids “mixed micelles”) show an isotropic NMR signal (see Fig. 1.2B). 
 
Fig. 1.2. Polymorphic phase behavior of phospholipids as studied by 31P NMR spectroscopy. 
Left column: (A) intact bilayer of POPC/POPG (= 3/1) prepared as MLVs; (B) same bilayer 
solubilized by Triton; (C) hexagonal phase (DOPE), occasionally termed "inverted micelles" in 
the CPP field (61). Middle column: same bilayer as (A) but prepared in the presence of 
different CPPs (at 4 mM): (D) non-amphipathic WR9, (E) amphiphilic analogue C14-WR9, (F) 
C16-WR9 and (G) C18-WR9. Right column: same bilayer as (A), but prepared in the presence of 
(H) non-amphipathic Antp or its (I) amphiphilic analogue p2AL. Spectra were recorded at 25 °C 
and are referenced to external H3PO4 85% at 0 ppm. Typically, 5 mg total lipid, 130 µL H2O 
and 1.4 mg peptide were used. 
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The assay therefore requires the work with MLVs. Because of potential vesicle 
aggregation and subsequent precipitation with CPPs (150), a horizontally aligned NMR 
radiofrequency coil (covering the entire sample tube) is preferred over a standard 
vertical high-resolution NMR probehead where aggregates sedimentate out of the 
sensitive volume of the probehead. Our laboratory typically uses a 4-turn solenoid of 14 
x 8 mm inner diameter. Sample tubes are borosilicate tubes (Fiolax, Duran; Mainz, 
Germany) or house-made screw vials with internal volumes of 400 and 150 µL, 
respectively. 
 
1. This assay is incompatible with phosphate-based buffers. MLVs are produced as 
described under Subheading 1.3.6. For rare lipids, only 5 mg total lipid and 150 µL of 
liquid are used, but lipid quantities can be increased up to 100 mg lipid / 100 mg of 
liquid (check hydration number for specific lipid) which leads to more signal and thus 
to faster experiments. 
2. For external calibration, 200 µL of concentrated phosphoric acid (85%) are used 
(sealed in a borosilicate tube). After magnetic field homogenization with the 1H 
frequency ("shimming") to the vial geometry, the 31P signal of concentrated phosphoric 
acid is calibrated to 0 ppm (pH dependant). Because of the steady magnetic field drift, 
this procedure is repeated every day, where 1 scan typically yields sufficient signal. 
3. The lipid samples are subsequently recorded using the same magnetic shim values 
and chemical shift calibration. 
4. Because of the broad chemical shift dispersion, NMR spectra are recorded with a set-
up for solid-state like compounds, i.e. fast digitizer, high power amplifier, and a 
probehead that can withstand that power .The inverse relation of excitation bandwidth 
and pulse length in FT NMR requires 90° pulses in the low µs range (typically 5 µs) for 
full spectral excitation. 
5. 31P NMR spectra are recorded using a Hahn echo sequence (90°-τ-180° with τ = 40 
µs), broadband proton decoupling, a recycle delay of 5 s (i.e. ~5 times T1), spectral 
width of 50 kHz, and 4K data size. Typically, 8000 transients are averaged, and the free 
induction decay is exponentially multiplied prior to Fourier transformation 
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corresponding to a 200 Hz line broadening. Compared to a simple pulse-and-acquire 
NMR sequence, the delayed acquisition of the Hahn echo sequence reduces 
contributions of preamplifier and resonance coil ringing after strong radio-frequency 
pulses (172). 
 
1.4.3. Membrane binding (isothermal titration calorimetry) 
The membrane binding of peptides can be driven by a variety of forces, such as 
hydrophobic partitioning, electrostatic attraction to charged lipid headgroups or 
stabilization through a conformational change (e.g. helix formation). As a consequence, 
membrane-peptide interactions are characterized by a variety of affinity constants, and 
these have not only different magnitudes, but also different molecular meanings (13, 
173): 
 
- The surface partition constant Kp, as defined here, describes the hydrophobic 
interaction. The molar amount of peptide bound (nP) to accessible (i.e. outer leaflet) 
lipid (nL), Xb = nP/nL, is used to calculate  
m
b
p c
X
  K =           (3) 
where cm is the peptide concentration close to the membrane surface. For uncharged 
lipids and uncharged peptides, the peptide concentration close to the membrane surface 
(cm) equals the free peptide concentration in bulk at equilibrium (ceq), so that a plot of 
ceq versus Xb yields a straight line with the slope KP (173). However, this correlation is 
not linear when electrostatic interactions are involved. In this case, 
 
- the apparent membrane partitioning constant Kapp is used including both hydrophobic 
and electrostatic interactions, and we define 
eq
b
app c
X
  K =           (4) 
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The electrostatic interactions between cationic peptides and anionic lipids cause the 
concentration of the peptide near the membrane (cm) to be higher than in bulk (ceq). 
Obviously, Kapp is larger than Kp because of ceq << cm. Characteristically, Kapp decreases 
with increasing peptide concentration because of electrostatic screening. Thus, a plot of 
ceq versus Xb is not linear for charged compounds. Using the Gouy-Chapman theory, cm 
and the membrane surface potential (Ψ0) can be calculated (150, 173-175) which, in 
turn, allows the calculation of Kp. This way, hydrophobic and electrostatic contributions 
to the peptide-lipid interaction can be differentiated, and a plot of cm versus Xb becomes 
linear (173). 
Several studies agree that non-amphipathic CPPs such as R9, Tat and PLL do not 
partition into to the hydrophobic core of model membranes but remain superficially 
bound (93, 94, 150, 176-178). Their interaction is thus best described by 
 
- a complex (LnP) formation of n lipids (L) with the peptide (P) according to 
n L + P << LnP          (5) 
This way, peptide binding can be visualized in terms of a multi-site binding model. 
Here, a complex formation constant K of defined stoichiometry is used. In contrast, KP 
and Kapp make no assumptions on the reaction stoichiometry. Assuming n identical 
binding sites on the multivalent peptide P, the binding of lipid L to individual sites on P 
can be defined by a single-site ("microscopic") binding constant 
[ ]
[ ][ ]L sitesempty 
sites filled k =           (6) 
where [ ] represents concentration. For statistical reasons (13), the first lipid (i.e. non-
saturating conditions) binds with a higher affinity than the last one (i.e. saturating 
conditions). Determination, of the CPP-lipid affinity by ITC relies on the principle that 
the peptide in the reaction cell (200 µL) is progressively saturated by repeated additions 
(19 x 2 µL) of the lipid, while the heat of reaction is recorded during each injection. For 
a precise fit of experimental data, sufficient data points in the transition region (i.e. 3-10 
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data points) must be available in the thermogram and, ideally, an initial plateau for the 
first few titrations (see Fig. 1.3C). As a rule of thumb, both conditions are met, if the 
starting concentration of the peptide (A0) in the reaction cell is close to  
A0 = 50·kd/n          (7) 
where kd is the estimated dissociation constant (kd = 1/K).  
Because of the volume ratio of the cell/syringe of ~5, and a desired 2-fold excess of 
B at the end of the titration series, the concentration of the ligand B is chosen to be 
500·kd (which results from B = 5·2·n·A0, where A0 is equivalent to Eq. 7). 
If A0 is 2 magnitudes higher than defined in Eq. 7, the transition region of the 
thermogram is almost rectangular (see Fig. 1.3C), so that the fitted kd represents only a 
upper limit of kd. If A0 is 2 magnitudes lower than in Eq. 7, the isotherm is very flat and 
the endpoint is uncertain, so that the fit to the data no longer produces clear-cut results 
(see Fig. 1.3C). If the concentration cannot be increased in the latter case for 
experimental reasons (e.g. high polydispersity and lamellarity for lipids > 100 mM, or 
protein self-aggregation at high concentration), the syringe can be refilled a second time 
(see Fig. 1.3B), or the content of syringe and reaction cell can be inversed. 
 
1. Prepare 4 mL of a peptide solution (sufficient for 6 experiments considering ~300 µL 
per pre-run cell rinsing and subsequent titration experiment) and 2 mL of SUVs 
(sufficient for 30 experiments considering ~60 µL per syringe filling) according to 
Subheading 1.3.5. The solutions are filled into a 4 mL glass vial and are degassed 
under stirring (ThermoVac, Microcal; Northampton, USA) at 0.7 atm during 7 min. 
Degassing is important especially for experiments above room temperature, because air 
bubbles lead to increased noise and baseline jumps in ITC due to the air compression 
and friction during stirring at high speeds (typically 1000 rpm). Prior to filling the 
instrument, the solutions are kept at experimental temperature in order to minimize the 
delay between cell filling and start of the first injection (which is typically 10-20 min  
for present instrument). 
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Fig. 1.3. Isothermal titration calorimetry (ITC). The reaction cell was filled with 204 µL of 60 
µM WR9. Every 2 min, 2 µL of lipid vesicles (SUVs) composed of neutral POPC and anionic POPG 
were added (25 °C). The concentration of POPG was held constant (8 mM), but POPC was 
varied in different experiments, so that the charge density of the membrane varied as follows: 
(A) POPG/POPC = 1/1 (typical for bacterial inner membrane), (B) POPG/POPC = 1/9 (typical for 
eukaryotic cell membrane). The heat release (raw data, upper panel) during each injection was 
integrated to yield the experimental heats of reaction (◊; lower panel). The line in the lower 
panel represents best fit to the experimental data using a multi-site binding model (28), where 
(A) K = 1.91x105, n = 5.51 POPG/WR9, ΔH = 1.18 kcal/mol POPGout.; (B) K = 1.08x103, n = 6.12 
POPG/WR9, ΔH = 1.69 kcal/mol POPGout. Because of the low degree of binding in (B), the empty 
syringe was refilled after the 19th injection (i.e. at 40 min). After refilling, the injection series 
was continued which is feasible within 10 min using latest ITC technology. Precise 
determination of even lower binding constants would require much higher peptide and lipid 
concentrations; however, total lipid concentration is already at a high limit (80 mM in B) for 
obtaining unilamellar vesicles and low polydispersity. (C) Experimental simulations of the 
binding isotherm according to the multisite binding model using various K (106, 105, 104 and 
103, as indicated) and similar conditions as in (A) and (B), i.e. 204 µL of 60 µM WR9, 36 x 2- µL 
injections of 8 mM POPG (which is 4.8 mM POPG on outer leaflet of SUVs), fixed n = 6.0 
POPGout/WR9, and ΔH = -1.2 kcal/mol POPGout. 
2. In a first experiment (“blank” experiment), SUVs are titrated into buffer in order to 
measure the heat of lipid dilution which is subtracted in subsequent experiments. 
3. After the blank experiment, the reaction cell is cleaned, typically with 2% Contrad 90 
(Socochim; Lausanne, Switzerland) during 15 min, followed by ample water rinsing. 
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4. The cell of the calorimeter thereafter contains smaller amounts of water from 
precedent cleaning procedures which could lead to dilution of the peptide. The cell is 
thus filled once with the peptide and the content is discarded. Thereafter the cell is filled 
again with the peptide for the proper experiment. 
5. Selection of the injection volumes is a compromise between sufficient signal/noise 
per injection and sufficient data points to construct an isotherm: the syringe content 
(38.5 µL) is typically divided into 19 x 2 µL aliquots, but the injector could handle 
smaller volumes with high precision which can be exploited whenever the reaction 
enthalpy is high. The spacing between the injections depends on the reaction kinetics 
(and stirrer speed): fast reactions such as ethanol dilutions can be recorded with an 
interval of 60 s, but present multi-site binding reaction is slower and is best recorded 
with an interval of 90-120s (awaiting reaction equilibrium) so that the total experiment 
time from cell filling to end is typically 1 h. 
6. The raw data (see Fig. 1.3A upper panel) are integrated to yield the heat per injection 
and thus a binding isotherm when plotting it against the molar ratio of the reactants (see 
Fig. 1.3A lower panel). A visual inspection yields a first approximation: in the case of 
an initial plateau, the ligand is almost completely bound, so that the heat (per mol of 
ligand) in the plateau region corresponds to the reaction enthalpy. The molar ratio at 
half of the plateau value allows one to estimate the stoichiometry of the reactants; 
finally the slope in the transition region serves as a rough approximation of the binding 
affinity; in the case of an initial plateau, the dissociation constant kd is typically << A0. 
Exact values of these parameters are determined by a fit to the data: 
7. A fit to the experimental isotherm (see Fig. 1.3A lower panel) using the multi-site 
binding model (see Eq. 6; for further details see ref. (13)) yields K, n, the reaction 
enthalpy ΔH and entropy ΔS. Because non-amphipathic CPPs typically do not diffuse 
across the bilayer (93, 94, 150, 176-178), only the outer leaflet is accessible to the CPP, 
and this lipid concentration is approximately 60% of the total lipid concentration for 
SUVs (119). 
8. Repeating the experiment at different temperatures is recommended for 2 reasons: on 
the one hand, a reaction might be driven entirely by entropy, so that the enthalpy would 
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be zero and the calorimeter would not detect any signal (despite the ongoing binding 
reaction). On the other hand, the slope of ΔH versus T yields the change in molar heat 
capacity (ΔCP
0) which gives important information about hydrophobic (typically 
negative ΔCP
0) and electrostatic (typically positive ΔCP
0) contributions to the reaction. 
Electrostatic contributions to the binding can be also assessed by repeating the 
experiment at different salt concentrations. 
9. Repeating the experiments with different buffers results in valuable information 
about protonation reactions (e.g. histidine rich CPPs) which can be detected by ITC 
because of the different ionization enthalpies of the buffers (179). 
 
 
1.5. Notes 
1.5.1. Membrane leakage (calcein dequenching) 
1.) Using this protocol, it is observed that non-amphipathic WR9 and penetratin do not 
produce membrane leakage (see Fig. 1.1C and D). In contrast, the amphipathic 
penetratin mutant p2AL leads to pronounced membrane leakage already at low 
micromolar concentrations (see Fig. 1.1E).  
2.) The electrostatic interaction between the anionic dyes and cationic CPPs also affects 
the result. For example, the interaction of WR9 with calcein results in a decrease of the 
fluorescence which could, in principle, mask the membrane leakage (Fig 1F). This 
effect is even stronger for the acylated WR9 derivatives (see Fig. 1.1F) and p2AL at 
high concentration (see Fig. 1.1E). In contrast, the CPP interaction with the dye ANTS 
leads to an increase in fluorescence (see Fig. 1.1G), so that smaller membrane leaks 
should be detected with improved sensitivity.  
3.) Even under these improved conditions using ANTS (see Fig. 1.1H), no membrane 
leakage is observed for WR9. These data agree with previous studies where non-
amphipathic CPPs could not produce membrane leakage at physiologically relevant 
conditions (52, 94, 150, 180-182). However, they have caused membrane leakage under 
particular conditions such as a higher molar CPP/lipid ratios (>0.2), more permeable 
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dyes (carboxyfluorescein), ionic gradients over the membrane, and pH >7.5 (183) which 
is considered to play a limited role in the in vivo CPP transduction (183).  
1.5.2. Membrane integrity (31P NMR spectroscopy) 
Using this protocol, it is observed (see Fig. 1.2) that none of the investigated CPPs 
forms inverted micelles with lipids that are typical for physiological membranes - even 
at very high peptide concentration (4 mM). However, all amphipathic CPPs damaged 
the membrane in a detergent-like manner supporting the membrane leakage data (see 
Fig. 1.1). The critical micellar concentration of C18-, C16-, and C14-WR9 were found to 
be 26 µM, 49 µM, and ~5 mM, respectively, as determined by surface activity 
measurements (data not shown). 
 
1.5.3. Membrane binding 
1.) CPP uptake in biological cells is typically observed at low micromolar 
concentrations, (= similar concentrations as used in Fig. 1.3). Using the present ITC 
protocol, it is observed that the non-amphipathic CPP WR9 has a poor affinity (K ~ 103) 
for model membranes that have an anionic lipid contents typical for mammalian cells 
(see Fig. 1.3B). This is in contrast to the high affinity of the CPP for other anionic 
compounds of the cell membrane such as heparan sulfate (K ~ 105) (161).  
2.) The lipid affinity of non-amphipathic WR9 becomes, however, important (even at 
micromolar concentrations) when the membrane has a high anionic lipid content (see 
Fig. 1.3A) such as encountered in bacterial membranes. This might be important for 
species selectivity of transfection reagents.  
 
1.5.4. Applications 
1.) Using a variety of different protocols on model membranes, it is concluded that non-
amphipathic CPPs, such as WR9 and penetratin, likely do not traverse cell membranes 
by direct interaction with lipids. 
 
 
40 
1.5. Notes 
 
2.) This is in stark contrast to amphipathic CPPs, such as acylated WR9 or amphipathic 
penetratin derivate p2AL that both considerably disturb the model membrane already at 
low micromolar concentration. 
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Chapter 2: 
 
Enzymatic tyrosine de-
phosphorylation activates the cell-
penetrating peptide pen-A(pY)L3 
 
 
2.1 Introduction 
A variety of diseases is characterized by altered regulatory pathways inside 
biological cells. The correction of these intracellular pathways by pharmaceutical means 
is believed to improve the outcome in diseases, where efficient treatment with small 
molecule drugs is not available. Drug candidates for that purpose are small-interference 
RNA (siRNA) and specific intracellular antibodies (“intrabodies”). Their action on 
intracellular regulatory pathways is transient as compared to stable gene therapies, so 
that eventual side effects are supposed to be easier manageable. The benefit of these 
drug candidates has been repeatedly confirmed on cells in culture. In contrast, their 
widespread use in intact organisms is delayed, mainly because of difficulties to get 
these rather large and charged drug entities across membranes of living cells. Diverse 
physical procedures, such as electroporation and gene guns, exist to destabilize cell 
membranes for that purpose, but these procedures are not approved for use in higher 
                                                 
3 Sections 2.1 to 2.3.4 consist of a manuscript for a publication. 
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organisms. Also chemical procedures exist for that purpose, such as cell-penetrating 
peptides (CPPs) that act by both increasing the cell surface concentration of the drug 
and by membrane destabilization. Depending on the structure of the CPP, the membrane 
destabilization is provided by electrostatic actions (e.g., non-amphipathic CPPs) or by 
insertion into the lipid bilayer of the membrane due to hydrophobic attraction (e.g., 
amphipathic CPPs). Because of the property of small amphipathic CPPs to destabilize 
membranes, there is often only a small difference between concentrations required for 
efficient membrane destabilization and their toxicity which is typically designated as 
narrow therapeutic index (NTI) in clinical pharmacology. For example, CPPs such as 
transportan, MPG, and TP10 are membrane-lytic at low micromolar concentrations, but 
similar concentrations are required to assure their efficient delivery of drugs or 
fluorophores across biological membranes. Transient membrane damage and eventual 
cell losses might be tolerated on cells in culture, where surviving transfected cells will 
rapidly recover and proliferate. In contrast, the use of drug and gene delivery techniques 
in larger organisms requires more specific procedures to make the membrane 
destabilization confined to particular tissues of interest. 
 
We here propose a new technique that might help to increase the tissue-specificity 
and therapeutic index of CPPs. The technique is based on the action of phosphatases – 
enzymes that are present in numerous tumour cells and also endocytotic vesicles. For 
this purpose, we introduced a tyrosine phosphate by substituting A10 in the hydrophobic 
face of the model peptide penetratin p2AL ((1) which destabilizes synthetic membranes 
at low micromolar concentrations. We hypothesized that the charged phosphate in the 
hydrophobic face prevents the deep membrane insertion of the model peptide Penetratin 
A9(pY)10L13 (Pen-A(pY)L) thus reducing its membrane perturbation. Upon enzymatic 
de-phosphorylation of the peptide to Penetratin A9Y10L13 (Pen-AYL), the hydrophobic 
face of the peptide should be restored likely restoring its membrane-lytic property. The 
influence of the (de-)phosphorylation of the tyrosine (Y10) residue on the membrane 
perturbation of the peptide was tested on phospholipid model membranes and also on 
living CHO-K1 cells in culture. 
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2.2. Materials and Methods 
2.2.1. Materials 
The lipids POPC, POPG, and DOPE-PEG were purchased from Avanti Polar 
Lipids (Avanti Polar Lipids, Alabaster, USA). The fluorescent dye ANTS and its 
quencher DPX were from Molecular Probes/Invitrogen (Luzern, Switzerland). The 
cross-linked dextran gel Sephadex G-75 was from Pharmacia/GE Healthcare (Uppsala, 
Sweden). Tris was purchased from Merck (Darmstadt, Germany). Alkaline phosphatase 
from porcine kidney, NaCl, Triton X-100 and all other chemicals were from Sigma-
Aldrich (Buchs, Switzerland). The Tris-buffered saline contained 20 mM, Tris 100 mM 
NaCl (pH 7.4), and the buffer for the enzyme stock solutions was made of 20 mM 
glycine, 100 mM NaCl (pH 10). The peptides (all with amidated carboxy-terminus), 
including their phosphorylated and TAMRA-labelled derivatives, were purchased from 
Peptide 2.0 (Chantilly, VA) as trifluoroacetate salt (purity ≥97% as judged by HPLC). 
Gibco cell culture medium (DMEM/F12 1:1 w/o L-Glutamin), PBS pH 7.2, 0.05% 
Trypsin-EDTA, L-Glutamin, fetal calf serum, penicillin and streptomycin were all 
provided by Life Technologies (Paisley, UK). 
 
2.2.2. Determination of peptide concentration 
Peptides were first weighed on a microbalance and dissolved in Tris buffered saline 
(TBS). The pH was adjusted with diluted NaOH to 7.4 and TBS was added to make the 
final volume. Thereafter, the concentration of the stock solution was determined 
spectrophotometrically in their denatured state (2) using a molar absorptivity of 5500 
M-1 cm-1 at 281 nm for Trp and data averaging of triplicate measurements. Stock 
solutions of pen-A(pY)L >1 mM were avoided because of gel formation at higher 
concentration. 
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2.2.3. Calculation of the mean hydrophobic moment 
The mean hydrophobic moment of the peptides was calculated according to the 
procedure of Eisenberg (3). In short, the direction of the hydrophobic moment was 
calculated assuming an angle of 100° separating the side chains of the amino acids 
along the helical backbone plotted as helical wheel projections (4). The amplitude of the 
hydrophobic moment was calculated using the hydrophobicity scale of Fauchere & 
Pliska (5) that is based on the l-octanol/pH 7.1 aqueous solution partition ratios (P) for 
N-acetylated and C-amidated amino acids; the hydrophobic parameter π of a side chain 
is then estimated as the difference of log P (N-acetyl-amino acid) from that of N-acetyl-
glycine amide having the side chain “H”. In this scale, the most and least hydrophobic 
amino acids have π values of +2.25 (Trp) and -1.01 (Arg), respectively. For the 
phosphorylated tyrosine (N-acetyl, C-amide), a π of -0.38 was used based on logP 
calculations of a fragementation method (ChemBioDraw Ultra 12) in agreement with 
experimental observations for phosphorylated tyrosine (6).  
 
2.2.4. Preparation of dye-loaded LUVs 
The fluorescent dye ANTS and its quencher DPX were dissolved in 20 mM Tris pH 
7.4 for final concentrations of 12.5 and 45 mM for ANTS and DPX, respectively, and 
the pH was adjusted to 7.4 with diluted NaOH. Desired quantities of lipid mixtures were 
calculated to yield a final concentration of 40 mM. The PEGylated lipid DOPE-PEG 
was included in order to prevent the aggregation of the vesicles upon contact with the 
multivalent CPPs (7). In short, chloroform/lipid mixtures were dried to a film under a 
stream of nitrogen, followed by evaporation overnight under high vacuum (0.1 mbar) at 
room temperature and dark. The dry lipid films were suspended with the dye solution, 
followed by 10 freeze-/thaw-cycles (30 min) and subsequent extrusion for 10 times 
through polycarbonate filters (100 nm pore size, Whatman, Maidstone, UK) with a 
barrel extruder (LIPEX, Northern Lipids, Burnaby, Canada) at ~15 bar. The resulting 
dye-loaded large unilamellar vesicles (LUVs) had a homogenous size distribution with a 
diameter of ~100 nm as confirmed by dynamic light scattering on a Zetasizer Nano ZS 
(Malvern; Worcestershire, UK).  
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Dye-filled vesicles were separated from extravesicular free dye by size-exclusion 
chromatography on a Sephadex G-75 column (43 x 1.8 cm). Running buffer was TBS. 
The size distribution of the harvested LUVs was measured again by dynamic light 
spectroscopy and 5-6 fractions with the lowest laser attenuation were combined. 
Thereafter, the total lipid content of the LUVs was determined by a phosphorous assay 
(8). 
 
2.2.5. Leakage assay 
Fluorescence measurements were carried out on a Jasco FP-6500 fluorescence 
spectrophotometer (JASCO Corp., Japan) under constant stirring. A quartz microcuvette 
(d = 5 mm) with a filling volume of 250 µL was used for measurements at room 
temperature. Excitation and emission wavelengths were set to 360 and 518 nm for 
ANTS-loaded vesicles. Both, excitation and emission slit widths were set to 3 nm. An 
aliquot of 8 - 35 µL of peptide stock solutions with indicated concentrations between 10 
µM and 1 mM were added to the vesicles (~1.75 mM LUVs). The change of 
fluorescence intensity upon peptide addition, corresponding to release and de-quenching 
of ANTS, was constantly measured during 10 min. Thereafter, the vesicles were 
solubilized in order to release all encapsulated ANTS using 25 µL 5% (v/v) Triton X-
100 to determine the maximum fluorescence intensity corresponding to full leakage. 
The percentage of dye release was estimated by the following equation 
0 max 0 (%)  100( - ) /( - )Leakage F F F F=  
where F and Fmax correspond to the fluorescence intensity of ANTS before and after the 
addition of detergent at ~10 min, respectively, and F0 represents the original 
fluorescence intensity of intact vesicles at t = 0 min. 
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2.2.6. Enzymatic de-phosphorylation 
Alkaline phosphatase from porcine kidney (APPK) was chosen because it showed 
pronounced de-phosphorylation activity (on p-nitrophenyl phosphate) at neutral pH (not 
shown). For that purpose, 0.86 mg of APPK was dissolved in 1 mL Gly buffer (pH 10), 
resulting in 5.55 μM stock solution using the molecular weight of 155 kD (9). Leakage 
assays involving enzymatic de-phosphorylation of pen-A(pY)L were done under the 
same conditions as without protein. Peptide induced dye-leakage percentages after 
addition of APPK were calculated as stated above, but changed F0 to the fluorescence 
intensity prior protein addition. 
 
2.2.7. Cell Culture 
Wild-type Chinese hamster ovary cells, CHO-K1 (ATCC; Manassas, VA), were 
grown in DMEM/F12 (1:1) medium supplemented with 10% (v/v) fetal calf serum 
(FCS), 1% (v/v) 200 mM L-Glutamine, 100 U/mL penicillin, and 100 μg/mL 
streptomycin using 75 cm2 large vented cell culture flasks (BD Biosciences; Allschwil, 
Switzerland). The cells were incubated at 37 °C in humidified air containing CO2 (5%). 
Every second day (at ∼80% confluency), the cells were detached (using trypsin and 
EDTA.Na4 at 0.5 and 0.2 g/L, respectively) and split at a ratio of 1:10 up to a maximum 
of 25 passages. 
 
2.2.8. Confocal Laser Scanning Microscopy 
CHO cells were seeded in 12-well dishes onto sterile noncoated microscopic 
coverslips and incubated for 48 h in order to obtain a confluency of ∼80%. Thereafter, 
cells were rinsed three times with ~2 mL PBS to remove residual FCS and to avoid 
peptide scavenging by albumin. Subsequently, 2 mL of the peptide solution (2 or 20 µM 
peptide) in DMEM/F12 (1:1) (containing antibiotics, but no FCS) was added. In case of 
additional phosphatase, the enzyme was added directly to the peptide solution 
immediately prior incubation. After 30 min of contact time in the cell incubator, cells 
were rinsed three times with PBS, mounted upside down on top of  25 μL Fluoromount 
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G (Southern Biotechnology Associates, Birmingham, AL) and imaged immediately for 
no longer than 15 min. Confocal images were acquired with an inverted confocal laser 
scanning microscope (Fluoview FV1000, Olympus, Japan) using a Plan-Apochromat 60 
× 0.7 NA lens with excitation at 559 nm (yellow laser diode) for TAMRA-labeled 
peptides and using differential interference contrast (DIC). 
 
 
2.3. Results and discussion 
2.3.1. Peptide design 
Different theories have been proposed to explain the interaction of peptides with 
biological and model membranes. Among them, the hydrophobic moment (µ) of helical 
peptides is one of the most prominent parameters to estimate the potential interaction of 
the peptide with phospholipid membranes and especially their membrane lytic 
properties (10). In general, it appears that not a maximum hydrophobicity of the 
peptide, but polar-nonpolar asymmetry (“amphiphilicity”) is key to membrane lysis 
(11), although other processes for membrane destabilization exist, such as self-
aggregation and pore formation of peptides. 
A large hydrophobic moment (µ ≈ 0.5 – 1) (12), for example, indicates that the 
helix is amphipathic perpendicular to its backbone, i.e. the hydrophobic and hydrophilic 
side chains of the amino acids are opposite each other along the long axis view of the 
peptide (Fig. 2.1) (13). The resulting amphipathicity (or “amphiphilicity”) facilitates the 
peptide’s partitioning into the interface region of phospholipid membranes which often 
destabilizes membranes more than a transmembrane orientation, such as studied with 
many antimicrobial peptides. 
In contrast, a low hydrophobic moment (µ ≈ 0 – 0.4) affects the membrane 
interface to a lesser extent, and the peptides can be either transmembranous or globular, 
depending on the overall prevalence of hydrophobic or hydrophilic amino acids, 
respectively (13). From literature and own experiments with penetratin, we knew 
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Fig. 2.1. Helical wheel projections of the peptides investigated. The 16 amino acids (single 
letter code) are plotted from the N-terminal end (1) to the C-terminus (16) using an angle of 
100° between adjacent amino acids. The direction (arrrow) and amplitude of the mean 
hydrophobic moment are indicated in the middle of the wheel. Amino acids with hydrophobic 
side chains are displayed in grey. (A) wild-type penetratin (non-lytic at 20 µM). (B) more 
amphipathic pen-AYL mutant (lytic). (C) tyrosine phosphate (pY10) in pen-AYL reduces the 
hydrophobic moment with consequences for lipid membrane binding. 
that wild-type penetratin (µ = 0.327) is not lytic to model membranes at low micromolar 
concentrations. In contrast, when the amphiphilicity is increased by a 3-amino acid 
substitution to penetratin mutant pen-A9A10L13 (pen-2AL; µ = 0.510), the peptide 
becomes highly lytic as a results of increased hydrophobic moment (1). The peptide’s 
effect on the membrane integrity was almost detergent-like, as shown by 31P NMR 
spectroscopy (14) and it showed full vesicle leakage at already low micromolar 
concentration. We assumed that a molecular switch between both molecules would offer 
a valuable biomedical tool for tissue-activated drug uptake or cell-specific lysis (e.g., 
for metastatic tissue), especially because biological phosphatases could be available to 
activate the peptide in-situ. 
Based on this assumption, we modified pen-2AL in a way that the Ala10 in the 
hydrophibic face (Fig. 2.1) was replaced by a tyrosine, that could be either 
phosphorylated or not. It is known that even small changes in the hydrophobic moment 
(i.e., (∆µ ≥ 0.06) may considerably influence the membrane lysis of peptides (15). We 
therefore assumed that de-esterification of the phosphate group might provide a 
molecular switch between the presumably non-lytic phosphorylated pen-A9(pY)10L13 
(pen-A(pY)L; µ = 0.469) and presumably lytic de-phosphorylated pen-A9Y10L13 (pen-
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AYL; µ = 0.549). As next step after peptide design, we tested the effect of the A10 → Y 
substitution on model membranes, because the action of pen-2AL on model membrane 
was almost detergent-like, as shown by 31P NMR spectroscopy (14). 
 
2.3.2. Peptide action on model membranes (LUVs) 
Aliquots between 8 and 35 µL peptide stock solutions were titrated under 
continuous stirring into 250 µL of 1.75 mM phospholipid model membranes (LUV 
suspensions filled with the self-quenching dye ANTS and an additional quencher DPX) 
to monitor the peptide’s membrane permeation capacity. Tab. 1 summarizes the final 
peptide concentrations and corresponding peptide/lipid (P/L) ratios using model 
membranes of both charged and uncharged phospholipids. 
At low micromolar concentration, the unphosphorylated pen-AYL (µ = 0.549) 
lysed both uncharged model membranes (POPC/DOPE-PEG, 96:4 n/n) and charged 
model membranes (POPC/POPG/DOPE-PEG, 76:20:4 n/n) (Fig. 2.2, right panel) with 
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Figure 2.2. Peptide induced ANTS leakage from LUVs. (Left panel) Concentration dependent 
ANTS leakage from POPC/POPG/DOPE-PEG (76:20:4 mol%) LUVs as induced at s by the 
injection of  unphosphorylated peptide Pen-A9Y10L13. Peptide concentrations correspond to 4, 
16, 32, 64, 96 and 128 µM (from bottom to top). At 600 s, Triton X100 was injected to 
determine the maximum fluorescence intensity corresponding to full leakage of vesicles; the 
maximum fluorescence intensity after triton addition was increased by the peptide, with the 
effect being less pronounced as compared to other fluorescent dyes,. (Right panel) Averaged 
ANTS leakage (n = 3 per concentration) from both charged (diamonds) and uncharged LUVs 
(circles) as induced by both pen-AYL (filled) and pen-A(pY)L (empty) as function of peptide 
concentration. 
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Tab. 1. Calculated dye-leakage from both charged and uncharged vesicles in presence of 
pAYL and pA(pY)L for 600 s. 
 
pen-AYL pen-A(pY)L pen-AYL pen-A(pY)L 
Dye leakage (%) 
[peptide] 
(µM) P/L uncharged LUVs 
LUVs with 20% surface 
charge 
0.5 0.0003 0.6 -0.3 2.4 2.1 
1 0.0006 0.6 2.5 2.0 0.0 
2 0.0012 1.1 -0.2 0.9 1.9 
4 0.0025 1.8 -0.4 4.9 0.9 
8 0.005 5.3 0.2 7.2 1.9 
16 0.01 5.7 0.6 9.5 6.1 
32 0.02 11.7 2.5 18.7 8.4 
64 0.04 19.9 2.9 49.4 12.4 
96 0.06 23.7 2.5 87.7 15.2 
128 0.08 24.3 - 90.9 - 
 
 
 
56 
2.3. Results and discussion 
 
high efficiency (Tab. 1). Interestingly, the lipid composition affected both the kinetics 
and extent of dye-leakage of the cationic peptide. 
In case of negatively charged vesicles, peptide-induced leakage was both larger and 
faster (Fig. 2.2, left panel) which could be explained by a higher membrane interface 
concentration of the peptide as a result of electrostatic attraction. For example, using 
same final peptide concentrations of 16 µM and 128 µM, the dye-leakage on charged 
membranes was 1.7 and 3.7 times more pronounced, respectively, as compared to 
uncharged membranes (Tab. 1). The difference of the peptide’s potency to induce dye-
leakage depending on the vesicle surface charge is readily visible at higher peptide 
concentrations e.g. at 96 µM, pen-AYL induces 87.7% and 23.7% dye-leakage for 
charged and uncharged, respectively. 
 
2.3.3. Additon of pen-A(pY)L to LUVs 
Titrations were done as described in the previous section. As evident in both Fig. 
2.2 and Tab. 1, the peptide’s ability to permeate LUVs is strongly decreased upon 
phosphorylation of the Tyrosine residue. Comparison between induced dye-leakages of 
the two peptides (Tab. 1) shows that Tyr-phosphorylation of pen-AYL causes loss of its 
ability to induce significant dye-leakage from uncharged LUVs. However, permeation is 
still observable at peptide concentration ≥16 µM in charged LUVs with up to 15.2% 
dye-leakage at 96 µM i.e. membrane permeation of pen-A(pY)L is 6 times less than that 
of pen-AYL with charged vesicles. 
Again, the concomitant increase of fluorescence emission intensity after TX100 
addition with increasing peptide concentration is due to an enhancing effect of the 
peptide on fluorescence emission of ANTS, which is even more pronounced for pen-
A(pY)L (data not shown). The “negative” leakage of uncharged vesicles in presence of 
pen-A(pY)L are probably due to the slight dilution (10:11) of the suspension upon 
peptide addition. 
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2.3.4. Enzymatic dephosphorylation of pen-A(pY)L in presence of LUVs 
The design behind the pen-A(pY)L peptide aimed at using enzymatic phosphate 
cleavage as a molecular switch in order to turn the peptide from its phosphorylated, 
membrane-inactive form into a membrane-active form, which then should lead to 
adjustable dye-leakage from LUVs in a concentration dependent manner. However, the 
activity of protein phosphatases can be very specific regarding both their substrate and 
solvent condition. For that reason, several phosphatases were tested upon their activity 
in TBS. Enzyme activity was monitored by means of UV absorption spectroscopy, 
using the unspecific substrate 4-nitrophenyl phosphate (4NPP). Alkaline phosphatase 
from porcine kidney (APPK) showed reasonable activity in TBS i.e. 1 mM 4NPP was 
completely dephosphorylated by 0.55 μM APPK in approximately 90 min, which 
corresponds to an averaged reaction rate of 19.5 μmole/min/μM protein. As apparent in 
Fig. 2.3, 0.25 μM APPK is able to dephosphorylate the pen-A(pY)L peptide, turning it 
into the membrane permeating pen-AYL. One hour after addition of APPK, peptide-
induced dye-leakage was 8.1 and 67.6% with 32 and 64 μM peptide, respectively. For 
comparison, pen-AYL (obtained from synthesis rather than phosphate cleavage) was 
able to induce 18.7 and 49.4%, respectively, at those two concentrations. Discrepancy 
between those values can partially be explained by kinetics. For instance, dye-leakage 
induced by 64 μM pen-AYL is still increasing after 600 s (Fig. 2.2) when the 
fluorescence intensity for calculation of leakage is taken. However, dye-leakage does 
not increase anymore after 300 s in the case of 32 μM pen-AYL (Fig. 2.2). It is thus 
reasonable to assume that most of the 64 μM peptide was dephosphorylated during the 
first 30 min after APPK addition. Hence, the reaction rate of pen-A(pY)L 
dephosphorylation by APPK would be 8.5 μmole/min, which is ~half of the 19.5 
μmole/min/μM observed for 4NPP dephosphorylation. The slight decrease in 
fluorescence intensity right after addition of APPK is likely due to dilution. 
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Figure 2.3. Alkaline phosphatase from porcine kidney (APPK) activates the phosphorylated 
peptide Pen-A9(pY)10L13. 1.75 mM POPC/POPG/DOPE-PEG (76:20:4 n/n) LUVs show only weak 
leakage in presence of pen-A(pY)L. At 600 s, 32 µM of the phosphorylated peptide pen-A(pY)L 
causes only 8.4% leakage and thus much less vesicle leakage as compared to the 
unphosphorylated peptide (compare to Fig. 2.2; different time scale). APPK was added at 1500 
s and activated the peptide as evident by e.g. 67.7% leakage with 64 µM pen-A(pY)L after 1 h 
(top trace). Full leakage was achieved with TX100 at ~5100 s. 
2.3.5. Addition of TAMRA-pen-AYL to CHO cells 
After having assessed the permeabilization of model membranes as induced by 
each peptide we investigated their uptake by living cells. For this purpose, we incubated 
CHO cells with TAMRA-labelled derivatives of each peptide for 30 min. The incubated 
cells were then investigated by means of confocal microscopy. Note that the 
fluorescence signal intensity is arbitrary and dependent on the voltage of the 
photomultiplier tube (PMT). We therefore indicated the applied voltage for each image 
to be able to compare the actual peptide concentrations in the cells. Differential 
interference contrast (DIC) images complement the fluorescence images by providing 
visual evidence of the cells’ condition and possible toxic effects (e.g. by membrane 
destabilization as with pen-2AL; compare Fig. 1.2 i in chapter 1) – they are provided 
and discussed in chapter 3.  
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We incubated the CHO cells with peptide concentrations of 2 and 20 µM. The 
lower concentration corresponds to commonly used concentrations in the low 
micromolar range from 1-10 µM where CPPs show cellular uptake (16-18). The higher 
concentration was chosen for comparison with the obtained leakage data (Fig. 2.2) and 
corresponds to the onset of dye leakage (>5% at 16 µM beside pen-A(pY)L in 
uncharged LUVs) from LUVs in presence of either peptide. 
The TAMRA signal of pen-AYL in CHO cells after incubation is shown in Fig. 
2.4. At 2 µM, most cells show endocytotic uptake of the peptide as indicated by the 
punctate fluorescence pattern. Roughly 5-10% of the cells show additionally a 
fluorescence signal in the cytoplasm. At 20 µM the peptide manages to enter into the 
cytoplasm of all cells. However, the corresponding DIC images show that many of these 
cells are dead or heavily damaged (see Fig. 3.5A in chapter 3). Note that this is not the 
case for the lower peptide concentration (Fig. 3.4A in chapter 3). 
 
2.3.6. Addition of TAMRA-pen-A(pY)L to CHO cells 
Fig. 2.5 shows a typical image of CHO cells after incubation with either 2 or 20 μM 
TAMRA-pen-pA(pY)L. The cells show, in contrast to TAMRA-pen-AYL, almost no 
uptake at the lower peptide concentration (note the highest used PMT voltage). On the 
other hand, at 20 μM the peptide apparently manages to reach the cytosol in at least 
25% of the cells (our numbers are chosen rather cautious because the arbitrariness of the 
fluorescence signal). The cells remained healthy at both peptide concentrations (see Fig. 
3.4B and 3.5B in chapter 3). Interestingly, TAMRA-pen-A(pY)L showed better 
relation between cellular uptake and toxicity than TAMRA-pen-AYL which, at the 
given conditions, either had low access to the cytosol or was toxic for the cells. 
2.3.7. Addition of TAMRA-pen-A(pY)L with phosphatase to CHO cells 
Finally, we incubated CHO cells with TAMRA-pen-A(pY)L in presence of 0.1 µM 
APPK. Note that the enzyme needs time to dephosphorylate the peptide. If we assume  
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Fig. 2.4. Confocal microscopy images (fluorescence channel) of CHO cells after incubation 
with 2 (A) or 20 μM TAMRA-pen-AYL (B) for 30 min. (A) With 2 μM most cells show a punctate 
fluorescence pattern with single cells having an even distribution throughout the cytoplasm. 
This is indicative that most of the peptide is trapped in endosomes but some manages to enter 
the cytosol. (B) All cells show heavy uptake of TAMRA-pen-AYL (also indicated by the lower 
PMT voltage compared to (A)). However, the cells are mostly dead (as indicated by DIC images, 
see chapter 3 for details), probably due to membrane permeation (compare with dye leakage 
in Fig. 2.2). (in brackets) PMT voltage. 
 
Fig. 2.5. Confocal images of CHO cells after incubation with 2 (A) or 20 μM TAMRA-pen-
A(pY)L (B) for 30 min. (A) No visible uptake of 2 μM TAMRA-pen-pA(pY)L. (B) Most cells show 
both endocytotic uptake and presence of the peptide in the cytoplasm after incubation with 20 
μM. The fluorescence pattern is comparable to the result obtained with 2 μM TAMRA-pen-AYL 
but here more cells show fluorescence in the cytoplasm. The cells were also still healthy (as 
judged by DIC, see chapter 3). (in brackets) PMT voltage 
A (725 V) B (600 V) 
A (650 V) B (500 V) 
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the rate of 8.5 μmole/min/μM as observed in the leakage assay 20 µM pen-A(pY)L 
would need 25 min to be completely dephosphorylated. The cells are therefore probably 
not exposed to activated peptide during the whole incubation period. 
As shown in Fig. 2.6 CHO cells show a very similar peptide uptake as without the 
addition of APPK. Intracellular TAMRA-pen-A(pY)L is almost not present after 
incubation at 2 µM. However, the peptide seems to be well distributed throughout the 
cells when incubated at 20 µM. Notable are the absence of punctate patterns and the 
needed PMT voltage of 500 V which was only as low as with 20 µM of the 
unphosphorylated TAMRA-pen-AYL. 
 
Fig. 2.6. CHO cells after incubation with 2 (A) or 20 μM TAMRA-pen-A(pY)L (B) in presence of 
0.1 μM APPK. (A) The cells show only very little signal after incubation with low peptide 
concentration. (B) In contrast, at higher concentration the peptide seems to be evenly 
distributed in the cells. The difference to incubation in absence of the enzyme is, however, not 
that pronounced. 
2.3.8. Conclusion 
In this chapter, we designed an inducible membrane permeation system based on 
the pen-2AL mutant (1) of the CPP penetratin. The substitution of A10 in pen-2AL by 
pY10 decreased the peptides’ hydrophobic moment that membrane permeation was 
A (725 V) B (500V) 
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strongly reduced as evident by the low dye leakage of LUVs in presence of pen-A(pY)L 
(Fig. 2.2, right panel). In contrast, unphosphorylated pen-AYL showed strong dye 
leakage from LUVs similar to pen-2AL (Fig. 2.2, right panel) indicating increased 
membrane permeation. The membrane inactive pen-A(pY)L then could be activated  by 
enzymatic dephosphorylation by APPK at submicromolar concentration (Fig. 2.3). 
Finally, we could demonstrate by fluorescence confocal microscopy the cellular uptake 
of pen-A(pY)L by living CHO cells (Fig. 2.5B).  Additionally provided APPK caused 
the peptide to further locate to the cytoplasm (Fig. 2.6B) illustrating its potential benefit 
for drug delivery. 
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Chapter 3: 
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3.1. Introduction 
The uptake of cell-penetrating peptides (CPPs) into a number of different living 
cells has been repeatedly reported in the past 20 years. The various cell types included 
bacterial, insect, mammalian, plant and yeast cells that typically differ in their 
membrane composition and their capacity for endocytosis. A common uptake 
mechanism, if at all existing, has therefore puzzled many investigators ever since. 
It appears that CPPs are promising vectors for intracellular delivery of a broad 
variety of biologically relevant (macro)molecules such as nucleic acids (e.g. 
oligonucleotides, pDNA, siRNA), peptides and proteins (references (1,2) and also 
introduction of chapter 1). In in vitro experiments both the CPP alone and the 
corresponding conjugate with the aforementioned compounds have been shown to be 
taken up by a variety of cell lines. 
Two major caveats, however, prevented their distribution in medical applications to 
date. Firstly, and probably most importantly, the actual mechanism of CPP uptake is not 
resolved yet. Both passive translocation and active uptake have been suggested 
according to the results of recent studies that imply variable uptake routes (3,4), usually 
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dependent on the applied concentration. Whenever referring to a potential common 
uptake mechanism, it is thus important to exclude artifacts of the observational methods 
and to review whether quantitative data of the uptake are available for comparison. The 
latter is rarely the case. 
For example, it has been found that the highly cationic CPPs bind electrostatically 
to the cell membrane of many cell types. The adsorbed CPP can lead to artifacts, 
whenever cells are prepared for microscopy. Fixation with methanol, for example, can 
create leaky cell membranes where the adsorbed CPP appears in the (dead) cells to a 
much higher extent than in vivo uptake would produce. 
Also, the high analytical sensitivity of the observation methods might create 
confusion as to what the CPP “uptake” is referring to. Fluorescent methods, such as 
confocal scanning laser microscopy and fluorescent cell sorting, have a measuring range 
of several orders of magnitude. Reports of absolute intracellular CPP content thus are 
challenging and rarely available for comparison. Likewise, gene expression can be 
technically amplified from a few molecules (e.g. copies of mRNA). As a result, it must 
be emphasized that the term “CPP uptake” was often used without specific quantitation 
and/or possibility for comparison. 
Tab. 2. Used peptides and their corresponding primary structure. Positively or negatively 
charged residues and groups are in red and blue, respectively. 
Peptide sequence (single letter code) 
TAMRA-pen-AYL TAMRA-RQIK  IWFQ  AYRM  LWKK 
TAMRA-pen-A(pY)L TAMRA-RQIK  IWFQ  A(pY)RM  LWKK 
 
Secondly, especially amphipathic CPPs (5) can be toxic to cells at low micromolar 
concentrations either by destabilizing the integrity of the lipid part of a membrane by 
membrane insertion (6) or by pore formation (7), similar to the action of some 
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antimicrobial peptides like melittin (8,9). Toxicity of CPPs on living cells is usually 
concentration dependent and does not necessarily concur with the concentration range 
where they succeed to enter cells. 
As discussed in the previous chapter, we studied the effect of the penetratin mutants 
pen-AYL and its phosphorylated variant pen-A(pY)L (sequence Tab. 2) on both 
synthetic and biological membranes to assess their property to permeate these. In the 
present chapter it is described that the observed difference of both peptides depends on 
the culture medium which gives further information on the biological uptake processes. 
Most importantly, CPP uptake was higher a cell culture medium that promoted cell 
adherence to the cell culture support (i.e. plastic dish or glass cover slips) which 
eventually substantiates earlier findings that cells in suspension are difficult to transfect 
as they are not infiltrated by CPPs. Specifically, it was found that CPPs at low 
micromolar (2 µM) concentration tend to detach the cells – especially when CPP was 
administered in PBS (phosphate buffered saline) instead of cell culture medium. At 
higher concentration (20 µM), however, the CPP helped to attach the cells to the glass 
support, in analogy to earlier findings with polylysine. 
 
 
3.2. Materials and methods 
3.2.1. Materials 
The TAMRA-labelled peptides (labelled at the amino-terminus; amidated carboxy-
terminus) were purchased from Peptide 2.0 (Chantilly, VA) as trifluoroacetate salt 
(purity ≥97% as judged by HPLC). All materials for cell culture (see previous chapter) 
were provided by Life Technologies (Paisley, UK). 
 
3.2.2. Cell Culture 
See previous chapter for details. 
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3.2.3. Confocal Laser Scanning Microscopy 
Microscopy was performed as already described in the previous chapter. Incubation 
of the cells was done at ~80% confluency for every sample. Only difference here was 
the choice of the incubation medium: immediately prior incubation, the TAMRA-
labeled peptides were diluted from a 100 µM stock solution (buffer 20 mM Tris 100 
mM NaCl pH 7.0) into either PBS pH 7.2 or pure DMEM/F12 (i.e. without serum, 
antibiotics or glutamine) to a final concentration of either 2 or 20 µM with a total 
volume of 2 mL. The cells grown on coverslips then were incubated with the 
corresponding peptide solution prior to microscopy. 
 
 
3.3. Results 
3.3.1. Cell adhesion when incubated with peptide dissolved in PBS 
As described in the previous chapter, wild-type Chinese hamster ovary (CHO) cells 
were incubated with the TAMRA-labelled pAntp mutants TAMRA-pen-AYL and 
TAMRA-pen-A(pY)L in order to track the cellular uptake of these peptides by means of 
fluorescence microscopy. In order to avoid the introduction of methodical artifacts by 
cell fixation (10,11), we only monitored live which were not fixated. Furthermore it is 
important to note that the concentration of the CPPs did influence the effect of 
secondary amphipathic CPPs (5) on both model membranes (see previous chapters) and 
biological membranes (see Drin et al. (12) for uptake of pAntp by K562 cells). For that 
reason, two concentrations of the CPPs were chosen (2 and 20 µM) to monitor the effect 
of these peptides on living cells. At comparable peptide concentration (16 µM), pen-
AYL showed 9% dye leakage out of large unilamellar vesicles (LUVs) composed of  
1.75 mM POPC/POPG/DOPE-PEG 76:20:4 n/n. i.e. a membrane charge that reflects 
eukaryotic cells (see previous chapters for other peptide concentrations and lipid 
contents). 
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Fig. 3.1. DIC of cover slips originally covered with CHO cells (~80% confluency) after 
incubation in PBS for 30 min with 2 µM TAMRA-pen-AYL (A) or TAMRA-pen-A(pY)L (B). Note 
that the cover slips mostly showed sparse single cells (similar to Fig. 3.3) and the shown 
examples are rather exceptional. Generally, most cells were detached after incubation with 2 
µM of either peptide 
Prior to the 30 min incubation of the cells with the peptides, the cells were rinsed with 
phosphate buffered saline (PBS). After the incubation with either peptide (2 µM in 
PBS) the cells detached from the surface (see differential interference contrast (DIC) in 
Fig. 3.1) leading to sparse single cells or groups of cells. Despite of very gentle 
pipetting the PBS solution along the recipient wall, most parts of the cover slip were 
simply devoid of cells under these conditions. Cells were therefore assumed to be 
detached, which was also supported by the round shape of the cells with very little 
presence of adhesion structures. 
In contrast, cells that are attached to the glass support were flat and showed many 
adhesion structures (compare to Fig. 3.4) when incubated with higher CPP 
concentrations which, in analogy to polylysine glass coatings, might act as a “glue” 
between cells and the glass support. Upon closer inspection of the individual steps of 
the experimental procedure it became apparent that the cell monolayer was detaching 
from the cover slips during the careful washing steps with PBS after incubation of cells 
with 2 µM of either peptide.  
A B 
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Fig. 3.2. DIC of CHO cells after incubation in PBS for 30 min with 20 µM pAntp mutants. 
Approximately half of the cells, and thus much more as in Fig. 3.1, remained at the cover slip 
during incubation and related washing steps. Cells incubated with 20 µM TAMRA-pen-AYL 
frequently died during the procedure (A), whereas they remain healthy in presence of 20 µM 
TAMRA-pen-A(pY)L (B). 
At 20 µM peptide concentration a part of the cells clearly stayed attached to the cover 
slide. Nevertheless, as the incubation with peptide was done with cells at a confluency 
of approximately 80%, about 50% must have been detached even at the 20 µM peptide 
concentration (see Fig. 3.2). Despite the high fraction of adsorbed cells, it appears by 
visual examination of the cells incubated with 20 µM TAMRA-pen-AYL that some 
cells were destroyed by the peptide (indicated by both dark or empty cell ruins and cell 
debris across the cover slide; Fig. 3.2A). The inherent nature of the DIC imaging 
contrast suggests that the dark appearance of some cells is due to dense aggregates that 
might be caused by peptide binding to various cellular polyanions, such as DNA, RNA 
and heparin sulfate. 
On the other hand, cells incubated with 20 µM of phosphorylated TAMRA-pen-
A(pY)L appear to be undamaged (Fig. 3.2B). They show, however, a similar loss of 
approximately half of the cells originally attached to the cover slide as when incubated 
with 20 µM TAMRA-pen-AYL. 
A B 
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In conclusion, the incubation of CHO cells with TAMRA labeled pAntp mutants in 
PBS impairs cell adhesion and promotes detachment of the cells from the support glass 
at 2 µM, independent of the peptide (Fig. 3.1). In contrast, toxicity, as apparent from 
dense cell aggregates, is observed for the amphipathic TAMRA-pen-AYL, but not for 
the phosphorylated mutant. The cell detachment is reduced at higher peptide 
concentration (20 µM) for either peptide (Fig. 3.2). 
 
3.3.2. Cell adhesion when incubated with pure PBS 
As described above, higher peptide concentration markedly reduced the detachment 
of cells during the incubation period, so that CPPs might be considered as an adhesion 
factor for the cells. We therefore incubated CHO cells with pure PBS for 30 min in 
order to verify whether PBS alone (and the involved mechanical forces from pipetting) 
induces the cell detachment from the cover slides. Indeed, as evident in Fig. 3.3, 
incubation with PBS produces the same cell detachment as incubation with 2 µM of 
either peptide: Apparently, PBS alone (or in combination with the rinsing forces) causes 
detachment of the cells from the glass surface. 20 µM concentration of either peptide 
seems to counteract this effect, probably in a similar manner as coating glass surfaces 
with polylysine (see (13)) for improved cell adhesion. 
 
 
Fig. 3.3. Only spare single cells of the 
originally attached CHO cells remained on 
the glass cover slide after a 30 min 
incubation with pure PBS (originally 
confluency was ~80%). The incubation with 
PBS caused most cells to detach from the 
surface and being flushed away during the 
subsequent washing steps. 
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Fig. 3.4. DIC of CHO cells after incubation in DMEM/F12 for 30 min with 2 µM TAMRA-pen-
AYL (A) or TAMRA-pen-A(pY)L (B). The cells stayed attached to the cover slip and appeared 
healthy after incubation with either peptide. 
  
Fig. 3.5. DIC of CHO cells after incubation in DMEM/F12 for 30 min with 20 µM TAMRA-pen-
AYL (A) or TAMRA-pen-A(pY)L (B). Although the cells did not detach during the incubation 
period, 20 µM TAMRA-pen-AYL seems to be much more toxic (as evident by cell ruins and 
debris) for the cells in contrast to the phosphorylated variant. 
A B 
A B 
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3.3.3. Cell adhesion when incubated with peptide dissolved in DMEM/F12 
After observing the unfavorable loss in cell adherence upon incubation with PBS, 
we changed the solvent for incubation with the pAntp mutants to pure DMEM/F12 (1:1 
v/v) without adding fetal calf serum (FCS) or other additives. In particular, addition of 
serum was omitted to prevent interaction or even precipitation between its protein 
components (especially albumin) and the CPP. When dissolved in DMEM/F12, 
incubation with either peptide did not cause the loss of cell adhesion that was observed 
after incubation in PBS. At 2 µM, both peptides did not cause cell detachment from the 
cover slips, and cells had a healthy aspect (Fig. 3.5), as apparent by the cell shape and 
multiple adhesion structures.  
When increasing the concentration of the unphosphorylated TAMRA-pen-AYL to 
20 µM, the cell adhesion still remained but, similar as with PBS, half of the cells 
appeared to be in critical condition, as again indicated by both dark or empty cell ruins 
and lots of cell debris (Fig. 3.5A). In contrast, the phosphorylated TAMRA-pen-
A(pY)L peptide did not harm the cells at 20 µM as they still have a healthy appearance 
after incubation (Fig. 3.5B). For both peptides several dark spots are visible in the 
extracellular space which is probably caused by dense peptide aggregates that produce 
no fluorescence – most likely because of fluorescence quenching within the aggregates 
as reported previously (4). 
In conclusion, the present observations suggest that the selection of the incubation 
medium has a profound effect on the ability of CHO cells to adhere on glass cover slips 
and thus the conclusion derived from the remaining cells on the CPP uptake. Cells being 
detached may represent more than 50% of the total cells and would not appear in the 
microscopic observations, so that CPPs effects on the detached cells would remain 
undocumented. Incubation of cells with peptides dissolved in DMEM/F12 prevents cell 
detachment during an incubation period of 30 min. 
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3.4. Discussion 
We have investigated the effect of cell culture medium on CHO cells during the 
incubation with two CPPs, TAMRA-pen-AYL and TAMRA-pen-A(pY)L, at 2 and 20 
µM. Both the effect on cell adhesion to the noncoated glass cover slips and CPP’s 
toxicity were assessed by means of confocal microscopy using DIC which provided 
excellent visual assessment of cell morphology. The cells were incubated with peptide 
dissolved in either PBS or DMEM/F12. 
 
3.4.1. Cell adhesion in dependence of incubation medium 
The adhesion of CHO cells to the glass support after the incubation period was 
strongly dependent on the choice of incubation medium. In the absence of peptide or at 
low peptide concentration, incubation with PBS could not preserve the cell-glass 
contact leading to an almost complete loss of cell adherence to the glass support within 
30 min. This effect could be attenuated by a tenfold increase of peptide concentration, 
where only half of the cells detached after incubation with 20 µM of either peptide. In 
contrast, cells incubated with peptide dissolved in DMEM/F12 stayed attached to the 
cover slips independent of peptide concentration. 
In cell culture, attachment of cells to plastic or glass surfaces is dependent on 
various (extra)cellular adhesion molecules (CAMs; e.g. laminin or fibronectin) and 
membrane-spanning receptor proteins (integrins) that mediate the interaction between 
the supporting surface and the cell (14). Importantly, there is evidence that the binding 
of CAMs to the integrin receptor is regulated by divalent cations such as Mg2+ or Ca2+ 
(15,16). As PBS buffer is devoid of divalent cations we assume that their absence 
during incubation induced the overall cell detachment. In contrast, the DMEM/F12 
mixture contains millimolar amounts of both Mg and Ca and therefore ensures proper 
function of the CAMs. Note that we hereby exclude insufficient supply with nutrition 
during the incubation period as a reason for cell detachment, mainly because the cells 
stay attached to the surface as well when incubated in presence of electrolytes. 
On the other hand, we could observe a decreased detachment of cells after 
incubation in PBS with either peptide at 20 µM. A higher peptide concentration 
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therefore seems to diminish the effect of PBS on cell adhesion. A potential mechanism 
might be that the peptide acts as adhesive between cell and cover slip. A widespread 
fixation technique is surface coating with poly-L-lysine (13). Immobilization of cultured 
cells is achieved by electrostatic mediation between the negatively charged silicate 
groups and carboxylic acids of the glass (17) and cell surface (e.g. proteoglycans; see 
Kjellén for an extensive review (18)), respectively, by the highly cationic poly-L-lysine 
homopolymers. As both peptides are highly positively charged under the given 
conditions, we assume a similar principle to attach the cells to the glass surface with 
CPPs. 
 
3.4.2. Cell toxicity of TAMRA-pen-AYL 
In toxicity studies using peptide concentrations up to 100 µM, the wild-type 
penetratin did not show noticeable toxicity (19,20). At the same time, wild-type 
penetratin could not permeate model bilayers such as LUVs – unless under particular 
conditions such as with giant unilamellar vesicles (21) or in presence of a 
transmembrane potential (22). Substitution of the amino acids N9 → A, R10 → Y and 
K13 → L did change both toxicity and cell-uptake, and this has been described in the 
previous chapter. It thus might speculated whether cell uptake and cell permeation are 
coupled. 
In particular, the toxicity of the peptide increased upon the 3 amino acid 
substitution and was concentration dependent as observed by means of DIC microscopy 
of CHO cells after incubation with TAMRA-pen-AYL. At 2 µM concentration, pen-
AYL did not lead to apparent damage of the CHO cells, whereas incubation with 20 µM 
peptide showed clear cell toxicity, independent of the used incubation medium. At 20 
µM most of the cells were obviously damaged as evident by cell ruins and scattered cell 
debris evident in DIC images.  
The CPP uptake into living cells apparently correlates with the membrane 
perturbation observed on membrane models using LUVs (see previous chapter). 
Detectable membrane permeation of LUVs by pen-AYL started at a peptide 
concentration of ≥4 µM. At 16 and 96 µM pen-AYL, 10 and 88% dye leakage from 
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POPC/POPG/DOPE-PEG (76:20:4 n/n) LUVs was monitored, respectively. In contrast, 
the phosphorylated pen-A(pY)L induced only 6 and 15% dye leakage at 8 and 96 µM, 
respectively. In analogy to the CPP uptake, also the cell toxicity was dependent the CPP 
used and its concentration. During the 30-min incubation with the CPP at 20 µM, only 
pen-AYL, but not the phosphorylated pen-A(pY)L , damaged the cells  leading to the 
question whether CPP uptake is not an early sign of cell damage.  
In this respect, we have previously investigated the effect of pen-2AL (12), the 
precursor peptide of pen-AYL, on the membrane integrity with 31P NMR spectroscopy. 
Pen-2AL showed pronounced disturbance of the membrane similar to the detergent 
Triton X-100 (first chapter; (23)). Taken these observations together, we assume that 
the mechanism responsible for membrane permeation in LUVs might be similar to cell 
toxicity under the described conditions. Furthermore, the effect is concentration 
dependent where approximately 10 µM concentrations separated toxic and non-toxic 
effects of TAMRA-pen-AYL on living CHO cells. Similar concentrations were required 
to initiate the cell permeation so that this concentration threshold seems to be the 
current tradeoff between transduction efficacy and toxicity for the particular system. 
The close concentrations for effective membrane permeation on the one hand and 
systemic toxicity on the other hand would not be tolerated for clinical applications. The 
here described CPP phosphorylation might thus prevent systemic CPP toxicity prior to 
reaching the organ of interest. 
 
 
 
 
76 
3.5. References 
 
3.5. References 
1. Lundberg, P., and Langel, U. (2003) J Mol Recognit 16, 227-233 
2. Stewart, K. M., Horton, K. L., and Kelley, S. O. (2008) Org Biomol Chem 6,  2242-
2255 
3. Fischer, R., Kohler, K., Fotin-Mleczek, M., and Brock, R. (2004) J Biol Chem  279, 
12625-12635 
4. Ziegler, A., and Seelig, J. (2011) Biochemistry 50, 4650-4664 
5. Fernandez-Carneado, J., Kogan, M. J., Pujals, S., and Giralt, E. (2004)  Biopolymers 
76, 196-203 
6. Saar, K., Lindgren, M., Hansen, M., Eiriksdottir, E., Jiang, Y., Rosenthal-Aizman, K., 
Sassian, M., and Langel, U. (2005) Anal Biochem 345, 55-65 
7. Deshayes, S., Plenat, T., Charnet, P., Divita, G., Molle, G., and Heitz, F. (2006) 
Biochim Biophys Acta 1758, 1846-1851 
8. Dempsey, C. E. (1990) Biochim Biophys Acta 1031, 143-161 
9. Raghuraman, H., and Chattopadhyay, A. (2007) Biosci Rep 27, 189-223 
10. Lundberg, M., and Johansson, M. (2001) Nat Biotechnol 19, 713-714 
11. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., 
Chernomordik, L. V., and Lebleu, B. (2003) J Biol Chem 278, 585-590 
12. Drin, G., Cottin, S., Blanc, E., Rees, A. R., and Temsamani, J. (2003) J Biol Chem 278, 
31192-31201 
13. Mazia, D., Schatten, G., and Sale, W. (1975) J Cell Biol 66, 198-200 
14. Yamada, K. M. (1983) Annu Rev Biochem 52, 761-799 
15. Gailit, J., and Ruoslahti, E. (1988) J Biol Chem 263, 12927-12932 
16. Plow, E. F., Haas, T. A., Zhang, L., Loftus, J., and Smith, J. W. (2000) J Biol Chem 
275, 21785-21788 
17. Behrens, S. H., and Grier, D. G. (2001) J Chem Phys 115, 6716-6721 
18. Kjellen, L., and Lindahl, U. (1991) Annu Rev Biochem 60, 443-475 
19. Jones, S. W., Christison, R., Bundell, K., Voyce, C. J., Brockbank, S. M. V., Newham, 
P., and Lindsay, M. A. (2005) Br J Pharmacol 145, 1093-1102 
20. Mueller, J., Kretzschmar, I., Volkmer, R., and Boisguerin, P. (2008) Bioconjug Chem 
19, 2363-2374 
21. Thoren, P. E., Persson, D., Isakson, P., Goksor, M., Onfelt, A., and Norden, B. (2003) 
Biochem Biophys Res Commun 307, 100-107 
22. Terrone, D., Sang, S. L. W., Roudaia, L., and Silvius, J. R. (2003) Biochemistry 42, 
13787-13799 
23. Sauder, R., Seelig, J., and Ziegler, A. (2011) Methods Mol Biol 683, 129-155 
 
 
77 
  
 
 
 
78 
4.1. Introduction 
 
Chapter 4: 
 
Gel formation of pen-Antp variants 
 
 
4.1. Introduction 
The Penetratin peptide (1) (see Tab. 4.1 for peptide sequences) is among the best 
studied cell-penetrating peptides (CPP) (2), both in terms of its physicochemical 
properties and its effect on biological cells. Based on the more amphipathic Penetratin 
mutant called pen-2AL (designed and described by Drin et al. (3)) we designed a 
peptide pair to trigger membrane transduction in presence of a phosphatase. In the 
previous chapters, we could show that dephosphorylation by a phosphatase turns the 
membrane inactive peptide pen-A(pY)L into the membrane destabilizing pen-AYL (see 
chapter 2 for details). We consider this system as an innovative concept for the 
intracellular delivery of large and/or anionic (macro)molecules that are unable to reach 
the cytosol, largely because the chemical properties of the cargo molecules naturally 
preclude passage of the cell membrane. We made, however, a unforeseen property of 
the peptides when prepared at >~500 µM concentrations, i.e. a self-clustering especially 
for the zwitterion pen-A(pY)L. 
As described in chapters 1 and 2 (see determination of peptide concentration), we 
prepared 1 mM stock solutions of each peptide by weighing desired amounts (e.g. 2.7 
mg pen-AYL/mL solvent) as trifluoroacetate salt into a 2 mL glass vial followed by 
adding the approximate volume of corresponding buffer. Then the final peptide 
concentration has been determined spectrophotometrically using the 2 tryptophan  
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Tab. 4.1. Amino acid sequences of pen-Antp and its investigated variants. Positively or 
negatively charged residues and groups are in red and blue, respectively. Residues that were 
substituted from the original Penetratin peptide are underlined. 
peptide Sequence (single letter code) 
pen-Antp (penetratin) RQIK IWFQ NRRM KWKK 
pen-2AL RQIK IWFQ AARM LWKK 
pen-AYL RQIK IWFQ AYRM LWKK 
pen-A(pY)L RQIK IWFQ A(pY)RM LWKK 
residues. The peptides dissolved quickly and the solutions were clear and did not show 
any aggregates visible by eye. If the pen-A(pY)L solution, however, was allowed to 
stand for ≥36 h at 4 °C, the dissolved peptide either settled to the bottom of the vial 
forming a gel-like structure (see Fig. 4.1) or turned the originally fluid solution into a 
viscous liquid that would not flow down when turned upside down indicating that the 
zwitterionic molecule might have a tendency for self-aggregation. The gel-like structure 
could be dissolved again by shaking with a vortex mixer and subsequent ultrasound 
bath4. Note that this visual observation could only be made for the 1 mM stock solutions 
but not with solutions of lower peptide concentration, be it diluted from stock or 
dissolved as powder directly into the desired liquid. 
We were then interested in the reason of this behavior and therefore wanted to 
investigate the possible driving intermolecular force. With this respect, it is important to 
note that the only difference between this peptide and the also studied pen-AYL peptide, 
which did not show any aggregation at all, is a phosphor-ester at the tyrosine. 
Apparently, the negatively charged phosphate group alone is able to promote the 
interaction between individual peptides in a way that leads to some sort of gelation- 
                                                 
4 All peptides solutions were treated accordingly immediately prior any dilution or addition in the 
leakage assay (see chapter 2). Specifically, the solutions were mixed for 1-2 s, followed by a 5 min bath 
in ultrasound. 
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hereby referred as peptide clusters - although the peptides’ net charge is still largely 
positive. 
Aggregation i.e. formation of clusters out of single dissolved peptides, brings 
mainly two technical issues when working with such solutions: i) it precludes a proper 
determination of the peptide concentration 
because of inhomogeneity and ii) 
concentrated stock solution thus must be 
avoided in order to prevent inaccurate 
dilutions during both preparations and the 
actual experiment itself. 
As an opportunity for investigating 
this effect, all investigated peptides include 
2 tryptophan (Trp) residues, which allow i) 
examination of the concentration by means 
of optical absorbance and ii) changes in the 
polarity of the Trp proximity by means of 
fluorescence spectroscopy methods. In particular, the fluorescence emission of the Trp 
indole group is highly dependent on the polarity of its proximate environment i.e. 
around 350 nm in water with a blue shift when brought into a more hydrophobic 
environment (4). In addition to Trp residues, the peptide also contains a tyrosine (Tyr) 
moiety that is also a weak fluorophore, but its emission wavelength, in contrast to Trp, 
is not dependent on the environmental polarity. 
The dependency of the Trp fluorescence emission on its environment polarity thus 
builds the basis for the following investigation to possibly identify the intermolecular 
force leading to the observed gelation of the pen-A(pY)L peptide. We therefore 
measured the Trp fluorescence emission of each peptide both at distinct concentrations 
and either presence or absence of salt in order to screen for electrostatic charge effect 
being responsible for the interaction. In the case of the charge of the phosphate group 
contributing to the aggregation we expect this effect to be more prominent in the 
absence of salt due to the diminished conductivity (“electrostatic screening”). 
 Fig. 4.1. 1 mM pen-A(pY)L in TBS. Note 
the gel-like structure at the bottom of 
the glass vial observed only at that high 
concentrations. 
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To supplement the data gained by Trp fluorescence spectroscopy, all peptide 
solutions were further investigated by both dynamic and static light scattering and 
analytical ultracentrifugation. 
 
 
4.2. Materials and methods 
4.2.1. Materials 
 1.  Buffer (unless indicated otherwise): 20 mM Tris 100 mM NaCl pH 7.4 
  (TBS). 
 2.  DMSO (Dimethyl sulfoxide) (Sigma-Aldrich, Buchs, Switzerland) 
 3.  L-Tryptophan (Sigma-Aldrich, Buchs, Switzerland). 
 4.  L-Tyrosine (Sigma-Aldrich, Buchs, Switzerland). 
 5.  PEI (Poly(ethyleneimine, 50% (w/v) in H2O) (Sigma-Aldrich, Buchs, 
  Switzerland). 
 6.  Tris (Merck, Darmstadt, Germany). 
 
4.2.2. Peptide solutions 
All peptides were synthesized by Peptide 2.0 (Chantilly, VA) with amidated 
carboxy-terminus and supplied as trifluoroacetate salt. Purity was ≥97% as judged by 
HPLC. The 1, 10 and 100 µM stock solutions were prepared by dissolving 1 mg 
amounts in 90% of the final volume which would result in approximately the desired 
peptide concentration. Then the pH was adjusted to 7.4 and solvent added to make the 
final volume. 1 mM stock solutions were prepared the same way but weighing peptide 
amounts corresponding to a final volume of 1.5 mL. All peptide solutions were allowed 
to equilibrate for ≥24 h prior to investigation. Solvent volumes or amounts of peptide 
powder were calculated using the nominal weight of the corresponding trifluoroacetate 
salt. 
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4.2.3. Peptide concentration determination 
The concentrations of the peptide solutions were determined by Trp absorbance (5) 
by means of UV-Vis spectroscopy using a single beam Hewlett-Packard 8354 
spectrophotometer. Absorbance of 200 µL volumes was measured in quartz micro 
cuvettes with a path length of 1 cm at 280 nm after blanking with the corresponding 
buffer. The peptide concentration was then calculated with an extinction coefficient ϵ = 
5’500 M-1cm-1 per Trp. In case of non-linear response (>1.5 OD), the solution was 
diluted in order to lower the OD below 1.5. Denoted standard deviations were 
calculated as 
σ = �Σ (x - x�)2n          (1) 
with 𝑥 = sample value, ?̅? = sample mean average and n = sample number. 
 
4.2.4. Fluorescence Spectroscopy 
All experiments were done with a Jasco FP-6500 fluorescence spectrophotometer 
(JASCO Corp., Japan). Measurements were performed at room temperature using a 0.5 
cm (inner diameter) rectangular quartz cuvette with a sample volume of 0.25 mL. 
Spectrophotometer settings were partially varied for different solute concentrations and 
are shown in Tab. 4.2. All peptide solutions, unless stated otherwise, were excited at 
295 nm to minimize Tyr emission. 
Specific settings such as excitation and emission wavelengths, slit width or 
photomultiplier voltage varied depending on the investigated fluorophore and its 
concentration and are indicated in the corresponding results section. Prior to 
measurements, the peptide solutions were dipped in an ultrasound bath for 5 min and 
quickly vortexed to break down eventual existing clusters. During the measurement, the  
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Tab. 4.2. Settings for 
fluorescence emission 
measurements. 
Fluorescent solute refers 
to either the free L-amino 
acids or peptide. 
Response for 1 µM was 
increased to decrease 
signal noise. 
a Photomultiplier tube 
(PMT) voltage was 
adjusted that maximum 
fluorescence intensities 
were approximately equal 
for all measurements.  
b only for spectrum 
measurements. 
samples were stirred with a tiny fluoropolymer coated stir bar magnet unless indicated 
otherwise. 3 fluorescence emission spectra were successively recorded, and the 
wavelength corresponding to maximal signal intensity was noted. All denoted values 
are arithmetic averages of a triplicate experiment with standard deviations calculated 
using equation (1). 
 
4.2.5. Peptide adsorption to glass 
For every measurement, pen-Antp was always freshly diluted from a 100 µM stock 
solution. In experiments involving PEI, the quartz cell was incubated for 30 minutes 
with 1% (w/v) PEI dissolved in distilled water and thoroughly flushed with water prior 
every measurement to prevent adsorption of the peptides to the glass. The settings of the 
spectrometer were as follows: ex/em bandwidths 3 nm, photomultiplier tube (PMT) 
voltage 550 V, response time 0.1 s and 0.5 s for single and constant excitations 
respectively, data pitch 1 s for constant excitations. Wavelengths for excitation and 
emission were set to 280 and 351 nm, respectively. 
  
[fluorescent solute] (µM) 
  
1000 100 10 1 
Slits (nm) 3 3 3 5 
Response time (s) 0.1 0.1 0.1 0.2 
PMT (V)a 300 300 400 450 
Data Pitch (nm)b 0.5 0.5 0.5 0.5 
Scan Speed 
(nm/min)b 
500 500 500 500 
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4.2.6. Dynamic light scattering 
TBS and DMSO were filtered with Filtropure S 0.2 (PES, 0.2 μM; Sarstedt AG, 
Sevelen, Switzerland) and Fluoropore (PTFE, 0.45 µM; Millipore; Billerica, MA) 
membranes, respectively, prior both dissolution of peptide or mixing. Measurements 
were done on a Zetasizer Nano ZS ZEN3600 (Malvern, Worcestershire, UK) equipped 
with a HeNe laser (633 nm) and backscattering detection. 0.5 mL solutions were 
measured using rectangular PS semi-microcuvettes with an optical pathway of 10 mm 
(Sarstedt AG, Sevelen, Switzerland) at 25 °C. For peptide solutions ≤100 μM the 
measurement position (z) and light attenuation was set to 4.65 mm and 11 (100% 
transmission), respectively. All samples were measured in triplicates of 10 runs each. 
Intensity- and volume weighed size distributions, PDI and averaged diameters were all 
calculated by the Zetasizer software provided by Malvern. 
 
4.2.7. Static light scattering 
All measurements were done with the Jasco FP-6500 fluorescence 
spectrophotometer. Specifically, the following settings were used: 1 nm bandwidth, 2 s 
response time, 400 V PMT and both excitation and emission wavelengths at 400 nm. 
250 µL peptide solutions were measured in a micro quartz cuvette (5 mm inner width) 
and constantly stirred with a tiny fluoropolymer coated stir bar magnet. The detector 
was at a 90° angle to the excitation beam. 5 measurements were acquired in 30 s 
intervals and averaged. 
 
4.2.8. Analytical ultracentrifuge (AUC) 
Sedimentation velocity data were measured on a Beckman XL-I (Beckman Coulter, 
Indianapolis, IN) analytical ultracentrifuge equipped with interference (RI) detection. 
Experiments either with or without salt were performed with an An50Ti (8 holes) or 
An60Ti (4 holes) rotor, respectively. Sample and buffer cells were loaded with 400 and 
420 µL volumes, respectively, and had a light path length of 12 mm. 999 RI scans were 
recorded for each individual peptide solution at 3’000 rpm during ~150 minutes and 20 
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°C. Fitting of AUC data was done with the Sedfit program (6) (7) using the continuous 
c(s) distribution model. Meniscus and bottom for data of the liquid column, and the fit 
limits were adjusted graphically. The data were then fitted using the following 
parameters: resolution 100, s_min 0.0001, s_max 50-100, frictional ratio 1.4, partial 
spec. volume 0.73, buffer density 1.0054, buffer viscosity 0.01002, fitted baseline, RI 
Noise and Time Independent Noise. 
 
 
4.3. Results 
4.3.1. Preparation of experimental setup 
In order to determine appropriate instrumental adjustments and experimental 
conditions, the dependence of Trp fluorescence emission on excitation wavelength, 
potential peptide adsorption and the component of Tyr fluorescence emission were 
investigated. 
Fig. 4.2. Maximum Trp emission 
wavelength in dependence of 
excitation wavelength. 1, 10 and 
100 µM L-Trp dissolved in TBS 
were excited at indicated 
wavelengths. Error bars are the 
standard deviation of every 
triplicate experiment. See text 
and Fig. 3 for deviance of 1 and 
10 µM Trp at wavelengths of 
>295 and >300 nm, respectively. 
At low concentration (1 µM), the 
curve fitting no longer allowed 
accurate determination of 
optimum λem, because of the 
presence of a shoulder peak that 
gave maximum signal when 
excited at 296-310 nm. 
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Dependence of maximal tryptophan emission on excitation wavelength. 
First, the optimum excitation wavelength for maximum Trp emission was set. For 
this purpose, the maximum fluorescence emission and wavelength upon different 
excitation wavelengths for monomeric L-Trp dissolved in Tris buffered saline (TBS) 
was determined. This was done by measuring fluorescence emission spectra of 1, 10 
and 100 µM L-Trp when excited at wavelengths in the near UV range. Because the 
maximum Trp absorbance is expected at 280 nm and potential Tyr absorption (up to 
295 nm) ((5) and (8) page 446 ff.) in future measurements should be avoided, individual 
spectra were recorded with increasing excitation wavelengths. Specifically, spectra were 
recorded at excitation wavelengths every 2.5 nm in the range from 280 to 310 nm. 
Emission wavelengths with maximal intensity were independent of the excitation 
wavelength for 100 µM Trp (Fig. 4.2). The same was observed for 10 µM and 1 µM at 
wavelengths of >300 nm and >295 nm, respectively (also Fig. 4.2). At low 
concentration (1 µM), the curve fitting no longer allowed accurate determination of 
optimum λem, because of the presence of a shoulder peak that gave maximum signal 
when excited at 297.5-310 nm (visible in Fig. 4.3). This peak was also observed for 
buffer (TBS) or distilled water (ddH2O) (Fig. 4.4), so that it might originate either from 
the Raman band of water or from scattering in the instrument. Optimum emission 
wavelength of Trp was at ~350 nm and is shown in Tab. 4.3. It decreases by a couple of 
nm with lower concentration of Trp which might be the result of unclear maximum 
values in the curve fitting. 
 
Fluorescence contribution from tyrosine. 
In order to modify the pen-2AL peptide with a phosphate group, a Tyr (or pTyr) 
was introduced at the position of Ala10. Tyr absorbs approximately at the same 
wavelength range as Trp, but its molar extinction coefficient is lower. Specifically, the 
absorption maximum of Tyr (at 275.5 nm) has ϵ = 1500 M-1cm-1 whereas Trp (at 280 
nm) has ϵ = 5800 M-1cm-1 (5). In order to test whether the fluorescence of Tyr might 
interfere, the fluorescence emission of both fluorophores at the previously determined 
wavelength of maximal Trp emission (~350 nm) was measured. For this 
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Fig. 4.3. Fluorescence emission spectra of 1 µM L-Trp (A) and 1 µM L-Tyr (B) as excited at 
indica ted wavelengths. (A) The fluorescence intensity of the shoulder peak left-hand of the 
Trp emission maximum exceeds at wavelengths >295 nm and shifts the value for maximum 
intensity to lower wavelengths. (B) A similar picture emerges for the Tyr emission spectra. The 
shoulder peak shifts together with the excitation wavelength and has its maximum 
approximately 25 nm above it in both measurements. At low concentration (1 µM), the curve 
fitting no longer allowed accurate determination of optimum λem, because of the presence of a 
shoulder peak that gave maximum signal when excited at 296-310 nm. 
 
Fig. 4.4. Maximal emission 
intensity of the shoulder peak 
in various solutions. The 
correlation over distinct 
conditions and solutes implies 
a measuring artifact produced 
by the spectrophotometer. 
 
 
 
 
 
 
 
 
Tab. 4.3. Average (of triplicates) 
wavelength of maximal Trp fluorescence 
emission intensity.  
a averages were calculated with values 
between 280-295, 280-300 and 280-307.5 
nm for 1, 10 and 100 µM, respectively. 
b calculated with (1) (see methods). 
[L-Trp] (µM) 
Ø wavelength 
(nm)a 
Standard 
deviationb 
1 349.3 1.1 
10 352.9 0.9 
100 354.0 0.7 
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purpose, the emission spectra of free L-Tyr were measured with emission between 290 
and 450 nm when excited between 280 and 300 nm (2.5 nm steps). The Tyr signal 
portion corresponding to the averaged emission intensities at wavelengths of maximal 
Trp fluorescence emission (as gathered in Tab. 4.3) relative to the Trp signal (=100%) 
where then calculated and are shown in Tab. 4.4. 
 
Tab. 4.4. Average (of triplicates) 
of Tyr fluorescence emission 
intensity relative to Trp when 
excited at given wavelengths. 
Emission wavelengths correspond 
to rounded values as determined 
in Fig. 4.4. a Trp emission intensity 
corresponds to 100%. 
Overall, the relative signal portion of L-Tyr is less than 5% at both 10 and 100 µM 
and, as expected, decreases with increasing excitation wavelength. However, at 1 µM 
the portion of L-Tyr signal exceeds 5% at all wavelengths and reaches its maximum 
with 17.1% at 300 nm. The increase of the Tyr signal portion at wavelengths ≥295 nm 
can partially be explained by the slight blue shift of the Trp maximum emission 
wavelength (Tab. 4.3). Some of the spectra of 1 µM L-Tyr are shown in Fig. 4.3B for 
closer inspection. Similar to the Trp emission spectra a peak appears approximately 25 
nm above the excitation wavelength that raises the emission signal to relatively higher 
intensities when compared to 10 or 100 µM. As depicted in Fig. 4.4 the wavelength of 
maximal intensity of this peak aligns again linearly with the excitation wavelength, 
further indicating a measurement artifact. 
Regarding both the negligible portion of Tyr when excited at <295 nm and the fact 
that the peptides of interest contain 2 Trp but only 1 Tyr, we could safely chose to 
neglect the Tyr component of the fluorescence signal for further investigations on Trp 
fluorescence emission shifts. 
[L-Tyr] 
(µM) 
excitation wavelength (nm) 
280 285 290 295 300 
Tyr signal relative to Trp signal (%)a 
100 3.0 2.1 0.7 0.8 2.0 
10 3.8 3.1 2.1 3.7 9.4 
1 8.2 7.3 7.2 10.4 17.1 
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Fig. 4.5. Absorbance of 0.5 µM pen-Antp to the surface of the quartz cuvette over the time 
course of 10 min when excited constantly (A) or once every 30 s (B). (A) The fluorescence 
emission intensity decreases by ~60% when unstirred whereas the decrease is less than 20% 
when stirred. (B) The decrease of fluorescence is approximately halved when not constantly 
excited. Incubation of the cuvette with 1% (w/v) PEI before the measurement slightly 
diminishes this decrease in fluorescence emission for all conditions. 
Peptide adsorption. 
As reported by several authors (9-11), peptides with multiple positive charges such 
as pen-Antp (7 nominal positive charges) are prone to adsorption to glass- and 
fluorocarbon-based polymer surfaces. In the case of negatively charged quartz glass 
surfaces (e.g. in a glass cuvette used in spectroscopic measurements) (12) electrostatics 
dominate the adsorption whereas for plastic it is ascribed to hydrophobic interactions. 
Because pen-Antp can adopt a helical conformation possessing amphipathic properties, 
either interaction may take place depending on the present surface. 
Pen-Antp was shown to be taken up by live cells at already low micromolar 
concentration (13-15). Potential peptide adsorption at such concentrations to glass or 
plastic surfaces may bias experiments. For instance, part of a study done by Persson et 
al. reports an approximate 70% loss of Trp fluorescence of a stirred 0.5 µM pen-Antp 
solution in a 10 x 10 mm quartz cell within one hour (11). However, a foregone 30 min 
incubation of the cell with 1% (w/v) polyethyleneimine (PEI) could diminish the 
fluorescence loss below 25% (11). As the pen-Antp variants in our study are still highly 
positively charged (5 nominal charges), we repeated the experiment done by Persson 
describing adsorption of pen-Antp to quartz glass and fluoropolymer surfaces by means 
of Trp fluorescence.  
A B 
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Fig 4.5A shows triplicates of the normalized time traces of a constantly excited 0.5 
µM pen-Antp solution, both with and without magnetic stirrer in a 5 x 5 mm quartz cell 
either incubated with 1% (w/v) PEI for 30 min or not. Under these conditions, stirring 
of the solution during the measurement had a much more pronounced effect compared 
to incubation with PEI. The unstirred solution has a signal loss of approximately 60% 
whereas the stirred solution only loses 15 or 25% depending if incubated with PEI or 
not, respectively. Interestingly, the difference diminished when the solution was not 
excited constantly but only for single times every 30 s (Fig 4.5B). According to these 
results, photo-bleaching of the fluorophore seems to affect the fluorescence signal more 
than surface absorption of the peptide. Ultimately, incubation with PEI could prevent a 
relative signal decrease of 10% of a stirred 0.5 µM pen-Antp solution that is constantly 
excited with the mentioned parameters. In contrast to the results from Persson, stirring 
of the solution prevented the loss of fluorescence signal over time much more than 
incubation of the quartz cuvette with PEI. Since the solutions were continuously stirred 
and desorption of PEI might cause other (electrostatic) interferences, it was decided to 
not pre-saturate the glass with PEI. 
peptide buffer name 
pen-AYL 
20 mM Tris pH 7.4 pen-AYL no salt 
20 mM Tris 100 mM NaCl pH 7.4 pen-AYL TBS 
pen-A(pY)L 
20 mM Tris pH 7.4 pen-A(pY)L no salt 
20 mM Tris 100 mM NaCl pH 7.4 pen-A(pY)L TBS 
Tab. 4.5. Peptide solutions and their buffers. All solutions were prepared at peptide 
concentrations of 1, 10, 100 and 1000 µM. 
4.3.2. Peptide solutions 
The different peptide concentration were obtained in individual preparations in 
order to study the observed gel formation in 1 mM pen-A(pY)L stock solutions. We 
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chose peptide concentrations of 1, 10, 100 and 1000 µM of both pen-AYL and pen-
A(pY)L to both investigate a potential concentration dependence of this event and avoid 
improper dilution from concentrated stock solutions. For every concentration two 
peptide solutions were prepared using either TBS or a buffer solution of 20 mM Tris 
omitting electrolytes. An overview of the composition of all investigated peptide 
solutions is given in Tab. 4.5. 
Peptide concentration determination. 
The concentration of every peptide solution was determined by means of Trp 
absorption (5) using UV-Vis spectroscopy. The observed imprecision 
(spectrophotometer and fitting routine) of this method is less than 10 mOD and all of 
the pen-Antp variants include two Trp resulting in a total extinction coefficient of 
11’000 M-1cm-1. We therefore have a good signal-to-noise ratio with 1 mM peptide 
stock solutions (resulting absorbance of ~1.1 upon 1:10 dilution) and usually assessed a 
deviation of less than 5% from the calculated concentration e.g. a pen-2AL stock 
solution calculated as 1 mM was determined to have an apparent concentration of 0.96 
mM (data not shown). Precision was sufficient (<10% coefficient of variation) for 
concentrations down to 10 µM e.g. the calculated OD of a 10 µM pen-Antp solution in a 
cell of 1 cm length is 0.11. 
As apparent in Tab. 4.6, the measured peptide concentration is lower than 
calculated by weight (using the molecular weight of the corresponding trifluoroacetate 
salt). The small amounts weighed in for concentrations <100 µM added more error from 
the balance as compared to the imprecision of the spectrophotometric method. For 
example, the results from the 1 µM solutions were inconsistent because either i) some of 
them show negative absorbance or ii) a relatively high signal-to-noise ratio (e.g. 0.81 
for 1 µM pen-A(pY)L without salt). The 10 µM peptide solutions have concentration 
deviations between 31.9 and 95.5%. The 100 µM peptide solutions are closest to the 
calculated concentrations with deviations ranging from 12.4 to 16.4%, so that this mode 
of preparation was preferred in the following. At 1 mM, we measured again larger 
deviations between 13.3 and 68.2% which might be due to the tendency of gel 
formation of the penA(pY)L peptide. 
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  20 mM Tris 100 mM NaCl pH 7.4 
 
20 mM Tris pH 7.4 
   
 
   
calculated pept. conc. (mM)  calculated pept. conc. (mM) 
 
  
0.001 0.01 0.1 1a  0.001 0.01 0.1 1a 
pe
n-
AY
L 
sa
m
pl
e 
(O
D@
28
0 
nm
) 
1 -3.78E-03 7.06E-02 1.24E+00 1.08E+00  -9.88E-03 5.58E-02 9.30E-01 1.24E+00 
2 -3.22E-03 7.60E-02 1.23E+00 1.09E+00  -2.36E-02 5.36E-02 9.20E-01 1.27E+00 
3 -8.24E-03 7.38E-02 1.24E+00 1.09E+00  -2.62E-02 5.52E-02 9.20E-01 1.23E+00 
average -5.08E-03 7.49E-02 1.24E+00 1.09E+00  -1.99E-02 5.44E-02 9.23E-01 1.25E+00 
standard 
deviationb 
2.25E-03 2.22E-03 4.71E-03 4.71E-03  7.16E-03 9.29E-04 4.71E-03 1.70E-02 
conc. (mM) -4.62E-04 6.81E-03 1.12E-01 9.88E-01  -1.81E-03 4.95E-03 8.39E-02 1.13E+00 
∆ absolute -1.46E-03 -3.19E-03 1.24E-02 -1.21E-02  -2.81E-03 -5.05E-03 -1.61E-02 1.33E-01 
∆ % c -146.2 -31.9 12.4 -1.2  -280.8 -50.5 -16.1 13.3 
            
pe
n-
A(
pY
)L
 sa
m
pl
e 
(O
D@
28
0 
nm
) 
1 3.49E-02 2.40E-01 1.27E+00 1.88E+00  -5.88E-03 6.38E-02 9.30E-01 1.19E+00 
2 3.47E-02 2.20E-01 1.27E+00 1.82E+00  -5.58E-03 7.44E-02 9.10E-01 1.29E+00 
3 4.06E-02 2.10E-01 1.26E+00 1.85E+00  1.32E-02 6.56E-02 9.20E-01 1.29E+00 
average 3.67E-02 2.15E-01 1.27E+00 1.85E+00  5.80E-04 7.00E-02 9.20E-01 1.26E+00 
standard 
deviationb 
2.74E-03 1.25E-02 4.71E-03 2.45E-02  8.92E-03 4.63E-03 8.16E-03 4.71E-02 
conc. (mM) 3.34E-03 1.95E-02 1.15E-01 1.68E+00  5.27E-05 6.36E-03 8.36E-02 1.14E+00 
∆ absolute 2.34E-03 9.55E-03 1.52E-02 6.82E-01  -9.47E-04 -3.64E-03 -1.64E-02 1.42E-01 
∆ % c 233.9 95.5 15.2 68.2  -94.7 -36.4 -16.4 14.2 
Tab. 4.6. Concentration determination of the various peptide solutions by absorption at 280 
nm. All concentrations were calculated as 𝒄𝒑𝒆𝒑 = 𝑶𝑫𝟐𝟖𝟎𝒏𝒎𝜺𝑻𝒓𝒑 𝒍  with 𝜺𝑻𝒓𝒑 = 5’500 M-1cm-1 and 𝒍 = 1 
cm. (Red cells) negative absorbance signal. 
a diluted 1:10 prior measurement. 
b calculated with (1)  
c ∆ % is the relative deviation of the apparent concentration from the calculated concentration 
(calculated concentration = 100%). 
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4.3.3. Trypthophan fluorescence emission shifts of pen-Antp variants 
Because the Trp fluorescence is sensitive to changes in solvation, the potential 
clustering of peptides was investigated by means of the peptides Trp fluorescence shifts. 
Observations were done while varying both peptide concentration and presence of 
electrolytes (NaCl). Clustering of peptides was expected to shift the Trp fluorescence 
emission to shorter wavelengths (blue shift) if the Trp’s indole moiety is brought into a 
more nonpolar environment. 
 
Trp fluorescence of pen-2AL with salt. 
We first investigated the Trp fluorescence of pen-2AL, which has been reported to 
have a random coil conformation in aqueous solution without reports of aggregation (3). 
This peptide sequence differs in only 1 amino acid from both pen-AYL and pen-
A(pY)L. Tab. 4.7 shows the averaged wavelengths corresponding to maximal Trp 
emission in TBS which all are between 351-352 nm. This value closely matches the 
emission maximum of Trp in aqueous solution which is around 350 nm (also shown in 
Tab. 4.3) and goes along with the aforementioned observation of a monomeric state of 
pen-2AL at the given conditions. 
 
Trp fluorescence of pen-AYL. 
1 mM stock solutions of the peptide did not show gel-like aggregation as observed 
with DLS. The measured Trp emission maxima of pen-AYL both with and without 100 
mM NaCl are shown in Tab. 4.8. Similar to p2AL in TBS, the Trp emission maxima 
are ~ 352 nm for all but 2 conditions: at 100 µM with salt and at 1 mM without salt the 
emission shifts to shorter wavelengths of 345 and 348 nm, respectively, which might 
result from insufficient precision for the rather flat curve maximum observed. As the 
Trp emission maxima mostly resembled both that of pen-2AL and L-Trp in aqueous 
solution we assume that the two Trp of pen-AYL are in a polar, aqueous environment 
and therefore the peptide is primarily monomeric at the given conditions as well. 
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Tab. 4.7. Averaged (of triplicates) 
wavelengths corresponding to maximal 
Trp fluorescence emission intensity of 
pen-2AL dissolved in TBS at 
concentrations of 1, 10, 100 and 1000 µM. 
 
 
 
  
average maximum wavelength (nm) 
  
TBS pH 7.4 St. dev. (±) 20 mM Tris pH 7.4 St. dev. (±) 
[pen-AYL] 
(µM) 
1 351.9 0.9 352.6 0.9 
10 351.7 0. 9 352.4 0.5 
100 345.4 1.0 352.6 0.6 
1000 352.8 0.3 348.2 0.7 
Tab. 4.8. Averages (of triplicates) of maximal emission wavelengths of pen-AYL. Overall, 
emissin maxima are around 352 nm, matching that of Trp in aqueous solution. Exceptions are 
100 µM with salt and 1 mM without salt showing blue shifts of 7 and 4 nm, respectively. 
  
average maximum wavelength (nm) 
  
TBS pH 7.4 St. dev. (±) 20 mM Tris pH 7.4 St. dev. (±) 
[pen-
A(pY)L] 
(µM) 
1 351.6 1.3 352.6 1.7 
10 351.8 0.6 351.7 1.1 
100 350.6 0.6 352.3 0.7 
1000 342.6 0.6 344.4 0.9 
Tab. 4.9. Averages (of triplicates) of maximal emission wavelengths of pen-A(pY)L. The 
emission maximum of 1 mM both in presence and absence of salt is shifted to shorter 
wavelengths indicating a change of the polarity in the Trp proximity. Emission maxima of the 
other peptide solutions correspond to that free monomeric pen-2AL. 
  
average max wl (nm) 
  
TBS pH 7.4 St. dev. (±) 
[pen-
2AL] 
(µM) 
1 351.2 1.2 
10 351.7 1.0 
100 351.9 0.6 
1000 350.9 0.6 
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Trp fluorescence of pen-A(pY)L. 
As shown in Tab. 4.9, the Trp emission maxima of 1, 10 and 100 µM pen-A(pY)L 
are again mainly around 351-352 nm, independent of the presence or absence of salt. 
The peptide is therefore assumed to be primarily monomeric at these concentrations as 
well. However, at 1 mM, the emission maxima of both solutions show a shift down to 
342.6 and 344.4 nm with and without salt, respectively. This shift implies a change of 
polarity in the proximate environment of the Trps which correlates with the changes 
observed with DLS at these high concentrations. 
 
4.3.4. Dynamic light scattering of peptide solutions 
In a first attempt to assess the size of the peptide clusters we used dynamic light 
scattering (DLS) to investigate both peptides dissolved in TBS. The obtained size 
distributions (weighted with both signal intensity or volume) at both 100 µM and 1 mM 
are shown in Fig. 4.6 (pen-AYL) and Fig. 4.7 (pen-A(pY)L; the particle diameters of 
individual peaks in the volume-weighted graphs correspond to the average size 
distribution of three measurements). Solutions of 1 and 10 µM had not enough scattered 
signal for such small and monomeric peptides, so that measurements failed to deliver 
reliable data. 
It is important to note that the signal in the intensity distribution profile is 
dependent on the 6th power of the radius of the scattering particle. The signal intensity 
of registered particles accordingly increases by a factor of 106 for an order of magnitude 
in its size. This means the difference in signal intensity between two particles with a 
diameter of 10 and 1000 nm is 1012! Accordingly, size determination of small particles 
cannot be reliably measured with this technique in the presence of even small amounts 
of larger particles. As an important consequence, the following observations only serve 
as a suggestion that some of the peptide molecules in a preparation might be aggregated, 
whereas the technique does not allow to determine how much of all peptide molecules 
are aggregated. This is especially important to note, because the method is not sensitive 
to resolve the peptide diameter at concentrations <1 mM even in the absence of 
aggregates.  
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Pen-AYL solutions in TBS. 
The 1 mM pen-AYL peptide solution shows a distinct shift to larger particle sizes 
when compared to 100 µM (Fig. 4.6B and D). At 100 µM, the signal intensity 
distribution shows 3 peaks with comparable intensity (Fig. 4.6A), indicating that the 
main fraction of observable (!) particles has a size between 20 and 120 nm. There are, 
however, larger particles with a diameter around 700 nm present as well (Fig. 4.6B). 
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Fig. 4.6. DLS of 0.5 mL pen-AYL TBS solutions. Shown are the signal intensities (A, C) and 
corresponding volume-weighted (B, D) size distributions of 100 µM (A, B) and 1 mM (C, D) 
peptide, respectively. The peptide seems to mainly form two distinctly sized clusters; one at a 
dimension around 10 to 100 nm and another at 600 to 1200 nm. At 1 mM, equilibrium seems 
to shift to formation of the larger particles when compared to 100 µM. The indicated particle 
diameters were calculated from the averaged size distribution of the triplicate run. (B; inset) 
Volume-weighted size distribution of a 0.5 mL 340 µM pen-Antp TBS solution. 
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The polydispersity index5 (PDI) was 0.653 with a light transmission of 30% which  
confirm a really broad size distribution. At peptide concentration of 1 mM the signal of 
larger particle sizes (diameter of 1200 nm) dominates (Fig. 4.6D). Smaller particles 
were still detected and probably correspond to the smaller species observed at 100 µM 
but a specific size description is not appropriate because the large difference in signal 
intensity (Fig. 4.6C). Accordingly, we detected a high PDI of 0.538 and a diminished 
light transmission to 0.1% which further attests to an increased population of larger 
sized particles. 
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Fig. 4.7. DLS of 0.5 mL pen-A(pY)L TBS solutions. Shown are the signal intensities (A, C) and 
corresponding volume-weighted (B, D) size distributions of 100 µM (A, B) and 1 mM (C, D), 
respectively. The peptide is distributed in two fractions of different size at both 
concentrations. The main fraction shows a smaller diameter of 20 to 120 nm whereas the less 
large particles exist at couple of hundreds nm. Indicated particle diameters were calculated 
from the averaged size distribution of the triplicate run. 
                                                 
5 The PDI is a dimensionless parameter provided by a fit of the correlation data and describes the size 
distribution of the sample. A PDI of ≤0.05 corresponds to a monodisperse sample whereas a PDI of ≥0.7 
indicates a very broad size distribution of registered particles. 
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Pen-A(pY)L solutions in TBS. 
Solutions of 100 µM pen-A(pY)L show a similar signal distribution than 100 µM 
pen-AYL (Fig. 4.7A) suggesting the absence of larger aggregates (>1000 nm). 
Nevertheless, there are two size species, one between 10 to 100 nm and a second 
between 100 and 1000 nm. The corresponding diameters in Fig. 4.7B should be treated 
as rough estimates because of the apparent polydispersity of the sample. Specifically, 
the PDI amounts to 0.446 at 30% light transmission. 
Interestingly, the signal distribution at 1 mM pen-A(pY)L (Fig. 4.7C) matches the 
one of 100 µM pen-AYL very closely. In fact, the solution seems to comprise the same 
two populations of 20 to 120 nm and approximately 600 nm (Fig. 4.7D). PDI and light 
transmission were 0.557 and 1%, again like the corresponding pen-AYL sample. This 
result suggests that pen-A(pY)L does not produce distinct aggregates at concentration 
>1mM, but rather a gel-like structure that produces correlation times too long to be 
assessed by DLS. 
 
Pen-AYL and pen-A(pY)L in DMSO/TBS mixtures. 
Optical investigation (Fig. 4.1) of both peptides pen-AYL and pen-A(pY)L 
dissolved in TBS showed unknown fractions of larger peptide assemblies (eventually 
resulting from the amphipathic structure)). Formation of such clusters apparently occurs 
without requirement for ionic interactions, as indicated by the Trp fluorescence 
experiments. An alternative interaction could be hydrophobic attraction. If this was the 
case, the interaction between individual peptide molecules should be weakened in a less 
polar solvent such as dimethyl sulfoxide (DMSO), which is widely used as solvent for 
many nonpolar compounds. We therefore investigated 100 µM solutions of peptide 
dissolved in mixtures of DMSO/TBS with varying composition of the two solvents, 
ranging from 10 to 90% (v/v) of one or the other by means of DLS. In contrast to the 
peptide dissolved in pure TBS, however, we were not able to detect any peptide 
assemblies in mixtures with a DMSO content ≥70% (v/v). Thus, DMSO seems to 
manage to properly dissolve the peptide, thereby dropping its signal intensity below the 
detection threshold of the used device (reflecting also the observation that the 
monomeric peptide diameter could not be assessed with this technique at that low 
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peptide concentration). The measured volume distribution of 340 µM pen-Antp in TBS 
is shown in the inset of Fig. 4.6B as comparison with the signal of a monomeric peptide 
of virtually the same size. We therefore chose to simply plot both the count rate and PDI 
of the measured peptide solutions against the DMSO content to display the dependence 
of peptide cluster formation on the solvent composition. 
Fig. 4.8A shows the count rate of 100 µM peptide in dependence of its DMSO 
content (at constant measurement depth (4.65 mm) and light attenuation (100% 
transmission). Both peptides show a similar tendency to assemblies at a DMSO content 
of ≤40% (v/v).  The small difference in count rate, however, suggests that the fraction of  
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Fig. 4.8. DLS of 100 µM pen-AYL and pen-A(pY)L in mixtures of TBS and DMSO. (A) Averaged 
count rate (in kcps using same attenuator and z-position settings of 11 and 4.65 mm) in 
dependence of the volume content of TBS. The signal below 50% (v/v) TBS corresponds to that 
of pure DMSO what we interpret as dissolved peptide. Count rates for both pure TBS and 
DMSO are indicated for reference. (B) PDI of the same measurements. At a TBS content below 
50% (v/v) the polydispersity escalates accordantly to the decrease in count rate in A. 
assemblies is likely representing a minor part of all peptide molecules. Above 40% (v/v) 
DMSO, the signal basically corresponds to that of pure DMSO what we interpreted with 
monomeric peptides. The observed molecule size slightly increased at 20 and 30% (v/v) 
DMSO and ultimately dropped again above. A very similar dependence on the DMSO 
content of the solvent is apparent for the PDI of the investigated peptide solutions (Fig. 
4.8B). The samples show a very high polydispersity and, more importantly, a large  
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Fig. 4.9. Static light scattering of 
pen-Antp and its variants. 
Pen-Antp and pen-AYL both 
with and without salt show an 
approximately linear correlation 
between concentration and 
light scattering, implying a 
monomeric state at the given 
conditions.  
In contrast, pen-A(pY)L in both 
conditions and pen-2AL show a 
clearly increased signal at 1 mM, 
but not at lower concentrations. 
 
 
 
fluctuation in solvent with a DMSO content of ≥50% (v/v). The large fluctuation might 
be explained by the absence of a scattering signal and thus an insufficient precision of 
the method for peptide monomers. Formation of peptide clusters is then further 
indicated by the decrease of the PDI to approximately 0.3 at a DMSO content of ≤50% 
(v/v). 
 
4.3.5. Static light scattering of peptide solutions 
In order to compare the signs for assemblies of the amphipathic peptide at 
concentrations >100 µM, the data obtained from the Tryptophan fluorescence with a 
distinct technique, we harnessed static light scattering (SLS) of the same peptide 
solutions. The solutions were irradiated with monochromatic light with a wavelength of 
400 nm, thereby avoiding specific absorption by atomic groups of the peptides 
(specifically, Tyr and Trp around 280 nm and the peptide bond around 230 nm). As the 
scattering of light is dependent on the 6th power of the diameter of the scattering 
particle, the signal intensity is expected to linearly increase with the peptide 
concentration for monomeric peptides. The signal by peptide clusters, however, is 
expected to increase non-linearly because of increasing size of the particles. With only 4 
concentrations for every peptide and the low signal with diluted solutions, however, we 
lack in sufficient data for a quantitative analysis such as Zimm plots.  
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Fig. 4.9 shows the results of SLS. For reference of a monomeric peptide solution, 
we included solutions of pen-Antp as well. The light scattered by pen-p2AL and pen-
AYL either with or without salt had similar intensities as the corresponding pen-Antp 
solutions indicating a monomeric state for those peptides at the given conditions as 
well. In contrast, both pen-A(pY)L solutions scattered approximately 4 times more at 
concentrations >100 µM, which in turn correlates with the blue shift of the Trp emission 
of these solutions (see Tab. 4.9). Overall, the pen-2AL peptide showed the least 
scattering of all peptides. 
 
4.3.6. Sedimentation velocity by analytical ultracentrifugation of peptide solutions 
Theoretical background. 
The Brownian motion of a dissolved macromolecule, such as a peptide, depends on 
a number of factors including its physical properties such as mass, shape and density 
(mathematically described by the Einstein–Smoluchowski relation). On the other hand, 
its diffusion in a solvent is described by Fick’s Laws. When an external force, such as 
centrifugal force, is applied, the peptide then moves with a certain velocity against 
diffusion and flotation described by the sedimentation flux. Thus, we can obtain a 
peptide’s mass by investigation of its migration during centrifugation. This fact forms 
the basis for determination of several parameters such molecular mass, shape or size 
distribution by analytical ultracentrifugation (AUC).  
In an actual AUC experiment, sample cells get loaded with the sample solution 
assuming a homogeneous distribution of the dissolved molecule of interest across the 
cell. Optical detection of the peptide distribution is done by either absorbance 
measurements if it exhibits a chromophore or by interference created by differences of 
the refractive index in the solution caused by the molecule. In both cases, the signal 
from the sample cell is obtained by comparison to a reference cell containing only 
buffer. By applying centrifugal force the dissolved molecules then sediment to the 
bottom of the cell. Visually, sedimentation can be followed by the moving boundary of 
the dissolved peptide. Numerically, both the diffusional flux (𝑗𝐷(𝑟); defined by Fick’s 
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law) and the sedimentation flux (𝑗𝑠(𝑟)) of a molecule in a volume located at 𝑟 into a 
neighboring volume at 𝑟 + 𝑑𝑟 are described by 
𝑗𝐷(𝑟) = −𝐷 𝑑𝑐𝑑𝑟 
𝑗𝑠(𝑟) = −𝑠𝜔2𝑟𝑐(𝑟) 
with 𝐷 as the diffusion coefficient, 𝑠 as sedimentation coefficient, 𝑐 as molecule 
concentration and 𝜔 as angular velocity of the rotor. Using these two equations and 
further assuming a sector-shaped cell, the Lamm equation 
𝑑𝑐
𝑑𝑡
= 1
𝑟
𝑑
𝑑𝑟
�𝑟𝐷
𝑑𝑐
𝑑𝑟
− 𝑠𝜔2𝑟2𝑐� 
can be derived, which describes the evolution of the concentration distribution between 
the meniscus and the bottom of the cell in a centrifugal field over time. Computed 
analysis of the Lamm equation can be done on a regular PC using a dedicated software 
tools (e.g. Sedfit (7)). 
 
Sedimentation velocity experiments. 
We investigated the dissolved peptide in order to gain further insights into the 
actual mass or size distribution of the peptide assemblies observed at concentrations 
above 100 µM. Therefore, a sedimentation velocity experiment was performed. 
Importantly the time required for interference detection of the entire cell is much shorter 
as compared to absorbance detection (~1 s vs ~90 s, depending on settings) which is 
important when 7 cells are measured in series, especially in case of rapidly sedimenting 
particles. For this reason, we switched to interference detection because it is able to scan 
the cells more rapidly. A typical result is depicted in Fig. 4.10 where the first 10 plus 
every 10th from 20 to 100 scans of 100 µM pen-A(pY)L in TBS are shown. The absence 
of a moving sedimentation boundary suggests either complete sedimentation of the 
peptide to the bottom of the cell faster than the instruments time resolution or that the  
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Fig. 4.10. AUC data of scans 1-10 and every 10th from 20 to 100 of 100 µM pen-A(pY)L in TBS. 
(Top) Raw data from interference detection which has been fitted between the indicated 
limits. No sedimentation is detected. (Middle) Residuals of the fit. (Bottom) Calculated size 
distribution of the sample which could not succeed due to the absence of the sedimentation 
boundary. 
 
Fig. 4.11. AUC data of scans every 50th scan from 1 to 951 of 100 µM pen-A(pY)L in 20 mM 
Tris pH 7.4. (Top) Raw data from interference detection which has been fitted between the 
indicated limits. Also over the time course of 2 h no sedimentation is observed. (Middle) 
Residuals of the fit. A size distribution could not be calculated due to the absence of the 
sedimentation boundary.  
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Fig. 4.12. AUC data of every 10th from the first 100 scans of 100 µM pen-AYL in 20 mM Tris 
100 mM NaCl pH 7.4. (Top) Raw data from interference detection which has been fitted 
between the indicated limits. There is a visible boundary movement which is spun to the 
bottom in less than 15 min. (Middle) Residuals of the fit. 
 
Fig. 4.13. AUC data of the first 10 scans of 100 µM pen-AYL in 20 mM Tris 100 mM NaCl pH 
7.4. (Top) Raw interference data which has been fitted between the indicated limits. (Middle) 
Residuals of the fit. (Bottom) Size distribution of the sample showing the calculated 
sedimentation coefficients peaks with the corresponding indicated molecular mass.  
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molecules/assemblies are too small to sediment at the specific rotational speed and 
duration. The same observation was made if more scans were made (see Fig. 4.11) – we 
therefore chose to simply show the raw data as detected by IR. 
After the AUC run of pen-AYL without salt, we further performed a concentration 
determination of the supernatant by means of Trp absorption to assess how much of the 
peptide might have sedimented to the bottom. Whereas the amount of the 1 µM peptide 
solution could not be detected because of insufficient signal intensity, we found peptide 
concentrations of 5.2 and 85 µM in the supernatant that was identical to the initial 
peptide concentrations in the cell of 5.0 and 84 µM (as determined prior the 
sedimentation velocity run; see Tab. 4.6), respectively. This suggests that no 
sedimentation of the peptide occurred. 
In contrast, when adding salt, the 100 µM pen-AYL in TBS solution showed 
detectable sedimentation. Data of the first 100 scans shows practically no change in 
sedimentation any longer after 15 minutes (Fig. 4.12). Because of the very fast 
sedimentation at only 3000 rpm, the fitted size distribution and the mass of the 
sedimented particles have poor precision and thus high residuals in the fit. The first 10 
scans are shown in Fig. 4.13 and show a better time resolution of the sedimentation 
boundary movement. Numerical analysis of these data with Sedfit renders two main 
peaks with masses of 149 kDa and 2.4 MDa which correspond to clusters of 54 and 870 
peptides, respectively (mpen-AYL = 2.77 kDa). In addition, the integral point to a much 
larger fraction at higher molecular masses which suggests that the peptide can cluster to 
even larger sizes as well. 
 
 
4.4. Discussion 
Aqueous solutions of the pen-pA(pY)L peptide showed formation of a gel-like state 
when prepared at low millimolar concentration (Fig. 4.1). This behavior was not 
observed for diluted solutions (< 1 mM) of the peptide. Because peptide aggregation 
might cause side-effects in bio-medical applications, we were interested in exploring the 
responsible mechanism that leads to the observed behavior. 
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From a physicochemical point of view (16) the peptide is not necessarily prone to 
aggregation. It contains a total of 5 basic amino acids (2 Arg and 3 Lys, compare Tab. 
4.1) which overall make it highly positively charged at the used pH despite the presence 
of a negatively charged phosphate group on the Tyr10. Because of that we would expect 
the peptide to rather repulse itself and not cluster in any way. 
In this chapter, we used various methods, namely DLS, SLS, Trp fluorescence and 
AUC, to describe both size and conditions required for the observed peptide clusters. 
 
SLS shows increased scattering only of the 1 mM pen-A(pY)L solution. 
In first experiments to investigate the potential presence of peptide clusters, we 
used SLS. Only the 1 mM pen-A(pY)L solutions showed markedly increased scattering 
whereas the other solutions basically had same signal intensity. The absence of NaCl in 
the peptide solutions had no pronounced effect beside that the signal of the 1 mM pen-
A(pY)L solution had a smaller fluctuation upon repeated measurements. This is a first 
indicator that ionic interactions may not be responsible for the clustering of the peptide. 
We also conclude that only the 1 mM pen-A(pY)L solutions contain peptide clusters 
that are scatter light significantly. Ultimately this is also reflected by its gel-like state on 
a macroscopic scale. 
 
The DLS data shows presence of some assemblies in solutions of both pen-AYL and 
pen-pA(pY)L. 
Investigation of 100 μM and 1 mM peptide dissolved in TBS by means of DLS 
showed the presence of smaller particles with a size distribution between 20 and 120 
nm, but also some larger particles with sizes up to 1 μm. The fraction of large particles 
increased for 1 mM pen-AYL. Especially for concentrations <1 mM, the technique is 
not sensitive enough to measure the ratio of monomeric peptides (like pen-Antp with an 
estimated hydrated diameter of ~1 nm) and larger assemblies. The high content of basic 
amino acids rather suggests charge repulsion between the molecules than some sort of 
attractive force that may lead to the observed cluster formation. Drin et al. describe both 
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pen-Antp and pen-2AL as monomeric at concentration of ≤130 μm (3), although 
without providing data for this assumptions. 
Comparison of the size distribution between pen-AYL and pen-A(pY)L shows no 
obvious differences beside the aforementioned increased number of larger particles for 
1 mM pen-AYL. Pen-A(pY)L basically shows the same size distribution at both 
concentrations. The PDI of every measurement was high with values between 0.45 and 
0.65 which indicate a high polydispersity regarding the size of the registered particles, 
but only low count rate and thus total number of scattering particles. Note that the 
potential signal of a monomeric peptide population may be overshadowed in the 
presence of already a few of the larger particles. We therefore cannot conclude the 
absence of monomeric peptide per se but notice the presence of larger sized particles 
which are assumed to be clusters of peptide. Taking further into account that we could 
not detect a prominent scattering signal of the pen-AYL solutions by means of SLS we 
assume that the observed particles are present in rather low numbers compared to the 
monomeric state. 
 
The presence of large particles could be dissolved with increasing DMSO content. 
The particles detected in all peptide TBS solutions could be dissolved by increasing 
contents of DMSO. Particle dissolution was observed at a DMSO content of ≥50% 
whereupon no particles could be detected anymore i.e. the measured signal 
approximated the value of pure solvent. The dissolution in a less polar solvent 
(compared to TBS) indicates a preference of these peptides for a nonpolar environment, 
which is an indication for hydrophobic interaction as reason for their clustering which 
might be the result of amphipathic self-association of the peptides. 
 
Adsorption of pen-Antp to quartz cuvette surface is negligible. 
Prior to the spectroscopic investigation of the peptide solutions we established the 
settings for proper conditions to determine Trp fluorescence emission shifts. Prior to 
that, we looked into potential adsorption of the pen-Antp to the quartz glass surface. 
Occurrence of peptide adsorption of polycationic peptides, such as CPPs, to glass or 
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fluorocarbon surfaces can introduce measurement errors as described already by several 
authors (9-11). 
If pen-Antp adsorbed to glass surface, we would measure a decrease in the free 
peptide over time using spectrophotometric measurements. As this is expected to 
correlate with a corresponding decrease in fluorescence we assessed the absorption of 
pen-Antp to quartz glass by the decline in Trp fluorescence over time. According to our 
results, the peptide adsorbs only little to the glass surface because Trp fluorescence 
decreased by ~15% over 10 min when constantly stirred (Fig. 4.5A). Trp fluorescence 
decrease was much more pronounced when the solution was not stirred. The signal loss 
was around 60% in absence of a magnet (Fig 4.5A). However, this signal loss could be 
largely avoided by doing a single fluorescence excitation every 30 s instead of a 
constant excitation (Fig. 4.5B). This led us to the assumption that the observed 
fluorescence decrease is not mainly caused by adsorption of the peptide but by 
bleaching of the indole group. Incubation of the quartz cuvette with 1% (w/v) PEI prior 
these measurements accordingly managed to prevent only a minor signal decrease of 
~10%. 
Adsorption of pen-Antp to quartz glass surface therefore did not seem to interfere 
enough in our experimental setup to be further considered. 
 
Trp fluorescence emission of pen-2AL resembles that of free L-Trp. 
The maximum wavelength of fluorescence emission of the Trp indole moiety is 
dependent on the polarity of its environment. When brought into a nonpolar proximity, 
the Trp emission maximum shifts to shorter wavelengths. We harnessed this feature to 
gain more insight into possible clustering of the pen-Antp variants investigated during 
foregone studies (see chapter 2 and 3). The sequence of Pen-2AL is different from pen-
AYL only by an Ala at position 10 and was described as a monomeric random coil 
peptide in aqueous buffer solution (3). Accordingly, we expected its Trp emission 
maximum to remain close to 351 nm at all conditions. Our measurements confirmed 
this assumption and provided us thereby with an actual reference value for a monomeric 
peptide.  
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Trp fluorescence emission of pen-AYL mostly resembles pen-2AL emission. 
Pen-AYL shows the same nominal charge of +5 as pen-2AL. Just from structural 
considerations we expected the peptide to show the absence of a pronounced 
fluorescence emission shift like with pen-2AL. Overall, our results agree with this 
assumption and show mostly a maximal emission at wavelengths around 352 nm which 
suggest a polar proximity. There were, however, two noteworthy exceptions. We 
observed for both 100 µM and 1 mM pen-AYL in TBS and without salt, respectively, 
significant blue shifts of several nm which could be a sign for the 20-100 nm assemblies 
observed in DLS. 
 
Only 1 mM pen-A(pY)L solutions show a significant blue shift in Trp emission. 
In contrast to the other peptides, pen-A(pY)L includes a negative charge by its 
phosphorylated Tyr10. As this is the only structural difference to the pen-AYL peptide, 
the observed aggregation of its 1 mM solution should be linked to the addition of the 
phosphate group. Interestingly, the Trp emission maximum of 1 mM pen-A(pY)L 
solutions is shifted down from ~351-352 nm to ~343-344 nm, which implies a change 
of the Trp residue into a nonpolar environment. The emission spectrum of Trp is highly 
sensitive to polarity changes in its proximity and already traces of polar molecules with 
hydrogen donors are enough to establish the hydrogen bonding interaction with the 
indole group that shift the emission maximum of 350 nm. For instance, the emission 
maximum of indole in an aqueous dioxane (80% v/v) solution or cyclohexane-ethanol 
(19:1 v/v) mixture are both at ~328 nm (4,17). Note that in pure dioxane the 
corresponding emission maximum lies at 310 nm (18) and the emission accordingly 
does not shift linearly with content of polar solute. The observed ~7 nm blue shift of the 
maximum emission wavelength therefore indicates a significant change in the proximal 
polarity of the Trp residue. Additionally, such a change can only stem from neighboring 
peptides as there are no other nonpolar components in the solution. 
 The blue shift takes place to almost the same extent in both presence and absence 
of NaCl which speaks against an ionic interaction leading to the clustering of the 
peptide. On the other hand, the emission maxima reside again around 351 nm at all 
lower peptide concentrations. We therefore conclude from the Trp fluorescence data 
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that cluster formation of pen-A(pY)L seems to happen above a certain concentration 
and between 100 μM and 1 mM. Both the blue shift of Trp in the 1 mM pen-A(pY)L 
solutions and the independence of the blue shift on salt further substantiates the results 
obtained by DLS. The pen-A(pY)L peptide thus seems to self-assembly due to 
hydrophobic attraction. 
 
Almost no peptide clusters observable by means of AUC. 
We further used the sedimentation velocity mode of AUC to potentially describe 
the observed peptide clusters in more detail regarding their size and molecular mass. 
Unfortunately, the sedimentation data of both peptides at concentrations of 1, 10 and 
100 μM both in presence and absence of salt did not show noticeable sedimentation. In 
support, the ensuing concentration determination of the supernatant by means of UV-vis 
spectroscopy showed that the peptide was still present at the starting concentration 
which implies that the rotational force was too weak to move the peptide under the used 
conditions. 
We could, however, detect a moving boundary in one of the peptide solutions. 
Specifically, it was monitored in 100 μM pen-AYL TBS during the very first minute. 
Within the first couple of scans, the signal was already spun to the bottom of the cell. 
Again, similar to the observation of the same solution with DLS, the finding of 
sedimenting particles in the pen-AYL solution, but not in the pen-A(pY)L one is 
surprising, but because of the sensitivity of the interference detection this might 
represent only a fraction of total peptide molecules. 
 
4.4.1. Conclusion 
The results of this study indicate that the pen-Antp variants pen-AYL and pen-
A(pY)L may self-associate to a certain degree. The size of these clusters has a broader 
distribution between 20 nm to ~4 um as suggested by DLS. On the other hand, the bulk 
of the peptide seems to remain dissolved in either a monomeric state or very small 
clusters as shown by SLS and the almost unchanged peptide concentration of the 
supernatant after AUC. We did not investigate whether the self-association changed 
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after 1 day. As a precaution to reduce the (small) fraction of self-assemblies, all 
solutions were prepared as shortly as possible prior any measurement and prepared by a 
combination of vortexing and ultrasound. 
Driving force of the peptide interaction seems to be hydrophobic attraction which is 
rather unintuitive regarding the nominal charge of these peptides, but comprehensible 
when referring to their amphipathic, i.e. detergent-like, structure. Accordingly, absence 
of salt had no influence on the peptides’ behavior and the experiments exploiting Trp 
fluorescence suggest a change of the Trp moiety from a polar to a nonpolar proximity 
which can only be provided by the peptide itself. Furthermore, the peptide assemblies 
dissolved when brought into the less polar solvent DMSO. When comparing pen-2AL 
and pen-A(pY)L, it is evident that the phenol group seems to favor the peptide 
interaction. 
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Chapter 5: 
 
Electron-spin labels as molecular 
probes to monitor membrane leakage 
 
 
5.1. Introduction 
The basis for further understanding and exploitation of CPPs in future clinical 
applications requires the investigation of the involved mechanisms with appropriate 
techniques and models. In particular, it has been shown that limited models have 
produced misleading results because of the particular properties of CPPs. For instance, 
it could be shown that cell fixation led to peptide uptake under conditions where an 
active participation of the cell in this process seemed highly unlikely (1). Because the 
same fixation bias might have occurred in preceding studies, CPPs were expected to be 
able to translocate across a lipid membrane in a “passive” manner i.e. in absence of 
supporting proteins. Biophysical methods, in combination with various lipid membrane 
models and compositions, might thus help in clarifying whether the passive 
translocation of CPPs is likely. 
In this regard, two important points have to be considered. First, the choice of a 
correct membrane model is crucial to be able to understand which physicochemical 
properties allow the peptide to cross the lipid bilayer. It is important to realize that the 
lipid bilayer portion of a biological membrane is not simply an isotropic hydrophobic 
film, but rather an anisotropic double layer that has a variable hydrophobicity and lateral 
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pressure across its normal (2) and also suffers from curvature stress in some membrane 
models. The most prominent membrane model to investigate the effect of any 
compound on a lipid bilayer of desired lipid composition are easy-to-handle and 
thermodynamically stable unilamellar vesicles6 ((3, 4); their preparation of varying size 
is thoroughly described in chapter 1). 
Next to translocation, also the interaction between CPP and membrane itself needs 
to be monitored in order to understand the influence of different membrane 
compositions on the macroscopically observed translocation. The specific changes on 
the molecular scale thus might help in an indirect way to understand the macroscopic 
level where the sum of its parts may be observed and not only individual elements. On 
the other hand, the techniques, which measure changes on the molecular level (usually 
spectroscopic methods), are often difficult to interpret in a stringent way which is 
explained in the following. 
A widely used method for the analysis of the translocation property of CPP is the 
so-called leakage assay (5). The underlying principle for detection of peptide 
translocation across a model membrane is the following: A fluorescent molecule 
(hereafter referred as fluorescent dye or simply dye) is entrapped at a self-quenching 
concentration inside of unilamellar vesicles of desired lipid concentration (see chapter 
1 for a minute protocol). The dye-filled vesicles then get exposed from the outside to 
CPPs of choice that eventually bind to the lipid membrane depending on molecular 
properties, such as both peptide and membrane surface composition/charge (6). 
Whenever the peptide manages to destabilize the membrane and/or travel across the 
membrane it is assumed that this process concomitantly leads to an influx of the 
peptide, but the measurement records only the efflux of the fluorescent dye which had 
been trapped inside of the vesicles. The dye gets diluted to concentrations below the 
quenching concentration limit and this can be conveniently detected by measuring the 
vesicle sample by means of a spectrofluorometer. 
                                                 
6 Also referred to as liposomes. Note that liposome is a general term for spherules made of lipid 
bilayer(s) without indication of size and lamellarity. It is thus suggested to clearly specify if the vesicles 
are either uni- or multilamellar, and which size they have (i.e., small, large or giant vesicles with 
according diameters of 30, 100 and >500 nm, respectively). 
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This method is very sensitive, and a spectrofluorometer is very convenient and easy 
to both apply and interpret. It therefore has become a popular method to demonstrate the 
effect of CPPs on model membranes. However, the method has some limitations when 
used with CPPs which can lead to eventual misinterpretation. First and especially 
delicate is the amount of dye leakage which is not necessarily reflecting similar 
proportions in peptide translocation across the membrane. Instead, it is an indication 
that the CPP at least temporarily destabilizes the lipid bilayer sufficiently in order to 
allow the dye escape from the lipid vesicle.  
A second point to take into account is the ionic strength of the enclosed volume. 
Standard protocols usually include a concentration of >50 mM of di-, tri- and tetravalent 
dyes ((5, 7-9) for comparison) which correspond to considerable charge difference 
between both sides of the membrane. For example, we assume a charge of -4 for calcein 
at neutral pH, so that the ionic strength of a 50 mM solution is 400 mM (excluding other 
ions). The difference in ionic strength in- and outside of the vesicle then establishes a 
transmembrane potential which can also lead to increased membrane permeation (10). 
Thirdly, negatively charged fluorescent dyes such as calcein or carboxyfluorescein 
are prone to electrostatic interaction with CPPs as they are highly positively charged. 
We thus monitored either gain or loss in fluorescent signal intensity for various dyes in 
presence of CPPs. Such effects may then bias the calculation of the dye leakage (e.g. 
mask dye leakage), leading potentially to measuring artifacts (see Fig. 1.1 e-f in 
chapter 1 for reference). 
Overall, the dye leakage method is based on a good approach by monitoring the 
membrane permeability in presence of the CPP. It carries however some inherent 
limitations e.g. by using negatively charged7 fluorescent dye molecules that lead to 
peptide-dye interaction which may distort fluorescence emission of the dye. Thus, 
complementary methods would be helpful to include reporter molecules that do not 
                                                 
7 Alternatively, a positively charged fluorescent dye such as divalent propidium iodide (which is 
hazardous, like all chemicals binding selectively to DNA) could be enclosed in the vesicles. In this case, 
however, negatively charged lipids such as POPG should be omitted in the lipid composition to prevent 
interaction of the dye with the membrane. In turn, this compromises the resemblance to eukaryotic cell 
membranes as these usually show a content of negatively charged lipid around 20% (see Pankov (2006) 
(11. Pankov R, Markovska T, Antonov P, Ivanova L, Momchilova A. 2006. Chemico-Biological 
Interactions 164: 167-73)). 
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interact with CPPs so that the signal would not be biased. Humphries proposed an 
interesting approach in this regard using the nitroxide spin label TEMPO-choline to 
detect complement-induced lysis of multilamellar vesicles by means of electron 
paramagnetic resonance (EPR) (12). The main advantage here is the use of a spin label 
which comes in the form of a nitroxide-based, persistent radical of low positive or 
absent charge thus not being prone to electrostatic interaction with the CPP. The 
following chapter therefore summarizes our attempt to establish an EPR based assay to 
monitor the permeabilization property of CPPs on model membranes. 
 
 
5.2. Materials and methods 
Materials. 
The various spin labels, the fluorophores calcein and ANTS as well as the detergent 
Triton X-100 were all purchased from Sigma-Aldrich (Buchs, Switzerland). DPX was 
supplied by Molecular Probes (Eugene, OR). Lipids for preparation of large unilamellar 
vesicles (LUVs) were obtained from Avanti Polar Lipids (Alabaster, AL). Disposable 
micropipettes for EPR spectroscopy were purchased from BRAND (Wertheim, 
Germany). 
 
Preparation of spin label solutions. 
Each spin label stock solution was prepared by weighing appropriate amounts 
producing concentrations of 100 mM upon dissolution in 5 mL. For this purpose, the 
dry amounts were dissolved in 4.5 mL buffer (20 mM Tris 100 mM NaCl pH 7.4; TBS) 
and the pH was adjusted to 7.4 (or pH 5 for the solution of 4-amino-TEMPO). 
Thereafter, buffer was added to make the final volume of 5 mL. Solutions of lower spin 
label concentration (i.e., <100 mM) were prepared by dilution of the stock solution with 
TBS. The stock solutions were stored in glass vials and protected from light with 
aluminum wrap. 
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Preparation of LUVs. 
Lipid vesicles were prepared as described in chapter 1 and 2 and were composed of 
POPC/POPG/DOPE-PEG (76:20:4 n/n) mixtures. Loading of LUVs with spin label was 
done by suspending the dried lipid film with 1 mL of the corresponding spin label stock 
solution (100 mM). Lipid suspensions were made by alternating gentle stirring using a 
vortex mixer and equilibration intervals of ~5 min until all lipid was suspended as 
assessed by visual inspection. 
 
Fluorescence spectroscopy. 
The fluorescence measurements were performed with the same procedure and 
settings as described in chapters 1 and 2. 
 
EPR spectroscopy. 
The spectra were recorded on a MS100 benchtop EPR spectrometer manufactured 
by Magnettech (Berlin, Germany) using a microwave irradiation of 9.4 GHz. Samples 
were measured in disposable 50 μL micropipettes, sealed with putty and subsequently 
placed in the measurement cavity of the instrument. For measurement of the microwave 
irradiation, we used a 53181A frequency counter from Agilent (Santa Clara, CA). 
Spectra were recorded with the following parameters: center field at 337 mT; field 
sweep of 6 mT over 60 s; power attenuation of 11 dB; receiver gain of 20. The denoted 
amplitudes and linewidths all correspond to the middle peak of the resonance signal. 
 
 
5.3. Results 
5.3.1. Binding of pen-AYL to Calcein reduces its fluorescence signal in a 
concentration dependent manner 
The principle of fluorescence leakage assays resides on the concentration dependent 
signal of these dyes. This behavior is exemplified in Fig. 5.1 by the common fluorescent  
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Fig. 5.1. Concentration dependence of calcein fluorescence emission intensity (orange 
diamonds) (PMT 200 V). The dye has its emission maximum at ~100 µM and is increasingly 
quenched at higher concentrations. The green diamonds show the same dependence in 
presence of 250 µM POPC/POPG (3:1 n/n) LUVs which do not significantly interfere with the 
calcein fluorescence emission. 
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Fig. 5.2. Fluorescence emission intensity of 30 µM calcein in dependence of pen-AYL 
concentration (average of triplicate, PMT 220 V). 30 µM calcein corresponds to a reasonable 
final concentration after full vesicle lysis in a leakage assay. It is apparent that the calcein signal 
is strongly diminished in presence of pen-AYL concentrations above 10 µM with almost full 
quenching at 100 µM. 
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dye calcein. The signal intensity has a maximum around 100 µM and gets increasingly 
quenched with increasing dye concentration (self-quenching). Accordingly, the 
concentration at which the dye is enclosed in the vesicles of desired lipid concentration 
has to be carefully calculated so that release of the dye produces a concentration of 
maximum signal or concentrations below. At these conditions, the 
concentration/fluorescence intensity correlation should be linear and thus appropriate to 
quantify the leakage. 
Instead, we have found that this relation is not linear, because fluorescence 
emission of negatively charged dyes was considerably disturbed in presence of CPPs. 
Fig. 5.2 shows the fluorescence signal of a 30 µM calcein solution in presence of the 
pen-Antp mutant pen-AYL with increasing CPP concentration. The calcein signal starts 
to decrease at a pen-AYL concentration slightly below 10 µM and is reduced to only 
11% of its original intensity at 120 µM pen-AYL. These concentrations are 
characteristic for the experiments done in chapter 2 which shows that the interaction 
between dye and peptide may severely bias the results derived from the 
permeabilization assays. This observation is fundamental, because the quenching of the 
dye starts at low micromolar peptide concentration which is equivalent to CPP 
concentrations commonly observed to be taken up by living cells. Whereas pen-AYL 
manages to permeabilize model membranes at this concentration (as shown in chapter 
2), it thus cannot be measured to what extend the dye had been released. 
 
5.3.2. ANTS fluorescence is increased in presence of pen-Antp mutants 
8-aminonaphthalene-1,3,6-trisulfonic acid (ANTS) is another negatively charged 
fluorescent dye molecule which is commonly used in fusion and leakage assays, usually 
in combination with its quencher p-xylene-bis-pyridinium bromide (DPX) (13). In 
analogy to calcein, we found that ANTS interacts with pen-Antp and its mutants as 
well, but in contrast to calcein its fluorescence intensity is increased upon interaction 
with the CPP. Fig. 5.3 shows the titration of 75 µM ANTS 270 µM DPX with 
increasing concentration of either pen-AYL or pen-A(pY)L. The increase in  
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Fig. 5.3. Fluorescence emission intensity of 75 µM ANTS 270 µM DPX in presence of 
increasing concentration of pen-AYL and pen-A(pY)L (average of triplicate, PMT 400 V). 
In contrast to calcein, interaction of the peptides with ANTS increases the fluorescence 
intensity. This effect is more pronounced with the phosphorylated pen-A(pY)L peptide. Note 
that the increase in fluorescence manifests itself again at a peptide concentration ≥10 µM. 
fluorescence signal intensity as induced by pen-A(pY)L is considerable. For example, 
the fluorescence intensity in presence of 100 µM pen-A(pY)L is doubled as compared 
to 10 µM pen-A(pY)L, whereas the increase with 100 µM pen-AYL is only 33%. These 
experiments support our hypothesis that negatively charged dyes may interact 
electrostatically with CPPs, thereby changing their fluorescence intensity both 
positively or negatively. The critical concentration for this to happen starts at 
concentrations as low as 10 µM. In conclusion, the leakage assay might be appropriate 
to demonstrate membrane permeabilization, whereas fluorescence quenching by CPP 
binding might bias its proper quantification (or even mask the release). Alternate 
methods thus appear certainly complementary. 
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Fig. 5.4. EPR signal of 4-amino-TEMPO in dependence of concentration. Shown is the first 
derivative of the actual absorption lines. Below 10 mM the signal amplitude increases with 
spin label concentration (reddish lines). Above 10 mM, instead the line width starts to increase 
(green lines) due to electron-spin exchange. 
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Fig. 5.5. Concentration dependence of the linewidth of the middle peak of the EPR signal of 
4-amino-TEMPO. The linewidth is independent of the spin label concentration below 10 mM. 
(Inset) Concentration dependence of the amplitude of the middle peak. The amplitude 
increases with concentration up to 10 mM where the broadening of the linewidth starts to 
counteract. The signal of the two points at 100 and 130 mM is higher than that of lower 
concentrations because the lines coalesce due to electron-spin exchange (see Fig. 5.4 at 100 
mM).  
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5.3.3. Using paramagnetic spin labels as probe for membrane permeabilization  
The concept of using EPR instead of fluorescence spectroscopy for the leakage 
assay is based on the different physical property of the molecular probe. Whereas the 
emission of the fluorophore was found to be changed upon electrostatic interaction with 
the CPP, it is likely that such a peptide-induced signal change can be avoided by using 
larger reporter molecules (instead of charged molecules) that do not cross the membrane 
because of their size (instead of charge). Inside the vesicles, the reporter molecule is 
chosen also at high concentration so that its mobility is hindered (with consequences on 
the correlation time). Upon dilution into the extravesicular space (e.g., upon membrane 
destabilization with CPPs), the reporter gets diluted causing a change in correlation 
time. In principle, these changes could be also detected with fluorescence correlation 
spectroscopy (FCS) of FITC-labeled dextran, for example, but the FCS was not as 
easily available – in contrast to the EPR instrument. 
The concentration dependence of the EPR signal of 4-amino-TEMPO is shown in 
Fig. 5.4. The spectra are obviously characteristically different from the fluorescence 
spectra where only the signal intensity correlates with the concentration of the 
fluorophore. A linear increase in signal with concentration is observed in the EPR 
spectra as well (compare also Fig. 5.5). Above 10 mM, the unpaired electrons get into 
proximity and start to interact with each other (electron-spin exchange) leading first to 
broadening of the spectral line at intermediate concentrations and ultimately to 
coalescence at >75 mM (Fig. 5.5). Accordingly, the concentration of the enclosed spin 
label was calculated for the leakage assays, so that dilution as caused by CPP-induced 
leakage produces a sufficient difference between the two states of intact vesicles 
containing highly concentrated spin label and permeabilized and/or solubilized vesicles 
with diluted spin label in bulk solution, i.e. intravesicular concentration of >10 mM, and 
amount of lipid vesicles, such as to produce a concentration of the spin label to the 
linear range of <10 mM upon complete vesicle leakage 
Obviously, it is possible to assess either the signal amplitude or spectral linewidth 
of the TEMPO resonance to detect membrane permeabilization. We decided to use the 
dependence of the linewidth because the half-width is not as influenced by smaller 
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differences in sample volume of radiofrequency excitation. Also, the linewidth is less 
prone to ambiguity, because the signal amplitude decreases at both above and below the 
concentration of maximum signal intensity. The middle peak of the resonance signal 
was chosen because of highest signal-to-noise ratio (all three peaks share the same 
linewidth at concentrations below 100 mM) and will further simply referred to as 
“linewidth”. 
 
5.3.4. The EPR signal of TEMPO is stable in the presence of pen-Antp mutants 
As a first experiment, it was tested whether the EPR based permeabilization assay 
is biased by varying CPP concentrations. Also, the concentration dependence of the 
nitroxide label must not change in presence of both the CPP of interest and model 
membranes such as LUVs. It was found that the CPP did not disturb the EPR signal as 
shown for 10 mM TEMPO in Fig. 5.6 where the linewidth remains constant in presence 
of either lipid vesicles (POPC/POPG/DOPE-PEG (76:20:4 n/n) LUVs) or peptide (pen-
AYL or pen-A(pY)L). Concentrations of either component were chosen in the range 
where they would be used in a potential permeabilization assay. 
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Fig. 5.6. Linewidth (of the middle peak) of 10 mM TEMPO in presence of lipid vesicles (A) or 
CPP (B). The signal resides at ~0.15 mT independently of the presence of either model 
membranes or CPP. The orange diamond on the y-axis is the linewidth of 10 mM TEMPO in 
buffer (TBS). (A) Lipid composition of LUVs is POPC/POPG/DOPE-PEG (76:20:4 n/n). (B) Added 
CPPs were pen-AYL (red diamonds) or pen-A(pY)L (blue diamonds). The independence of the 
spin label resonance in presence of the used CPP concentration is a clear improvement as 
probe for membrane permeabilization in comparison to fluorescent dyes which are susceptible  
for CPP-induced signal changes.  
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5.3.5. Preparation of nitroxide spin label-loaded vesicles 
In order to investigate the CPP-induced membrane permeabilization by EPR, lipid 
vesicles with encapsulated spin label were prepared. In a first trial, preparation of 
TEMPO-loaded LUVs was done in the same way as for vesicles loaded with fluorescent 
dye (see chapter 1 for detailed description). We successfully managed to gather the 
LUVs after size size-exclusion chromatography (SEC) over a column as confirmed by 
both dynamic light scattering (DLS) and determination of the lipid concentration of the 
eluate by means of colorimetric phosphate assay. However, when the lipid-containing 
fractions were investigated on their EPR signal we could not detect any TEMPO. The 
spin label is apparently hydrophobic enough to simply diffuse across the vesicle 
membrane into the elution buffer. We therefore used various spin label derivatives that 
were either positively charged or covalently bound to polar molecules with large 
molecular mass to prevent passive diffusion from the LUVs. 
 
4-amino-TEMPO. 
This TEMPO derivative was chosen because of its amine group which is expected 
to be charged at the used pH of 7.4. We suspended the lipids in a 130 mM stock 
solution of 4-amino-TEMPO. Although we detected the presence of spin label in the 
LUV-containing fractions, it seemed to escape LUVs over time. Fig. 5.7A shows 
linewidth of the 4-amino-TEMPO signal in the lipid-containing eluate at different 
concentrations prior and after the addition of the detergent Triton X-100 (5% v/v in 
ddH2O; TX100). All linewidths correspond to a 4-amino-TEMPO concentration ≤10 
mM and accordingly cannot get narrower (compare Fig. 5.5). Upon further 
examination, the corresponding amplitudes of the resonance signal (Fig. 5.7B) 
decreased with concentration as we would expect upon dilution. However, the signal 
and linewidth remained identical after the addition of TX100 which indicates that the 
spin label could not be incorporated into the vesicles at concentrations high enough that 
would restrict the motility of the molecules. The diffusion of the spin label across the 
membrane becomes also evident by a closer look to the eluate after elution of the LUVs. 
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Fig. 5.7. 4-amino-TEMPO signal of the eluate after SEC at indicated lipid concentrations. (A) 
The linewidth of the signal does not change after addition of the strong detergent TX100 (5% 
v/v). Also shown in the bottom right corner is the structure of 4-amino-TEMPO8 (B) Similarly, 
the signal amplitude remains the same after detergent addition (spectra after TX100 addition 
are identical and are therefore omitted; see text for details). We therefore assume that the 
spin label can diffuse across the membrane and the spectra depict a state where the spin label 
is equally distributed in- and outside of the LUVs. 
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Fig. 5.8. 4-amino-TEMPO signal in fractions eluted from the gel-filtration column after 
passing of the LUVs. The indicated times correspond to minutes after the last gathered LUV-
containing fraction. The signal increases with time but even closely to the LUVs some spin label 
is detected which implies constant diffusion of 4-amino-TEMPO into the elution buffer. The 
fraction of the originally excluded spin label (right after suspending the lipid) elutes 
approximately an hour after the LUVs. For comparison, the signal of the undiluted LUV-
containing suspension is shown as well. 
                                                 
8 TEMPO structures from http://www.sigmaaldrich.com 
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The signal amplitude increases steadily with time which is consistent with leakage 
along the column (Fig. 5.8). 
Preparation of 4-amino-TEMPO containing LUVs was repeated with a 130 mM 
spin label stock solution at pH 5 to ensure a charged amine group to a similar result. 
 
4-phosphonooxy-TEMPO. 
As an alternative charged spin label we investigated the negatively charged 4-
phosphonooxy-TEMPO (structure in Fig. 5.9A). In contrast to 4-amino-TEMPO, it does 
not show line broadening at a concentration up to 100 mM but the amplitude of the 
resonance increases with concentration (Fig. 5.9) as expected. However, the suspension 
of lipid with 100 mM 4-phosphonooxy-TEMPO yielded LUVs showing a resonance 
amplitude of 390 a.u. (at same radiofrequency settings) which correspond to an enclosed 
spin label concentration of ~5 mM (compare inset Fig. 5.9). Again, the signal did not 
change after TX100 addition. In contrast to 4-amino-TEMPO, however, the spin label 
did not escape into the eluate samples of the column (Fig. 5.10) indicating that not the 
escape, but the inability to incorporate sufficiently high concentrations into the LUVs 
was leading to the poor usability of the label for leakage experiments. 
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Fig. 5.9. Concentration dependence of the 4-phosphonooxy-TEMPO resonance (structure in 
top right corner). In contrast to 4-amino-TEMPO, the line broadening does not take place at 
the used concentrations. (Inset) The amplitude of the resonance increases with concentration. 
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Fig. 5.10. Resonance amplitude of supposedly enclosed 4-phosphonooxy-TEMPO (green) and 
fractions gathered at indicated time (pink) after the LUV-containing eluate. The value of the 
undiluted LUV-containing sample corresponds to ~5 mM 4-phosphonooxy-TEMPO. Free spin 
label arrives 75 after the LUVs. 
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Fig. 5.11. Concentration dependence of the linewidth of the EPR signal of PEG-bis-TEMPO. 
Concentrations were calculated by using a labeling extent of 0.5 mmol/g weighed PEG-bis-
TEMPO. 
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Poly(ethylene glycol)-bis-TEMPO. 
After finding the rather surprisingly low concentration of charged spin labels in 
LUVs we tried to detain the spin label inside the vesicles by coupling it to a polymer. 
Poly(ethylene glycol) (PEG) is a relatively hydrophilic polymer which we use 
extensively as a lipid component that prevents fusion of lipid vesicles at sufficient 
length and content (14, 15). Unfortunately, the degree of polymerization is poorly 
specified by the (few) manufacturers of the spin-labeled molecules, so that we do not 
know the exact molecular weight and thus the exact concentration of the prepared 
solutions. We can, however, make a rough estimation. The extent of labeling is declared 
as 0.25-0.75 mmol/g which we assumed to be 0.5 mmol/g for simplicity reasons. 302 
mg of PEG-bis-TEMPO were dissolved in 1 mL buffer which then would correspond to 
a 75.5 mM stock solution (two spin labels per PEG chain). Fig. 5.11 shows the 
linewidths of a dilution series of this stock solution which are similar to the linewidths 
of 4-amino-TEMPO. For instance, PEG-bis-TEMPO has linewidths of 0.145 and 0.325 
mT at 9.6 and 75.7 mM, respectively, compared to 0.138 and 0.414 mT for 4-amino-
TEMPO at 10 and 75 mM, respectively. Assuming the above described estimation of 
the PEG-bis-TEMPO concentration of the stock solution we then can calculate the 
number of ethylene glycol polymerization: 302 mg dissolved in 1 mL give a molecular 
mass of 4027 Da. This corresponds to a number of about 85 ethylene glycol units that 
should be large enough to sterically prevent passive diffusion across the membrane. 
The preparation of LUVs by pressure extrusion after solubilizing the lipid with the 
PEG-bis-TEMPO stock solution was difficult and only possible by starting with 400 nm 
pore sizes and subsequent stepwise reduction in pore size of the polycarbonate filter 
over 200 to 100 nm. However, the separation of vesicles and excluded spin label was 
again not sufficient. Similar to the previous trials the concentration of detected spin 
label was constant over the whole eluate, independent of the presence of LUVs (see 
Tab. 5). Additionally, there was a transition from clearly defined LUVs (indicated by 
constant attenuator, diameter and (low) polydispersity index) to lower concentration of 
similarly sized particles with higher polydispersity (fractions 16 to 45 in Tab 5). 
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Tab. 5. DLS and EPR data of the eluate of the SEC column loaded with 40 mM lipid and 302 
mg PEG-bis-TEMPO (after extrusion). The linewidth of the TEMPO signal remains equal over 
the complete course of the column. Furthermore, the by means of DLS detected size and 
polydispersity of the particles in the eluate shifts slowly from clearly defined LUVs (Fractions 1-
14 in light green) to smaller diameters and higher polydispersity, presumably PEG-bis-TEMPO 
aggregates. The chosen column material apparently is not able to separate these two species. 
The linewidth of the detected EPR signal corresponds to an approximate concentration of 5 
mM (compare with Fig. 5.11). 
Time 
(min) 
Fraction PDI Attenuator 
average diameter 
(nm) 
linewidth 
(mT) 
0 1 0.377 11 152.15 
 
1 2 0.068 5 106.1 
 
2 3 0.051 5 114.9 
 
3 4 0.058 5 107.2 
 
4 5 0.039 5 116.7 0.120 
5 6 0.048 5 114.9 
 
6 7 0.065 5 108.3 
 
7 8 0.078 5 126.7 
 
8 9 0.064 5 117.6 
 
9 10 0.043 5 108.6 
 
10 11 0.026 5 119 0.125 
11 12 0.059 5 116 
 
12 13 0.036 5 109.7 
 
13 14 0.026 5 121.8 
 
14 15 0.035 5 112 
 
15 16 0.033 6 113.2 0.120 
16 17 0.051 6 116.2 
 
17 18 0.062 6 114 
 
18 19 0.052 6 112.6 
 
19 20 0.006 7 115.2 0.125 
25 25 0.069 7 123.7 0.120 
35 30 0.109 8 127.9 0.125 
45 35 0.266 10 112.4 0.125 
55 40 0.301 10 109.6 0.125 
75 45 0.219 10 117 0.115 
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5.4. Discussion 
Permeabilization assays as a valuable tool to demonstrate CPP-membrane interaction. 
The mechanism of CPP translocation across biological membranes inside the cell 
interior is likely not unique for the various CPPs. Earlier studies pointed at an energy-
independent uptake mechanism into living cells (16-18) which gave rise to several 
models (summarized in (19)) such as the so-called direct membrane “transduction”. 
Recent consensus on the matter, however, shows that the cationic CPPs in general are 
taken up at least to some extend by surface, adhesion, followed by endocytosis-driven 
cellular uptake and subsequent escape from the endosome (20, 21). In analogy to the 
original explanations for CPP translocation across the plasma membrane, the CPPs have 
to escape the endosome to avoid degradation in the lysosome. In order to investigate the 
translocation of the CPP it is thus crucial to both i) use an appropriate model system and 
ii) exclude possible CPP interactions with the reported model system (and thus method 
bias). 
The typical leakage assay suits the first of the criteria because of the close 
resemblance of the model membrane system such as unilamellar vesicles with the lipid 
part of a biological membrane. 
 
Apparent membrane leakage may be distorted due to fluorescent dye-CPP interaction. 
Regarding the second point, however, we observed unexpected limitations. We 
found that the fluorescence signal of the dyes calcein and ANTS is influenced by the 
presence of 10 μM or higher concentration of various CPPs (compare chapter 1 for the 
effect of nonaarginine (WR9) or pen-2AL on calcein fluorescence emission). The CPPs 
either enhanced or reduced the fluorescence intensity of the anionic fluorophore. 
Whereas calcein emission was strongly reduced (almost complete quenching in 
presence of 100 μM pen-AYL) the ANTS signal increased upon interaction with CPPs 
(e.g. 92% signal increase in presence of 100 μM pen-A(pY)L). It is thus not possible 
with the leakage assay to accurately assess the fraction of membrane leakage. These 
findings are substantial, because the peptides show uptake by living cells at this 
concentration range. 
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The signal change is most likely caused by the electrostatic interaction between the 
highly positively charged CPP and the negatively charged dye. Interestingly, the 
zwitterionic phosphorylated pen-A(pY)L increased the fluorescence intensity more than 
the more positively charged pen-AYL which might be also related to the density of the 
resulting complexes.  
As a consequence, we suggest to exclude potential intensity changes that may be 
caused by interaction of the CPP of interest and the used fluorescent dye. 
 
The EPR signal of nitroxide-based spin labels is independent of presence of CPPs. 
In order to avoid the bias of the multivalent CPP on the signal of the fluorophore, 
we replaced the fluorescent probe with a spin label that allows detection by EPR (as 
similarly performed with multilamellar vesicles by Humphries (12)). Commonly used 
spin labels in life science research areas are derivatives of stable nitroxide radicals such 
as TEMPO. 
The EPR signal amplitude of these spin labels is usually increasing with 
concentration. Its resonance amplitude shows a concentration dependence that is similar 
to fluorescent dyes that start to self-quench at a certain concentration threshold (e.g. 
~100 µM for calcein). Accordingly, the amplitude increases with spin label 
concentration until its maximum and then subsequently decreases again. In addition to 
the amplitude, also the linewidth of the resonance showed a concentration dependence 
(reflecting the motional averaging). In particular, a maximum in signal amplitude is 
observed at concentrations where spin exchange starts to take place. Even higher 
concentrations then  lead to a broadening of the linewidth. As a result, either the signal 
amplitude or the linewidth (or both together) may be used to assess membrane 
permeabilization upon vesicular release/dilution of the spin label. 
Also the EPR signal of the spin label should not change in presence of CPP. Our 
measurements show that the EPR spectrum of TEMPO indeed is independent of both 
lipid and CPP for the concentrations between 0.1 to 10 mM and 1 to 100 μM, 
respectively. Thus, the principle conditions for a robust leakage assay based on 
detection by means of EPR are given – in contrast to the leakage assay using fluorescent 
dyes and detection by means of fluorescence spectroscopy.  
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The entrapped nitroxide-based spin labels seem to leak from LUVs. 
For optimum assay performance and reproducibility of the leakage assay it is 
required that the probe compound remains enclosed in the vesicles for a period of some 
hours to days in order to differentiate dilution of the probe by passive vesicle release 
from destabilization of the lipid bilayer by an external component, such as the CPP.  
We observed that the TEMPO molecule is hydrophobic enough to diffuse across 
the lipid bilayer of model membranes such as LUVs and is therefore unsuitable as 
probe. In analogy, we could not entrap sufficient amounts of the examined TEMPO 
derivatives in LUVs. In all cases, the signal of the undiluted LUVs after gel 
chromatography was only a fraction (corresponding to <10 mM) of the signal as 
compared to the spin label stock solution (>50 mM). In support of passive diffusion 
across the membrane, we detected increasing amounts of spin label in the column eluate 
right after the LUV-containing fractions which indicate leakage over the whole course 
of the column.  
Finally, addition of detergent to the gathered LUVs did neither change the EPR 
signal amplitude nor linewidth illustrating the concentration inside the vesicles was not 
sufficiently high to cause the required motional restriction.  
 
5.4.1 Conclusion 
Usage of fluorescent dyes as molecular probe to detect leakage may be critical in 
the investigation of CPPs because the fluorescent signal is biased by the electrostatic 
interaction of the CPP with the charged dye at low micromolar concentrations that are 
biologically relevant. In contrast, the EPR signal of nitroxide-based spin labels is not 
prone to CPP-induced distortion. However, retention of the spin labels inside LUVs 
needs to be improved by custom synthesis in order to be a useful molecular probe for 
this kind of assay.  
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